Professor Matthew Kiernan | Brain Sciences UNSW

Tabs

Main

University role:

Adjunct Professor

Phone:

9382 2438

Email:

m.kiernan@unsw.edu.au

Matthew Kiernan is Professor of Neurology at the Prince of Wales Clinical School, University of New South Wales and Consultant Neurologist at the Institute of Neurological Sciences, Prince of Wales Hospital and Sydney Children’s Hospital. He is also Senior Scientist at Neuroscience Research Australia. His research team’s focus is clinical neurology, in particular disease pathophysiology and treatment strategies of neurological disorders. Currently his team is investigating the mechanisms and the possible prevention of neurodegeneration in motor neurone disease; chemotherapy-induced neurotoxicity; stroke; Machado-Joseph disease; spinal muscular atrophy and other inherited neuropathies. We are also involved in clinical trials investigating potential drug treatments for motor neurone disease, multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.

His team’s research is intrinsically linked to the provision of clinical services, particularly the Multidisciplinary Motor Neurone Disease Clinic; the Hereditary Nerve and Muscle Clinics and diagnostic neurophysiology clinics, all run through Prince of Wales Hospital. Neurological consultation and clinical neurophysiological services are also provided at the Professorial Suite, Prince of Wales Hospital.

Matthew Kiernan is the Editor-in-Chief of the Journal of Neurology, Neurosurgery and Psychiatry (BMJ Publishing Group). He is also the Vice President of the Australian Brain Foundation, the largest priming institution for neuroscience in Australia and Chairman of the Scientific Committee responsible for distributing funding towards research and medical education for the treatment and prevention of neurological disorders.

Research

Research Activity Links:

Cognition and behaviour in motor neuron disease - James Burrell

Multidisciplinary care and disease progression in motor neurone disease

Novel assessment of functional adaption and motor plasticity following stroke - Dr William Huynh

Field of Research (FOR) Tag:

Neurology and Neuromuscular Diseases

Socio-economic Objective (SEO) tags:

Neurodegenerative Disorders Related to Ageing

Media

Facebook:

http://www.facebook.com/pages/Nerve-Central-Kiernan-Lab/106472562780852

Publications related to this Person

Books

Kiernan MC, (ed.), 2007, The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

Book Chapters

Hardiman O; Kiernan MC; van den Berg LH, 2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders, Springer International Publishing, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8

huynh W; lee M; kiernan MC, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235

Vucic S; Kiernan MC, 2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138

Kiernan MC, 2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9

Farrar M; Kiernan MC, 2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), edn. 3rd, John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2

Park SB; Kiernan MC, 2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, edn. First, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3

Park SB; Kiernan MC, 2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b

Vucic O; Burke D; Kiernan MC, 2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, edn. Original, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104

Kiernan MC, 2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, edn. 1, Nova Science Publications, New York, USA, pp. 169 - 181

Lin CS; Kiernan MC; Burke D; Bostock H, 2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, edn. C, Elsevier, Amsterdam, pp. 381 - 403, http://dx.doi.org/10.1016/S1567-4231(09)70078-4

Burke D; Kiernan MC, 2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, edn. C, Elsevier, Amsterdam, pp. 927 - 943, http://dx.doi.org/10.1016/S1567-4231(09)70104-2

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy: 2-Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9

KIERNAN MC; BURKE D; BOSTOCK H, 2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9

Kiernan MC; Burke D, 2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, edn. C, Elsevier BV, The Netherlands, pp. 359 - 366, http://dx.doi.org/10.1016/S1567-4231(04)04020-1

Kiernan MC, 2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, edn. Original, Academic Press, San Diego, pp. 639 - 642

Burke DJ; Kiernan MC; Mogyoros I; Bostock H, 1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, edn. Original, Elsevier, Amsterdam, pp. 43 - 53

Burke DJ; Mogyoros I; Kiernan MC; Bostock H, 1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, edn. 7, Elsevier, Amsterdam, pp. 145 - 154, http://dx.doi.org/10.1016/j.clinph.2018.03.014

Journal articles

Tse NY; Tu S; Chen Y; Caga J; Dobson-Stone C; Kwok JB; Halliday GM; Ahmed RM; Hodges JR; Piguet O; Kiernan MC; Devenney EM, 2022, 'Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights', Journal of Neurology, vol. 269, pp. 4241 - 4252, http://dx.doi.org/10.1007/s00415-022-11049-3

Grima N; Henden L; Fearnley LG; Rowe DB; D'Silva S; Pamphlett R; Adams L; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Bahlo M; Blair IP; Williams KL, 2022, 'NEK1 and STMN2 short tandem repeat lengths are not associated with Australian amyotrophic lateral sclerosis risk', Neurobiology of Aging, vol. 116, pp. 92 - 95, http://dx.doi.org/10.1016/j.neurobiolaging.2022.04.012

De Oliveira HM; Silsby M; Jaiser SR; Lai HM; Pavey N; Kiernan MC; Williams TL; Vucic S; Baker MR, 2022, 'Electrodiagnostic findings in facial onset sensory motor neuronopathy (FOSMN)', Clinical Neurophysiology, vol. 140, pp. 228 - 238, http://dx.doi.org/10.1016/j.clinph.2022.04.020

Kiernan MC, 2022, 'Brainspotting: Adventures in Neurology', Journal of neurology, neurosurgery, and psychiatry, vol. 93, pp. 800 - 801, http://dx.doi.org/10.1136/jnnp-2022-329455

Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, vol. 30, pp. 5965 - 5974, http://dx.doi.org/10.1007/s00520-022-07024-3

Cornblath DR; Kiernan MC; Kimura J; Koltzenburg M; Lewis RA; Parry GJ; Pollard JD; Sumner AJ, 2022, 'Letter to the Editor re "Complete Foot Drop With Normal Electrodiagnostic Studies: Sunderland 'Zero' Ischemic Conduction Block of the Common Peroneal Nerve" by Peters and Colleagues.', Annals of Plastic Surgery, vol. Publish Ahead of Print, http://dx.doi.org/10.1097/sap.0000000000003245

Gallina A; Disselhorst-Klug C; Farina D; Merletti R; Besomi M; Holobar A; Enoka RM; Hug F; Falla D; Søgaard K; McGill K; Clancy EA; Carson RG; van Dieën JH; Gandevia S; Lowery M; Besier T; Kiernan MC; Rothwell JC; Tucker K; Hodges PW, 2022, 'Consensus for experimental design in electromyography (CEDE) project: High-density surface electromyography matrix', Journal of Electromyography and Kinesiology, vol. 64, http://dx.doi.org/10.1016/j.jelekin.2022.102656

Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S, 2022, 'Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis', Journal of neurology, neurosurgery, and psychiatry, vol. 93, pp. 668 - 678, http://dx.doi.org/10.1136/jnnp-2021-327909

Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2022, 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis', Brain, vol. 145, pp. 1598 - 1609, http://dx.doi.org/10.1093/brain/awac077

Goutman SA; Hardiman O; Al-Chalabi A; Chió A; Savelieff MG; Kiernan MC; Feldman EL, 2022, 'Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis', The Lancet Neurology, vol. 21, pp. 480 - 493, http://dx.doi.org/10.1016/S1474-4422(21)00465-8

Goutman SA; Hardiman O; Al-Chalabi A; Chió A; Savelieff MG; Kiernan MC; Feldman EL, 2022, 'Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis', The Lancet Neurology, vol. 21, pp. 465 - 479, http://dx.doi.org/10.1016/S1474-4422(21)00414-2

Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, vol. 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y

Carroll AS; Howells J; Lin CSY; Park SB; Simon N; Reilly MM; Vucic S; Kiernan MC, 2022, 'Differences in nerve excitability properties across upper limb sensory and motor axons', Clinical Neurophysiology, vol. 136, pp. 138 - 149, http://dx.doi.org/10.1016/j.clinph.2021.12.006

Salmon K; Kiernan MC; Kim SH; Andersen PM; Chio A; Van Den Berg LH; Van Damme P; Al-Chalabi A; Lillo P; Andrews JA; Genge A, 2022, 'The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis', Brain, vol. 145, pp. 1207 - 1210, http://dx.doi.org/10.1093/brain/awab472

Shibuya K; Otani R; Suzuki YI; Kuwabara S; Kiernan MC, 2022, 'Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets', Pharmaceuticals, vol. 15, http://dx.doi.org/10.3390/ph15040433

Zhang S; Cooper-Knock J; Weimer AK; Shi M; Moll T; Marshall JNG; Harvey C; Nezhad HG; Franklin J; Souza CDS; Ning K; Wang C; Li J; Dilliott AA; Farhan S; Elhaik E; Pasniceanu I; Livesey MR; Eitan C; Hornstein E; Kenna KP; Blair I; Wray NR; Kiernan M; Mitne Neto M; Chio A; Cauchi R; Robberecht W; van Damme P; Corcia P; Couratier P; Hardiman O; McLaughin R; Gotkine M; Drory V; Ticozzi N; Silani V; Veldink JH; van den Berg LH; de Carvalho M; Mora Pardina JS; Povedano M; Andersen P; Weber M; Başak NA; Al-Chalabi A; Shaw C; Shaw PJ; Morrison KE; Landers JE; Glass JD; Ferraiuolo L; Snyder MP, 2022, 'Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis', Neuron, vol. 110, pp. 992 - 1008.e11, http://dx.doi.org/10.1016/j.neuron.2021.12.019

D'Souza A; Wang C; Tu S; Soligo DJ; Kiernan MC; Barnett M; Calamante F, 2022, 'A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state-of-the-art tracking methods', Journal of the Peripheral Nervous System, vol. 27, pp. 67 - 83, http://dx.doi.org/10.1111/jns.12478

Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Piguet O; Kiernan MC; Rohrer JD; Ahmed RM, 2022, 'Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72', Brain Sciences, vol. 12, pp. 336 - 336, http://dx.doi.org/10.3390/brainsci12030336

Hop PJ; Zwamborn RAJ; Hannon E; Shireby GL; Nabais MF; Walker EM; van Rheenen W; van Vugt JJFA; Dekker AM; Westeneng HJ; Tazelaar GHP; van Eijk KR; Moisse M; Baird D; Al Khleifat A; Iacoangeli A; Ticozzi N; Ratti A; Cooper-Knock J; Morrison KE; Shaw PJ; Basak AN; Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Grassano M; Gotkine M; Lerner Y; Zabari M; Vourc'H P; Corcia P; Couratier P; Mora Pardina JS; Salas T; Dion P; Ross JP; Henderson RD; Mathers S; McCombe PA; Needham M; Nicholson G; Rowe DB; Pamphlett R; Mather KA; Sachdev PS; Furlong S; Garton FC; Henders AK; Lin T; Ngo ST; Steyn FJ; Wallace L; Williams KL; Neto MM; Cauchi RJ; Blair IP; Kiernan MC; Drory V; Povedano M; de Carvalho M; Pinto S; Weber M; Rouleau GA; Silani V; Landers JE; Shaw CE; Andersen PM; McRae AF; van Es MA; Pasterkamp RJ; Wray NR; McLaughlin RL; Hardiman O; Kenna KP; Tsai E; Runz H; Al-Chalabi A; van den Berg LH; Van Damme P; Mill J; Veldink JH; Heijmans BT; t Hoen PAC; van Meurs J; Jansen R; Franke L; Boomsma DI; Pool R; van Dongen J; Hottenga JJ; van Greevenbroek MMJ; Stehouwer CDA; van der Kallen CJH; Schalkwijk CG; Wijmenga C; Zhernakova S; Tigchelaar EF; Slagboom PE, 2022, 'Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS', Science Translational Medicine, vol. 14, http://dx.doi.org/10.1126/scitranslmed.abj0264

Perez-Siles G; Ellis M; Ashe A; Grosz B; Vucic S; Kiernan MC; Morris KA; Reddel SW; Kennerson ML, 2022, 'A Compound Heterozygous Mutation in Calpain 1 Identifies a New Genetic Cause for Spinal Muscular Atrophy Type 4 (SMA4)', Frontiers in Genetics, vol. 12, http://dx.doi.org/10.3389/fgene.2021.801253

Silsby M; Yiannikas C; Ng K; Kiernan MC; Fung VSC; Vucic S, 2022, 'Posturography as a biomarker of intravenous immunoglobulin efficacy in chronic inflammatory demyelinating polyradiculoneuropathy', Muscle and Nerve, vol. 65, pp. 43 - 50, http://dx.doi.org/10.1002/mus.27398

Vucic S; Wray N; Henders A; Henderson RD; Talman P; Mathers S; Bellgard M; Aoun S; Birks C; Thomas G; Hansen C; Thomas G; Hogden A; Needham M; Schultz D; Soulis T; Sheean B; Milne J; Rowe D; Zoing M; Kiernan MC, 2022, 'MiNDAUS partnership: a roadmap for the cure and management of motor Neurone disease', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 23, pp. 321 - 328, http://dx.doi.org/10.1080/21678421.2021.1980889

Kutlubaev MA; Caga J; Xu Y; Areprintseva DK; Pervushina EV; Kiernan MC, 2022, 'Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, pp. 1 - 10, http://dx.doi.org/10.1080/21678421.2022.2053721

Mazumder S; Kiernan MC; Halliday GM; Timmins HC; Mahoney CJ, 2022, 'The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review', Neuropathology and Applied Neurobiology, pp. e12845, http://dx.doi.org/10.1111/nan.12845

Lin C; Li T; Tu S; Park S; Vucic S; Kiernan M, 2022, 'TH-265. Evidence of sensory and fine motor dysfunction in peripheral and central nervous systems in Kennedy’s disease (KD)', Clinical Neurophysiology, vol. 141, pp. S171 - S171, http://dx.doi.org/10.1016/j.clinph.2022.07.451

Agarwal S; Highton-Williamson E; Caga J; Howells J; Dharmadasa T; Matamala JM; Ma Y; Shibuya K; Hodges JR; Ahmed RM; Vucic S; Kiernan MC, 2021, 'Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis', Scientific Reports, vol. 11, http://dx.doi.org/10.1038/s41598-021-81612-x

Gabery S; Ahmed RM; Caga J; Kiernan MC; Halliday GM; Petersén Å, 2021, 'Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, vol. 47, pp. 979 - 989, http://dx.doi.org/10.1111/nan.12709

Caga J; Tu S; Dharmadasa T; Tse NY; Zoing MC; Huynh W; Mahoney C; Ahmed RM; Kiernan MC, 2021, 'Apathy is associated with parietal cortical-subcortical dysfunction in ALS', Cortex, vol. 145, pp. 341 - 349, http://dx.doi.org/10.1016/j.cortex.2021.02.029

van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra HJ; Bakker OB; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker AM; Gawor K; Westeneng HJ; Tazelaar GHP; van Eijk KR; Kooyman M; Byrne RP; Doherty M; Heverin M; Al Khleifat A; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith BN; Gromicho M; Chandran S; Pal S; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Sendtner M; Meyer T; Başak N; van der Kooi AJ; Ratti A; Fogh I; Gellera C; Lauria G; Corti S; Cereda C; Sproviero D; D’Alfonso S; Sorarù G; Siciliano G; Filosto M; Padovani A; Chiò A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh RH; Bell S; Vourc’h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Mora Pardina JS; Assialioui A; Rojas-García R; Dion PA; Ross JP; Ludolph AC; Weishaupt JH; Brenner D; Freischmidt A; Bensimon G; Brice A; Durr A; Payan CAM; Saker-Delye S; Wood NW; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J, 2021, 'Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology', Nature Genetics, vol. 53, pp. 1636 - 1648, http://dx.doi.org/10.1038/s41588-021-00973-1

Kiernan MC, 2021, 'The end of the affair?', Journal of neurology, neurosurgery, and psychiatry, vol. 92, pp. 1249 - 1250, http://dx.doi.org/10.1136/jnnp-2021-328176

Devenney EM; McErlean K; Tse NY; Caga J; Dharmadasa T; Huynh W; Mahoney CJ; Zoing M; Mazumder S; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR; Piguet O; Ahmed RM; Kiernan MC, 2021, 'Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage', Frontiers in Neurology, vol. 12, http://dx.doi.org/10.3389/fneur.2021.743688

Vucic S; Ferguson TA; Cummings C; Hotchkin MT; Genge A; Glanzman R; Roet KCD; Cudkowicz M; Kiernan MC, 2021, 'Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment', Muscle and Nerve, vol. 64, pp. 532 - 537, http://dx.doi.org/10.1002/mus.27392

Di Lazzaro V; Bella R; Benussi A; Bologna M; Borroni B; Capone F; Chen KHS; Chen R; Chistyakov AV; Classen J; Kiernan MC; Koch G; Lanza G; Lefaucheur JP; Matsumoto H; Nguyen JP; Orth M; Pascual-Leone A; Rektorova I; Simko P; Taylor JP; Tremblay S; Ugawa Y; Dubbioso R; Ranieri F, 2021, 'Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia', Clinical Neurophysiology, vol. 132, pp. 2568 - 2607, http://dx.doi.org/10.1016/j.clinph.2021.05.035

Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB, 2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, vol. 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6

Vucic S; Henderson RD; Mathers S; Needham M; Schultz D; Kiernan MC; Mekhael L; Ryder J; Orden B; Menon P; Pavey N; Higashihara M; Dharmadasa T; Huynh W; Ramsey E; Zoing M; Mazumder S; Thornton N; Hall LA; Allcroft P; Toubia M; Hopkins S, 2021, 'Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study', Annals of Clinical and Translational Neurology, vol. 8, pp. 1991 - 1999, http://dx.doi.org/10.1002/acn3.51446

Caga J; Devenney E; Huynh W; Zoing MC; Ahmed RM; Kiernan MC, 2021, 'Illness Cognitions in ALS: New Insights Into Clinical Management of Behavioural Symptoms', Frontiers in Neurology, vol. 12, pp. 740693, http://dx.doi.org/10.3389/fneur.2021.740693

Kang A; Arnold R; Gallagher M; Snelling P; Green J; Fernando M; Kiernan MC; Hand S; Grimley K; Burman J; Heath A; Rogers K; Bhattacharya A; Smyth B; Bradbury T; Hawley C; Perkovic V; Krishnan AV; Jardine MJ, 2021, 'Effect of hemodiafiltration on the progression of neuropathy with kidney failure: A randomized controlled trial', Clinical Journal of the American Society of Nephrology, vol. 16, pp. 1365 - 1375, http://dx.doi.org/10.2215/CJN.17151120

Suzuki YI; Ma Y; Shibuya K; Misawa S; Suichi T; Tsuneyama A; Nakamura K; Matamala JM; Dharmadasa T; Vucic S; Fan D; Kiernan MC; Kuwabara S, 2021, 'Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation', Journal of Neurophysiology, vol. 126, pp. 840 - 844, http://dx.doi.org/10.1152/jn.00083.2021

Vucic S; Pavey N; Haidar M; Turner BJ; Kiernan MC, 2021, 'Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS', Neuroscience Letters, vol. 759, pp. 136039, http://dx.doi.org/10.1016/j.neulet.2021.136039

Nathani D; Spies J; Barnett MH; Pollard J; Wang MX; Sommer C; Kiernan MC, 2021, 'Nerve biopsy: Current indications and decision tools', Muscle and Nerve, vol. 64, pp. 125 - 139, http://dx.doi.org/10.1002/mus.27201

Kiernan MC, 2021, 'Neurology and clinical neurophysiology: An artificial divide', Practical Neurology, vol. 21, pp. 274 - 275, http://dx.doi.org/10.1136/practneurol-2021-002946

McManus L; Lowery M; Merletti R; Søgaard K; Besomi M; Clancy EA; van Dieën JH; Hug F; Wrigley T; Besier T; Carson RG; Disselhorst-Klug C; Enoka RM; Falla D; Farina D; Gandevia S; Holobar A; Kiernan MC; McGill K; Perreault E; Rothwell JC; Tucker K; Hodges PW, 2021, 'Consensus for experimental design in electromyography (CEDE) project: Terminology matrix', Journal of Electromyography and Kinesiology, vol. 59, pp. 102565, http://dx.doi.org/10.1016/j.jelekin.2021.102565

Devenney EM; Tu S; Caga J; Ahmed RM; Ramsey E; Zoing M; Kwok J; Halliday GM; Piguet O; Hodges JR; Kiernan MC, 2021, 'Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum', Annals of Clinical and Translational Neurology, vol. 8, pp. 1576 - 1591, http://dx.doi.org/10.1002/acn3.51363

Tu S; Huang M; Caga J; Mahoney CJ; Kiernan MC, 2021, 'Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS', Frontiers in Neurology, vol. 12, pp. 704059, http://dx.doi.org/10.3389/fneur.2021.704059

Forrest SL; Kim JH; De Sousa C; Cheong R; Crockford DR; Sheedy D; Stevens J; McCrossin T; Tan RH; McCann H; Shepherd CE; Rowe DB; Kiernan MC; Halliday GM; Kril JJ, 2021, 'Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis', European Journal of Neurology, vol. 28, pp. 2192 - 2199, http://dx.doi.org/10.1111/ene.14849

Fifita JA; Chan Moi Fat S; McCann EP; Williams KL; Twine NA; Bauer DC; Rowe DB; Pamphlett R; Kiernan MC; Tan VX; Blair IP; Guillemin GJ, 2021, 'Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis', Frontiers in Immunology, vol. 12, pp. 701550, http://dx.doi.org/10.3389/fimmu.2021.701550

Ahmed RM; Kiernan MC, 2021, 'Author Response: Phenotypic Variability in ALS-FTD and Effect on Survival', Neurology, vol. 96, pp. 1103 - 1104, http://dx.doi.org/10.1212/WNL.0000000000012073

Nguyen C; Caga J; Mahoney CJ; Kiernan MC; Huynh W, 2021, 'Behavioural changes predict poorer survival in amyotrophic lateral sclerosis', Brain and Cognition, vol. 150, http://dx.doi.org/10.1016/j.bandc.2021.105710

Ahmed RM; Tse NY; Chen Y; Henning E; Hodges JR; Kiernan MC; Irish M; Farooqi IS; Piguet O, 2021, 'Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature', Annals of Clinical and Translational Neurology, vol. 8, pp. 1318 - 1329, http://dx.doi.org/10.1002/acn3.51369

Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB, 2021, 'Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response', Oncologist, vol. 26, pp. 366 - 374, http://dx.doi.org/10.1002/onco.13697

Chan Moi Fat S; McCann EP; Williams KL; Henden L; Twine NA; Bauer DC; Pamphlett R; Kiernan MC; Rowe DB; Nicholson GA; Fifita JA; Blair IP, 2021, 'Genetic analysis of GLT8D1 and ARPP21 in Australian familial and sporadic amyotrophic lateral sclerosis', Neurobiology of Aging, vol. 101, pp. 297.e9 - 297.e11, http://dx.doi.org/10.1016/j.neurobiolaging.2021.01.005

Hannaford A; Pavey N; van den Bos M; Geevasinga N; Menon P; Shefner JM; Kiernan MC; Vucic S, 2021, 'Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis', Annals of Neurology, vol. 89, pp. 979 - 986, http://dx.doi.org/10.1002/ana.26045

Mahoney CJ; Ahmed RM; Huynh W; Tu S; Rohrer JD; Bedlack RS; Hardiman O; Kiernan MC, 2021, 'Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis', CNS Drugs, vol. 35, pp. 483 - 505, http://dx.doi.org/10.1007/s40263-021-00820-1

Higashihara M; Pavey N; van den Bos M; Menon P; Kiernan MC; Vucic S, 2021, 'Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis', Neurology, vol. 96, pp. e2090 - e2097, http://dx.doi.org/10.1212/WNL.0000000000011798

Garcia-Montojo M; Fathi S; Norato G; Smith BR; Rowe DB; Kiernan MC; Vucic S; Mathers S; van Eijk RPA; Santamaria U; Rogers ML; Malaspina A; Lombardi V; Mehta PR; Westeneng HJ; van den Berg LH; Al-Chalabi A; Gold J; Nath A, 2021, 'Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy', Journal of the Neurological Sciences, vol. 423, http://dx.doi.org/10.1016/j.jns.2021.117358

Huynh W; Tu S; Mahoney CJ; Schwartz R; Kiernan MC, 2021, 'Mills Syndrome: Clinical and Radiologic Asymmetry', Neurology, vol. 96, pp. 677 - 678, http://dx.doi.org/10.1212/WNL.0000000000011710

van den Bos MAJ; Higashihara M; Geevasinga N; Menon P; Kiernan MC; Vucic S, 2021, 'Pathophysiological associations of transcallosal dysfunction in ALS', European Journal of Neurology, vol. 28, pp. 1172 - 1180, http://dx.doi.org/10.1111/ene.14653

El-Wahsh S; Finger EC; Piguet O; Mok V; Rohrer JD; Kiernan MC; Ahmed RM, 2021, 'Predictors of survival in frontotemporal lobar degeneration syndromes', Journal of Neurology, Neurosurgery and Psychiatry, vol. 92, pp. 425 - 433, http://dx.doi.org/10.1136/jnnp-2020-324349

Weiss MD; Macklin EA; McIlduff CE; Vucic S; Wainger BJ; Kiernan MC; Goutman SA; Goyal NA; Rutkove SB; Ladha SS; Chen IHA; Harms MB; Brannagan TH; Lacomis D; Zivkovic S; Ma M; Wang LH; Simmons Z; Rivner MH; Shefner JM; Cudkowicz ME; Atassi N, 2021, 'Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial', Muscle and Nerve, vol. 63, pp. 371 - 383, http://dx.doi.org/10.1002/mus.27146

Trinh T; Park SB; Murray J; Pickering H; Lin CSY; Martin A; Friedlander M; Kiernan MC; Goldstein D; Krishnan AV, 2021, 'Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial', Supportive Care in Cancer, vol. 29, pp. 1103 - 1110, http://dx.doi.org/10.1007/s00520-020-05591-x

McCann EP; Henden L; Fifita JA; Zhang KY; Grima N; Bauer DC; Chan Moi Fat S; Twine NA; Pamphlett R; Kiernan MC; Rowe DB; Williams KL; Blair IP, 2021, 'Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis', Journal of Medical Genetics, vol. 58, pp. 87 - 95, http://dx.doi.org/10.1136/jmedgenet-2020-106866

Wainger BJ; Macklin EA; Vucic S; McIlduff CE; Paganoni S; Maragakis NJ; Bedlack R; Goyal NA; Rutkove SB; Lange DJ; Rivner MH; Goutman SA; Ladha SS; Mauricio EA; Baloh RH; Simmons Z; Pothier L; Kassis SB; La T; Hall M; Evora A; Klements D; Hurtado A; Pereira JD; Koh J; Celnik PA; Chaudhry V; Gable K; Juel VC; Phielipp N; Marei A; Rosenquist P; Meehan S; Oskarsson B; Lewis RA; Kaur D; Kiskinis E; Woolf CJ; Eggan K; Weiss MD; Berry JD; David WS; Davila-Perez P; Camprodon JA; Pascual-Leone A; Kiernan MC; Shefner JM; Atassi N; Cudkowicz ME, 2021, 'Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial', JAMA Neurology, vol. 78, pp. 186 - 196, http://dx.doi.org/10.1001/jamaneurol.2020.4300

Kiernan MC; Vucic S; Talbot K; McDermott CJ; Hardiman O; Shefner JM; Al-Chalabi A; Huynh W; Cudkowicz M; Talman P; Van den Berg LH; Dharmadasa T; Wicks P; Reilly C; Turner MR, 2021, 'Improving clinical trial outcomes in amyotrophic lateral sclerosis', Nature Reviews Neurology, vol. 17, pp. 104 - 118, http://dx.doi.org/10.1038/s41582-020-00434-z

Vucic S; Kiernan MC; Menon P; Huynh W; Rynders A; Ho KS; Glanzman R; Hotchkin MT, 2021, 'Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression', BMJ open, vol. 11, pp. e041479, http://dx.doi.org/10.1136/bmjopen-2020-041479

Shefner JM; Andrews JA; Genge A; Jackson C; Lechtzin N; Miller TM; Cockroft BM; Meng L; Wei J; Wolff AA; Malik FI; Bodkin C; Brooks BR; Caress J; Dionne A; Fee D; Goutman SA; Goyal NA; Hardiman O; Hayat G; Heiman-Patterson T; Heitzman D; Henderson RD; Johnston W; Karam C; Kiernan MC; Kolb SJ; Korngut L; Ladha S; Matte G; Mora JS; Needham M; Oskarsson B; Pattee GL; Pioro EP; Pulley M; Quan D; Rezania K; Schellenberg KL; Schultz D; Shoesmith C; Simmons Z; Statland J; Sultan S; Swenson A; Berg LHVD; Vu T; Vucic S; Weiss M; Whyte-Rayson A; Wymer J; Zinman L; Rudnicki SA, 2021, 'A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 22, pp. 287 - 299, http://dx.doi.org/10.1080/21678421.2020.1822410

Dharmadasa T; Howells J; Matamala JM; Simon NG; Burke D; Vucic S; Kiernan MC, 2021, 'Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis', European Journal of Neurology, vol. 28, pp. 90 - 97, http://dx.doi.org/10.1111/ene.14515

De Boer EMJ; Orie VK; Williams T; Baker MR; De Oliveira HM; Polvikoski T; Silsby M; Menon P; Van Den Bos M; Halliday GM; Van Den Berg LH; Van Den Bosch L; Van Damme P; Kiernan M; Van Es MA; Vucic S, 2021, 'TDP-43 proteinopathies: A new wave of neurodegenerative diseases', Journal of Neurology, Neurosurgery and Psychiatry, vol. 92, pp. 86 - 95, http://dx.doi.org/10.1136/jnnp-2020-322983

Caga J; Zoing MC; Foxe D; Ramsey E; D’Mello M; Mioshi E; Ahmed RM; Kiernan MC; Piguet O, 2021, 'Problem-focused coping underlying lower caregiver burden in ALS-FTD: implications for caregiver intervention', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 22, pp. 434 - 441, http://dx.doi.org/10.1080/21678421.2020.1867180

Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2021, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, http://dx.doi.org/10.1007/s11764-021-00988-x

Bedlack R; Armon C; Barkhaus P; Barnes B; Bereman M; Bertorini T; Carter G; Chen A; Crayle J; Cudkowicz M; Jackson C; Kiernan M; Levitsky G; McDermott C; Pattee G; Pioro E; Salmon K; Staats K; Stephens J; Wicks P, 2021, 'ALSUntangled 57: Vinpocetine', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 22, pp. 316 - 319, http://dx.doi.org/10.1080/21678421.2020.1786942

Hannaford A; Vucic S; Kiernan MC; Simon NG, 2021, 'Review article “spotlight on ultrasonography in the diagnosis of peripheral nerve disease: The evidence to date”', International Journal of General Medicine, vol. 14, pp. 4579 - 4604, http://dx.doi.org/10.2147/IJGM.S295851

Ahmed RM; Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD, 2021, 'Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach', Brain Communications, vol. 3, http://dx.doi.org/10.1093/braincomms/fcab257

Caga J; Kiernan MC; Piguet O, 2021, 'A Systematic Review of Caregiver Coping Strategies in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia', Journal of Geriatric Psychiatry and Neurology, pp. 8919887211060016, http://dx.doi.org/10.1177/08919887211060016

Sommer C; Carroll AS; Koike H; Katsuno M; Ort N; Sobue G; Vucic S; Spies JM; Doppler K; Kiernan MC, 2021, 'Nerve biopsy in acquired neuropathies.', J Peripher Nerv Syst, vol. 26 Suppl 2, pp. S21 - S41, http://dx.doi.org/10.1111/jns.12464

Phan K; He Y; Fu Y; Dzamko N; Bhatia S; Gold J; Rowe D; Ke YD; Ittner LM; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2021, 'Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia.', Commun Med (Lond), vol. 1, http://dx.doi.org/10.1038/s43856-021-00060-w

Katzeff JS; Bright F; Lo K; Kril JJ; Connolly A; Crossett B; Ittner LM; Kassiou M; Loy CT; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2020, 'Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation', Scientific Reports, vol. 10, http://dx.doi.org/10.1038/s41598-020-70687-7

Henden L; Twine NA; Szul P; McCann EP; Nicholson GA; Rowe DB; Kiernan MC; Bauer DC; Blair IP; Williams KL, 2020, 'Identity by descent analysis identifies founder events and links SOD1 familial and sporadic ALS cases', npj Genomic Medicine, vol. 5, http://dx.doi.org/10.1038/s41525-020-00139-8

Kiernan MC, 2020, 'Metabolomic insights into neurodegene rative disease', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 1250, http://dx.doi.org/10.1136/jnnp-2020-324856

Park SB; Thurbon R; Kiernan MC, 2020, 'Isaacs syndrome: The frontier of neurology, psychiatry, immunology and cancer', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 1243 - 1244, http://dx.doi.org/10.1136/jnnp-2020-324675

Cooper-Knock J; Zhang S; Kenna KP; Moll T; Franklin JP; Allen S; Nezhad HG; Iacoangeli A; Yacovzada NY; Eitan C; Hornstein E; Ehilak E; Celadova P; Bose D; Farhan S; Fishilevich S; Lancet D; Morrison KE; Shaw CE; Al-Chalabi A; Blair I; Wray N; Kiernan M; Neto MM; Chio A; Cauchi R; Robberecht W; van Damme P; Corcia P; Couratier P; Hardiman O; McLaughlin R; Gotkine M; Drory V; Ticozzi N; Silani V; Veldink J; van den Berg L; de Carvalho M; Pardina JM; Povedano M; Andersen P; Wber M; Başak N; Shaw C; Shaw PJ; Morrison K; Landers J; Glass J; Veldink JH; Kirby J; Snyder MP, 2020, 'Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene', Cell Reports, vol. 33, http://dx.doi.org/10.1016/j.celrep.2020.108456

Kiernan MC, 2020, 'Fasciculation anxiety syndrome in clinicians: FASICS', Practical Neurology, vol. 20, pp. 433 - 434, http://dx.doi.org/10.1136/practneurol-2020-002786

Farrar MA; Kiernan MC, 2020, 'Treating adults with spinal muscular atrophy with nusinersen', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 1139, http://dx.doi.org/10.1136/jnnp-2020-324036

Farrar MA; Kiernan MC, 2020, 'Spinal muscular atrophy — the dawning of a new era', Nature Reviews Neurology, vol. 16, pp. 593 - 594, http://dx.doi.org/10.1038/s41582-020-00410-7

Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, 'Taxane-induced peripheral neuropathy: differences in patient report and objective assessment', Supportive Care in Cancer, vol. 28, pp. 4459 - 4466, http://dx.doi.org/10.1007/s00520-020-05299-y

Kiernan MC; Shefner JM; Kaji R; Burke D, 2020, 'Amyotrophic lateral sclerosis: A new diagnostic paradigm', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 903 - 904, http://dx.doi.org/10.1136/jnnp-2020-324006

Tracy JA; Taylor BV; Kiernan M; Dyck PJ; Crum BA; Mauermann ML; Amrami KK; Spinner RJ; Dyck PJB, 2020, 'Nerve Pathology Distinguishes Focal Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy from Multifocal Motor Neuropathy', Journal of Clinical Neuromuscular Disease, vol. 22, pp. 1 - 10, http://dx.doi.org/10.1097/CND.0000000000000279

Li T; Timmins HC; King T; Kiernan MC; Goldstein D; Park SB, 2020, 'Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials', Hematological Oncology, vol. 38, pp. 229 - 243, http://dx.doi.org/10.1002/hon.2706

Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB, 2020, 'Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, vol. 131, pp. 1979 - 1985, http://dx.doi.org/10.1016/j.clinph.2020.02.028

Howells J; Sangari S; Matamala JM; Kiernan MC; Marchand-Pauvert V; Burke D, 2020, 'Interrogating interneurone function using threshold tracking of the H reflex in healthy subjects and patients with motor neurone disease', Clinical Neurophysiology, vol. 131, pp. 1986 - 1996, http://dx.doi.org/10.1016/j.clinph.2020.03.028

Kiernan MC; Cornblath DR, 2020, 'Subacute sensory neuronopathy and cancer: The identification of paraneoplastic syndromes', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 793 - 794, http://dx.doi.org/10.1136/jnnp-2020-323171

Shefner JM; Al-Chalabi A; Baker MR; Cui LY; de Carvalho M; Eisen A; Grosskreutz J; Hardiman O; Henderson R; Matamala JM; Mitsumoto H; Paulus W; Simon N; Swash M; Talbot K; Turner MR; Ugawa Y; van den Berg LH; Verdugo R; Vucic S; Kaji R; Burke D; Kiernan MC, 2020, 'A proposal for new diagnostic criteria for ALS', Clinical Neurophysiology, vol. 131, pp. 1975 - 1978, http://dx.doi.org/10.1016/j.clinph.2020.04.005

Upadhyay V; Katz M; Kiernan M; Henderson R, 2020, 'Review of the revised amyotrophic lateral sclerosis diagnostic criteria', Clinical Neurophysiology, vol. 131, pp. 1767 - 1768, http://dx.doi.org/10.1016/j.clinph.2020.05.008

Besomi M; Hodges PW; Clancy EA; Van Dieën J; Hug F; Lowery M; Merletti R; Søgaard K; Wrigley T; Besier T; Carson RG; Disselhorst-Klug C; Enoka RM; Falla D; Farina D; Gandevia S; Holobar A; Kiernan MC; McGill K; Perreault E; Rothwell JC; Tucker K, 2020, 'Consensus for experimental design in electromyography (CEDE) project: Amplitude normalization matrix', Journal of Electromyography and Kinesiology, vol. 53, http://dx.doi.org/10.1016/j.jelekin.2020.102438

Edwards LS; Halmagyi GM; Mallawaarachchi A; Thompson EO; Kiernan MC, 2020, 'Fatal cerebellar oedema in adult Leigh syndrome', Practical Neurology, vol. 20, pp. 338 - 339, http://dx.doi.org/10.1136/practneurol-2019-002409

Tu S; Wang C; Menke RAL; Talbot K; Barnett M; Kiernan MC; Turner MR, 2020, 'Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 21, pp. 396 - 402, http://dx.doi.org/10.1080/21678421.2020.1733020

Mahoney CJ; Dharmadasa T; Huynh W; Halpern JP; Vucic S; Mowat D; Kiernan MC, 2020, 'A novel phenotype of hereditary spastic paraplegia type 7 associated with a compound heterozygous mutation in paraplegin', Muscle and Nerve, vol. 62, pp. E44 - E45, http://dx.doi.org/10.1002/mus.26882

Kiernan MC, 2020, 'The Journal of Neurology, Neurosurgery and Psychiatry centenary milestone award 2020', Journal of neurology, neurosurgery, and psychiatry, vol. 91, pp. 677, http://dx.doi.org/10.1136/jnnp-2020-322976

Ahmed RM; Devenney EM; Strikwerda-Brown C; Hodges JR; Piguet O; Kiernan MC, 2020, 'Phenotypic variability in ALS-FTD and effect on survival', Neurology, vol. 94, pp. E2005 - E2013, http://dx.doi.org/10.1212/WNL.0000000000009398

Higashihara M; Van den Bos MAJ; Menon P; Kiernan MC; Vucic S, 2020, 'Interneuronal networks mediate cortical inhibition and facilitation', Clinical Neurophysiology, vol. 131, pp. 1000 - 1010, http://dx.doi.org/10.1016/j.clinph.2020.02.012

Menon P; Higashihara M; van den Bos M; Geevasinga N; Kiernan MC; Vucic S, 2020, 'Cortical hyperexcitability evolves with disease progression in ALS', Annals of Clinical and Translational Neurology, vol. 7, pp. 733 - 741, http://dx.doi.org/10.1002/acn3.51039

Vucic S; Higashihara M; Sobue G; Atsuta N; Doi Y; Kuwabara S; Kim SH; Kim I; Oh KW; Park J; Kim EM; Talman P; Menon P; Kiernan MC, 2020, 'ALS is a multistep process in South Korean, Japanese, and Australian patients', Neurology, vol. 94, pp. E1657 - E1663, http://dx.doi.org/10.1212/WNL.0000000000009015

Huynh W; Sharplin LE; Caga J; Highton-Williamson E; Kiernan MC, 2020, 'Respiratory function and cognitive profile in amyotrophic lateral sclerosis', European Journal of Neurology, vol. 27, pp. 685 - 691, http://dx.doi.org/10.1111/ene.14130

Kandula T; Farrar MA; Cohn RJ; Carey KA; Johnston K; Kiernan MC; Krishnan AV; Park SB, 2020, 'Changes in long term peripheral nerve biophysical properties in childhood cancer survivors following neurotoxic chemotherapy', Clinical Neurophysiology, vol. 131, pp. 783 - 790, http://dx.doi.org/10.1016/j.clinph.2019.12.411

Turner MR; Barohn RJ; Corcia P; Fink JK; Harms MB; Kiernan MC; Ravits J; Silani V; Simmons Z; Statland J; Van Den Berg LH; Mitsumoto H, 2020, 'Primary lateral sclerosis: Consensus diagnostic criteria', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 373 - 377, http://dx.doi.org/10.1136/jnnp-2019-322541

Dharmadasa T; Matamala JM; Howells J; Vucic S; Kiernan MC, 2020, 'Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices', Clinical Neurophysiology, vol. 131, pp. 958 - 966, http://dx.doi.org/10.1016/j.clinph.2019.11.057

Wan HWY; Carey KA; D'Silva A; Vucic S; Kiernan MC; Kasparian NA; Farrar MA, 2020, 'Health, wellbeing and lived experiences of adults with SMA: A scoping systematic review', Orphanet Journal of Rare Diseases, vol. 15, pp. 70, http://dx.doi.org/10.1186/s13023-020-1339-3

Huynh W; Ahmed R; Mahoney CJ; Nguyen C; Tu S; Caga J; Loh P; Lin CSY; Kiernan MC, 2020, 'The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis', Expert Review of Neurotherapeutics, vol. 20, pp. 281 - 293, http://dx.doi.org/10.1080/14737175.2020.1727740

Swash M; Burke D; Turner MR; Grosskreutz J; Leigh PN; Decarvalho M; Kiernan MC, 2020, 'Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 227 - 234, http://dx.doi.org/10.1136/jnnp-2019-321938

Mahoney CJ; Kiernan MC, 2020, 'Expanding the availability of medications for amyotrophic lateral sclerosis in Australia', Medical Journal of Australia, vol. 212, pp. 189 - 189.e1, http://dx.doi.org/10.5694/mja2.50482

Borire AA; Issar T; Kwai NC; Visser LH; Simon NG; Poynten AM; Kiernan MC; Krishnan AV, 2020, 'Sonographic assessment of nerve blood flow in diabetic neuropathy', Diabetic Medicine, vol. 37, pp. 343 - 349, http://dx.doi.org/10.1111/dme.14085

Yeh WZ; Dyck PJ; Van Den Berg LH; Kiernan MC; Taylor BV, 2020, 'Multifocal motor neuropathy: controversies and priorities', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 140 - 148, http://dx.doi.org/10.1136/jnnp-2019-321532

Carter A; Richards LJ; Apthorp D; Azghadi MR; Badcock DR; Balleine B; Bekkers JM; Berk M; Bourne JA; Bradley AP; Breakspear M; Brichta A; Carter O; Castles A; Chakli K; Cohen-Woods S; Conn SJ; Cornish J; Cornish K; de Zubicaray G; Egan GF; Enticott PG; Fitzgibbon BM; Forlini C; Fornito A; Griffiths L; Gullifer J; Hall W; Halliday G; Hannan AJ; Harrer S; Harvey A; Hatherly C; Hickie IB; Kennett J; Kiernan M; Kilpatrick T; Kiral-Kornek I; Korgaonkar MS; Lawrence AJ; Leventer R; Levy N; Licinio J; Lovell N; Mackellar G; Malcolm L; Mason A; Mattingley JB; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Poole-Warren L; Sah P; Sarnyai Z; Schofield PR; Shimoni O; Shum DHK; Silk T; Slee M; Smith AE; Soulis T; Sriram S; Stuart GJ; Tapson J; Thompson MB; van Schaik A; Vincent NA; Vissel B; Waters A, 2020, 'Erratum: A Neuroethics Framework for the Australian Brain Initiative (Neuron (2019) 101(3) (365–369), (S0896627319300054), (10.1016/j.neuron.2019.01.004))', Neuron, vol. 105, pp. 201, http://dx.doi.org/10.1016/j.neuron.2019.12.019

Timmins HC; Li T; Kiernan MC; Horvath LG; Goldstein D; Park SB, 2020, 'Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients', Journal of Pain, vol. 21, pp. 44 - 58, http://dx.doi.org/10.1016/j.jpain.2019.06.011

Kiernan MC; Bostock H; Park SB; Kaji R; Krarup C; Krishnan AV; Kuwabara S; Lin CSY; Misawa S; Moldovan M; Sung J; Vucic S; Wainger BJ; Waxman S; Burke D, 2020, 'Measurement of axonal excitability: Consensus guidelines', Clinical Neurophysiology, vol. 131, pp. 308 - 323, http://dx.doi.org/10.1016/j.clinph.2019.07.023

Kiernan MC, 2020, 'Jewels in the crown: A century of achievement for the Journal of Neurology, Neurosurgery & Psychiatry', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, pp. 1 - 2, http://dx.doi.org/10.1136/jnnp-2019-322443

de Carvalho M; Kiernan MC; Pullman SL; Rezania K; Turner MR; Simmons Z, 2020, 'Neurophysiological features of primary lateral sclerosis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 21, pp. 11 - 17, http://dx.doi.org/10.1080/21678421.2020.1837174

Mitsumoto H; Turner MR; Ajroud-Driss S; Andres P; Andrews J; Gomez EA; Atehortua JMS; Babu S; Barohn R; Bede P; Benatar M; Chew S; Conwit R; Corcia P; Cudkowicz M; Davis F; Carvalho MD; Drory V; Elman L; Factor-Litvak P; Fernandes JAM; Ferrey D; Finegan E; Fink J; Floeter MK; Fournier C; Genge A; Govindarajan R; Granit V; Haase G; Hardiman O; Harms M; Hayat G; Heiman-Patterson T; Hill B; Hübers A; Huey E; Jawdat O; Kano O; Kau K; Kiernan M; Kisanuki Y; Kurent J; Kwan J; Lange D; Ludolph A; Mackenzie I; Manfredi G; Marren D; Morita M; Murphy J; Nations S; Oskarsson B; Paganoni S; Pellerin D; Ravits J; Rezania K; Rouleau G; Scelsa S; Siddique T; Siddique N; Silani V; Simmons Z; Statland J; Traynor B; Blitterswijk MV; Berg LVD; Walk D; Warden D; Wymer J, 2020, 'Preface: promoting research in PLS: current knowledge and future challenges', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 21, pp. 1 - 2, http://dx.doi.org/10.1080/21678421.2020.1840795

Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, '8. Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, vol. 131, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2019.11.041

Mahoney CJ; Highton-Williamson E; Howells J; Ahmed R; Huynh W; Kiernan MC, 2020, '11. Neurophysiological correlates of impaired cognition in Amyotrophic Lateral Sclerosis', Clinical Neurophysiology, vol. 131, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2019.11.044

Li T; Timmins HC; McCrary JM; Trinh T; Horvath LG; Friedlander ML; Kiernan MC; Goldstein D; Park SB, 2020, '5. Neurophysiological characteristics in the development and recovery of peripheral neuropathy in oxaliplatin and paxlitaxel treated patients', Clinical Neurophysiology, vol. 131, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2019.11.038

Kiernan MC, 2020, 'Queen Square: a history of the National Hospital and its Institute of Neurology', Journal of Neurology, Neurosurgery & Psychiatry, vol. 91, pp. 560 - 561, http://dx.doi.org/10.1136/jnnp-2020-322776

van den Bos MAJ; Higashihara M; Howells J; Parvathi Menon ; Geevasinga N; Kiernan MC; Vucic S, 2020, '13. Transcallosal dysfunction an early marker of ALS', Clinical Neurophysiology, vol. 131, pp. e6 - e6, http://dx.doi.org/10.1016/j.clinph.2019.11.046

Silsby M; Fois AF; Yiannikas C; Kiernan MC; Fung VSC; Vucic S, 2020, '12. EMG bursting characteristics of upper limb muscles in patients with CIDP and tremor', Clinical Neurophysiology, vol. 131, pp. e5 - e6, http://dx.doi.org/10.1016/j.clinph.2019.11.045

Nathani D; Spies J; Barnett M; Wang M-X; Pollard J; Kiernan M, 2020, '15. Paraproteinaemic neuropathy: The role for nerve biopsy', Clinical Neurophysiology, vol. 131, pp. e7 - e7, http://dx.doi.org/10.1016/j.clinph.2019.11.048

Higashihara M; Menon P; Geevasinga N; Van den Bos MAJ; Kiernan MC; Vucic S, 2020, '6. Motor neuron disease with malignancy: a pathophysiologically distinct entity of motor neuron disease?', Clinical Neurophysiology, vol. 131, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2019.11.039

Yang Y; Halliday GM; Kiernan MC; Tan RH, 2019, 'TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions', Neurology, vol. 93, pp. e1748 - e1755, http://dx.doi.org/10.1212/WNL.0000000000008439

Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV, 2019, 'Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients', Clinical Neurophysiology, vol. 130, pp. 2088 - 2095, http://dx.doi.org/10.1016/j.clinph.2019.08.005

Kiernan MC, 2019, 'Milestones', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 1189, http://dx.doi.org/10.1136/jnnp-2019-321711

Ahmed RM; Devenney EM; Strikwerda-Brown C; Hodges JR; Piguet O; Kiernan MC, 2019, 'COG-01 Phenotypic variation in  ALS-FTD and effect on survival', Amyotrophic lateral sclerosis & frontotemporal degeneration, vol. 20, pp. 301 - 308, http://dx.doi.org/10.1080/21678421.2019.1647000

Ahmed R; Landin-Romero R; Liang C; Keogh J; Henning E; Emma D; Hodges J; Kiernan M; Sadaf F; Piguet O, 2019, 'Neural correlates of body composition in frontotemporal dementia', JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 405, http://dx.doi.org/10.1016/j.jns.2019.10.840

Ahmed R; Devenney E; Hodges J; Piguet O; Kiernan M, 2019, 'Effect of phenotypic presentation on survival in ALS-FTD', JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 405, http://dx.doi.org/10.1016/j.jns.2019.10.323

Gold J; Rowe DB; Kiernan MC; Vucic S; Mathers S; van Eijk RPA; Nath A; Garcia Montojo M; Norato G; Santamaria UA; Rogers ML; Malaspina A; Lombardi V; Mehta PR; Westeneng HJ; van den Berg LH; Al-Chalabi A, 2019, 'Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 20, pp. 595 - 604, http://dx.doi.org/10.1080/21678421.2019.1632899

Vucic S; Westeneng HJ; Al-Chalabi A; Van Den Berg LH; Talman P; Kiernan MC, 2019, 'Amyotrophic lateral sclerosis as a multi-step process: an Australia population study', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 20, pp. 532 - 537, http://dx.doi.org/10.1080/21678421.2018.1556697

Besomi M; Hodges PW; Van Dieën J; Carson RG; Clancy EA; Disselhorst-Klug C; Holobar A; Hug F; Kiernan MC; Lowery M; McGill K; Merletti R; Perreault E; Søgaard K; Tucker K; Besier T; Enoka R; Falla D; Farina D; Gandevia S; Rothwell JC; Vicenzino B; Wrigley T, 2019, 'Consensus for experimental design in electromyography (CEDE) project: Electrode selection matrix', Journal of Electromyography and Kinesiology, vol. 48, pp. 128 - 144, http://dx.doi.org/10.1016/j.jelekin.2019.07.008

Li T; Timmins H; King T; Kiernan M; Goldstein D; Park S, 2019, 'Bortezomib Induced Peripheral Neuropathy: A Systematic Review of Phase III Trials', CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 19, pp. E346 - E346, http://dx.doi.org/10.1016/j.clml.2019.09.571

Ke YD; Chan G; Stefanoska K; Au C; Bi M; Müller J; Przybyla M; Feiten A; Prikas E; Halliday GM; Piguet O; Kiernan MC; Kassiou M; Hodges JR; Loy CT; Mattick JS; Ittner A; Kril JJ; Sutherland GT; Ittner LM, 2019, 'CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation', Journal of Biological Chemistry, vol. 294, pp. 14149 - 14162, http://dx.doi.org/10.1074/jbc.RA118.005263

McMackin R; Muthuraman M; Groppa S; Babiloni C; Taylor JP; Kiernan MC; Nasseroleslami B; Hardiman O, 2019, 'Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 1011 - 1020, http://dx.doi.org/10.1136/jnnp-2018-319581

Higashihara M; Menon P; Geevasinga N; Van den Bos MAJ; Kiernan MC; Vucic S, 2019, 'Motor neuron disease with malignancy: Clinical and pathophysiological insights', Clinical Neurophysiology, vol. 130, pp. 1557 - 1561, http://dx.doi.org/10.1016/j.clinph.2019.05.026

Kiernan MC; Ziemann U; Eisen A, 2019, 'Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period', Muscle and Nerve, vol. 60, pp. 232 - 235, http://dx.doi.org/10.1002/mus.26617

Bright F; Werry EL; Dobson-Stone C; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kassiou M; Kril JJ, 2019, 'Neuroinflammation in frontotemporal dementia', Nature Reviews Neurology, vol. 15, pp. 540 - 555, http://dx.doi.org/10.1038/s41582-019-0231-z

Ahmed RM; Landin-Romero R; Liang CT; Keogh JM; Henning E; Strikwerda-Brown C; Devenney EM; Hodges JR; Kiernan MC; Farooqi IS; Piguet O, 2019, 'Neural networks associated with body composition in frontotemporal dementia', Annals of Clinical and Translational Neurology, vol. 6, pp. 1707 - 1717, http://dx.doi.org/10.1002/acn3.50869

Garg N; Park SB; Howells J; Vucic S; Yiannikas C; Mathey EK; Nguyen T; Noto Y; Barnett MH; Krishnan AV; Spies J; Bostock H; Pollard JD; Kiernan MC, 2019, 'Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy', European Journal of Neurology, vol. 26, pp. 1121 - 1129, http://dx.doi.org/10.1111/ene.13953

Menon P; Yiannikas C; Kiernan MC; Vucic S, 2019, 'Regional motor cortex dysfunction in amyotrophic lateral sclerosis', Annals of Clinical and Translational Neurology, vol. 6, pp. 1373 - 1382, http://dx.doi.org/10.1002/acn3.50819

Arnold R; Pianta TJ; Pussell BA; Endre Z; Kiernan MC; Krishnan AV, 2019, 'Potassium control in chronic kidney disease: implications for neuromuscular function', Internal Medicine Journal, vol. 49, pp. 817 - 825, http://dx.doi.org/10.1111/imj.14114

Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M, 2019, 'Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders', International Journal of Molecular Sciences, vol. 20, http://dx.doi.org/10.3390/ijms20133161

Edwards LS; Halmagyi GM; Barnett MH; Blair CA; Kiernan MC, 2019, 'Cerebellar oedema in fulminant adult leigh syndrome', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol. 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.79

Borire A; Issar T; Kwai N; Visser L; Poynten A; Simon N; Kiernan M; Krishnan A, 2019, 'THE UTILITY OF NERVE BLOOD FLOW IN THE ASSESSMENT OF PERIPHERAL NEUROPATHY', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol. 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.24

Huynh W; Sharplin LE; Caga J; Highton-Williamson E; Kiernan MC, 2019, 'RESPIRATORY FUNCTION AND COGNITIVE PROFILE IN MOTOR NEURON DISEASE', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol. 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.38

Devenney EM; Ahmed RM; Caga J; Highton-Williamson E; Ramsey E; Zoing M; Hodges J; Kiernan M, 2019, 'Unravelling psychosis in motor neurone disease - a study of clinical features, cognition, and survival', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol. 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.15

Nathani D; Barnett MH; Spies J; Pollard J; Wang MX; Kiernan MC, 2019, 'Vasculitic neuropathy: Comparison of clinical predictors with histopathological outcome', Muscle and Nerve, vol. 59, pp. 643 - 649, http://dx.doi.org/10.1002/mus.26431

Kiernan MC; Goadsby PJ; Burke D, 2019, 'Marco polo of australian neurology', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 627 - 628, http://dx.doi.org/10.1136/jnnp-2019-320989

Henderson RD; Garton FC; Kiernan MC; Turner MR; Eisen A, 2019, 'Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 570 - 575, http://dx.doi.org/10.1136/jnnp-2017-317245

Agarwal S; Ahmed RM; D'Mello M; Foxe D; Kaizik C; Kiernan MC; Halliday GM; Piguet O; Hodges JR, 2019, 'Predictors of survival and progression in behavioural variant frontotemporal dementia', European Journal of Neurology, vol. 26, pp. 774 - 779, http://dx.doi.org/10.1111/ene.13887

Dharmadasa T; Matamala JM; Howells J; Simon NG; Vucic S; Kiernan MC, 2019, 'The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS', Neuroscience Letters, vol. 699, pp. 84 - 90, http://dx.doi.org/10.1016/j.neulet.2019.01.050

Long Z; Irish M; Piguet O; Kiernan MC; Hodges JR; Burrell JR, 2019, 'Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia–motor neuron disease patients', Journal of Neurology, vol. 266, pp. 921 - 933, http://dx.doi.org/10.1007/s00415-019-09216-0

Tu S; Menke RAL; Talbot K; Kiernan MC; Turner MR, 2019, 'Cerebellar tract alterations in PLS and ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 20, pp. 281 - 284, http://dx.doi.org/10.1080/21678421.2018.1562554

Anderson S; Kiernan M; Ho PJ, 2019, 'Lenalidomide-related Progressive Multifocal Leukoencephalopathy: A Case Report and Review of Drug-related Cases in Multiple Myeloma', Clinical Lymphoma, Myeloma and Leukemia, vol. 19, pp. e169 - e171, http://dx.doi.org/10.1016/j.clml.2018.12.021

Riggare S; Thurbon R; Roman S; Richards T; Kiernan MC, 2019, 'Patient Editorial Board for JNNP', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 369 - 370, http://dx.doi.org/10.1136/jnnp-2019-320453

Tan RH; Guennewig B; Dobson-Stone C; Kwok JBJ; Kril JJ; Kiernan MC; Hodges JR; Piguet O; Halliday GM, 2019, 'The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability', Neurology, vol. 92, pp. E1354 - E1366, http://dx.doi.org/10.1212/WNL.0000000000007146

Ahmed RM; Phan K; Highton-Williamson E; Strikwerda-Brown C; Caga J; Ramsey E; Zoing M; Devenney E; Kim WS; Hodges JR; Piguet O; Halliday GM; Kiernan MC, 2019, 'Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia', Annals of Clinical and Translational Neurology, vol. 6, pp. 486 - 495, http://dx.doi.org/10.1002/acn3.721

Kennett J; Carter A; Bourne JA; Hall W; Levy N; Mattingley JB; Lawrence AJ; Forlini C; Malcolm L; Vincent N; Richards LJ; Egan GF; Breakspear M; Cornish K; Halliday G; Poole-Warren L; Sriram S; Soulis T; Fitzgibbon B; Kiral-Kornek I; Badcock DR; Balleine B; Bekkers JM; Berk M; Bradley A; Brichta A; Carter O; Castles A; Clements J; Cornish J; de Zubicaray G; Enticott PG; Fornito A; Griffiths L; Gullifer J; Hannan AJ; Harrer S; Harvey A; Hickie IB; Jazwinska L; Kiernan M; Kilpatrick T; Leventer R; Licinio J; Lovell N; Mackellar G; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Rossell S; Sah P; Sarnyai Z; Schofield PR; Shum DHK; Silk T; Slee M; Stuart GJ; Tapson J; van Schaik A; Vissel B; Waters A; Apthorp D; Cohen-Woods S; Conn SJ; Korgaonkar M; Mason A; Azghadi MR; Shimoni O; Smith A; Thompson MB, 2019, 'A Neuroethics Framework for the Australian Brain Initiative', Neuron, vol. 101, pp. 365 - 369, http://dx.doi.org/10.1016/j.neuron.2019.01.004

Geevasinga N; Howells J; Menon P; Van Den Bos M; Shibuya K; Matamala JM; Park SB; Byth K; Kiernan MC; Vucic S, 2019, 'Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS', Neurology, vol. 92, pp. e536 - e547, http://dx.doi.org/10.1212/WNL.0000000000006876

Gu Y; Dennis SM; Kiernan MC; Harmer AR, 2019, 'Aerobic exercise training may improve nerve function in type 2 diabetes and pre-diabetes: A systematic review', Diabetes/Metabolism Research and Reviews, vol. 35, http://dx.doi.org/10.1002/dmrr.3099

Agarwal S; Koch G; Hillis AE; Huynh W; Ward NS; Vucic S; Kiernan MC, 2019, 'Interrogating cortical function with transcranial magnetic stimulation: Insights from neurodegenerative disease and stroke', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 47 - 57, http://dx.doi.org/10.1136/jnnp-2017-317371

Huynh W; Dharmadasa T; Vucic S; Kiernan MC, 2019, 'Functional biomarkers for amyotrophic lateral sclerosis', Frontiers in Neurology, vol. 10, http://dx.doi.org/10.3389/fneur.2018.01141

Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ, 2019, 'Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol', BMJ Open, vol. 9, http://dx.doi.org/10.1136/bmjopen-2018-023736

Carroll AS; Burns J; Nicholson G; Kiernan MC; Vucic S, 2019, 'Inherited Neuropathies', Seminars in Neurology, vol. 39, pp. 620 - 639, http://dx.doi.org/10.1055/s-0039-1693006

McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SSL; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S, 2019, 'Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice', Journal of Neurology, Neurosurgery and Psychiatry, http://dx.doi.org/10.1136/jnnp-2019-321790

Dharmadasa T; Kiernan MC, 2019, 'Sound of the crowd: Wisdom of neurologists revisited', Practical Neurology, vol. 19, pp. 552, http://dx.doi.org/10.1136/practneurol-2019-002384

Higashihara M; Menon P; Geevasinga N; Bos MAD; Kiernan MC; Vucic S, 2019, '092 Motor neuron disease with malignancy: clinical and pathophysiological insights', Journal of Neurology, Neurosurgery & Psychiatry, vol. 90, pp. A29.3 - A30, http://dx.doi.org/10.1136/jnnp-2019-anzan.80

Bos MVD; Howells J; Higashihara M; Geevasinga N; Kiernan M; Vucic S, 2019, '018 Role of transcallosal inhibition in disease spread in ALS', Journal of Neurology, Neurosurgery & Psychiatry, vol. 90, pp. A7.2 - A7, http://dx.doi.org/10.1136/jnnp-2019-anzan.18

Tu S; Turner MR; Kiernan MC, 2019, '017 Widespread extra-motor abnormality is a prominent MRI signature of ALS: a cross-cohort study', Journal of Neurology, Neurosurgery & Psychiatry, vol. 90, pp. A7.1 - A7, http://dx.doi.org/10.1136/jnnp-2019-anzan.17

Bueno APA; Pinaya WHL; Moura LM; Bertoux M; Radakovic R; Kiernan MC; Teixeira AL; de Souza LC; Hornberger M; Sato JR, 2018, 'Structural and functional papez circuit integrity in amyotrophic lateral sclerosis', Brain Imaging and Behavior, vol. 12, pp. 1622 - 1630, http://dx.doi.org/10.1007/s11682-018-9825-0

Tu S; Menke RAL; Talbot K; Kiernan MC; Turner MR, 2018, 'Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 89, pp. 1250 - 1258, http://dx.doi.org/10.1136/jnnp-2018-318625

Vincent A; Pettingill P; Pettingill R; Lang B; Birch R; Waters P; Irani SR; Buckley C; Watanabe O; Arimura K; Kiernan MC, 2018, 'Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies with Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia', JAMA Neurology, vol. 75, pp. 1519 - 1527, http://dx.doi.org/10.1001/jamaneurol.2018.2681

Noto YI; Garg N; Li T; Timmins HC; Park SB; Shibuya K; Shahrizaila N; Huynh W; Matamala JM; Dharmadasa T; Yiannikas C; Vucic S; Kiernan MC, 2018, 'Comparison of cross-sectional areas and distal-proximal nerve ratios in amyotrophic lateral sclerosis', Muscle and Nerve, vol. 58, pp. 777 - 783, http://dx.doi.org/10.1002/mus.26301

Howells J; Matamala JM; Park SB; Garg N; Vucic S; Bostock H; Burke D; Kiernan MC, 2018, 'In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis', Journal of Physiology, vol. 596, pp. 5379 - 5396, http://dx.doi.org/10.1113/JP276624

Garg N; Park SB; Kiernan MC, 2018, 'Inflammatory neuropathies: all shapes and sizes', Journal of Neurology, Neurosurgery and Psychiatry, vol. 89, pp. 1128, http://dx.doi.org/10.1136/jnnp-2018-318513

Ahmed RM; Goldberg ZL; Kaizik C; Kiernan MC; Hodges JR; Piguet O; Irish M, 2018, 'Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning', Journal of Neurology, vol. 265, pp. 2562 - 2572, http://dx.doi.org/10.1007/s00415-018-9024-3

Van Den Bos MAJ; Higashihara M; Geevasinga N; Menon P; Kiernan MC; Vucic S, 2018, 'Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS', Neurology, vol. 91, pp. E1669 - E1676, http://dx.doi.org/10.1212/WNL.0000000000006438

Dharmadasa T; Kiernan MC, 2018, 'Utility of threshold tracking transcranial magnetic stimulation in ALS', Clinical Neurophysiology Practice, vol. 3, pp. 164 - 172, http://dx.doi.org/10.1016/j.cnp.2018.10.002

Devenney EM; Ahmed RM; Halliday G; Piguet O; Kiernan MC; Hodges JR, 2018, 'Psychiatric disorders in C9orf72 kindreds study of 1,414 family members', Neurology, vol. 91, pp. E1498 - E1507, http://dx.doi.org/10.1212/WNL.0000000000006344

Caga J; Hsieh S; Highton-Williamson E; Zoing MC; Ramsey E; Devenney E; Ahmed RM; Hogden A; Kiernan MC, 2018, 'The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 19, pp. 599 - 605, http://dx.doi.org/10.1080/21678421.2018.1497659

Ahmed RM; Dupuis L; Kiernan MC, 2018, 'Paradox of amyotrophic lateral sclerosis and energy metabolism', Journal of Neurology, Neurosurgery and Psychiatry, vol. 89, pp. 1013 - 1014, http://dx.doi.org/10.1136/jnnp-2018-318428

Borire AA; Issar T; Kwai NC; Visser LH; Simon NG; Poynten AM; Kiernan MC; Krishnan AV, 2018, 'Correlation between markers of peripheral nerve function and structure in type 1 diabetes', Diabetes/Metabolism Research and Reviews, vol. 34, http://dx.doi.org/10.1002/dmrr.3028

Garg N; Park SB; Howells J; Noto YI; Vucic S; Yiannikas C; Tomlinson SE; Huynh W; Simon NG; Mathey EK; Spies J; Pollard JD; Krishnan AV; Kiernan MC, 2018, 'Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels', Clinical Neurophysiology, vol. 129, pp. 2162 - 2169, http://dx.doi.org/10.1016/j.clinph.2018.07.021

Tsugawa J; Dharmadasa T; Ma Y; Huynh W; Vucic S; Kiernan MC, 2018, 'Fasciculation intensity and disease progression in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 129, pp. 2149 - 2154, http://dx.doi.org/10.1016/j.clinph.2018.07.015

Menon P; Kiernan MC; Vucic S, 2018, 'Cortical excitability varies across different muscles', Journal of Neurophysiology, vol. 120, pp. 1397 - 1403, http://dx.doi.org/10.1152/jn.00148.2018

Makker PGS; Matamala JM; Park SB; Lees JG; Kiernan MC; Burke D; Moalem-Taylor G; Howells J, 2018, 'A unified model of the excitability of mouse sensory and motor axons', Journal of the Peripheral Nervous System, vol. 23, pp. 159 - 173, http://dx.doi.org/10.1111/jns.12278

Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC, 2018, 'Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum', Journal of Neurology, vol. 265, pp. 1819 - 1828, http://dx.doi.org/10.1007/s00415-018-8917-5

Baker MR; Dharmadasa T; Jaiser SR; Kiernan MC, 2018, 'Amyotrophic lateral sclerosis – Time for beta testing?', Clinical Neurophysiology, vol. 129, pp. 1455 - 1456, http://dx.doi.org/10.1016/j.clinph.2018.04.613

Turner MR; Eisen A; Kiernan MC; Ravits J; Swash M, 2018, 'Kinnier Wilson's puzzling features of amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 89, pp. 657 - 666, http://dx.doi.org/10.1136/jnnp-2017-317217

van Hummel A; Chan G; van der Hoven J; Morsch M; Ippati S; Suh L; Bi M; Asih PR; Lee WS; Butler TA; Przybyla M; Halliday GM; Piguet O; Kiernan MC; Chung RS; Ittner LM; Ke YD, 2018, 'Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice', American Journal of Pathology, vol. 188, pp. 1447 - 1456, http://dx.doi.org/10.1016/j.ajpath.2018.03.002

Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ, 2018, 'Association of regulatory T-Cell Expansion with progression of amyotrophic lateral sclerosis a study of humans and a transgenic mouse model', JAMA Neurology, vol. 75, pp. 681 - 689, http://dx.doi.org/10.1001/jamaneurol.2018.0035

Edwards LS; Barnett MH; Kieman MC, 2018, 'RITUXIMAB AND MAINTENANCE MYCOPHENOLATE MOFETIL FOR TREATMENT OF REFRACTORY ANTI-N-METHYL-D-ASPARTATE-RECEPTOR (NMDAR) ENCEPHALITIS', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol. 89, pp. E44 - E45, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.112

Kandula T; Farrar MA; Cohn R; Mizrahi D; Carey K; Johnston K; Kiernan M; Krishnan A; Park SB, 2018, 'Chemotherapy induced peripheral neuropathy in long-term survivors of childhood cancer: neurophysiological, functional and patient reported outcomes.', JAMA Neurology, vol. 75, pp. 980 - 988, http://dx.doi.org/10.1001/jamaneurol.2018.0963

Dharmadasa T; Huynh W; Tsugawa J; Shimatani Y; Ma Y; Kiernan MC, 2018, 'Implications of structural and functional brain changes in amyotrophic lateral sclerosis', Expert Review of Neurotherapeutics, vol. 18, pp. 407 - 419, http://dx.doi.org/10.1080/14737175.2018.1464912

Issar T; Arnold R; Kwai NCG; Pussell BA; Endre ZH; Poynten AM; Kiernan MC; Krishnan AV, 2018, 'The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study', Clinical Neurophysiology, vol. 129, pp. 889 - 894, http://dx.doi.org/10.1016/j.clinph.2018.02.120

Dharmadasa T; Kiernan MC, 2018, 'Riluzole, disease stage and survival in ALS', The Lancet Neurology, vol. 17, pp. 385 - 386, http://dx.doi.org/10.1016/S1474-4422(18)30091-7

Noto YI; Simon NG; Selby A; Garg N; Shibuya K; Shahrizaila N; Huynh W; Matamala JM; Dharmadasa T; Park SB; Vucic S; Kiernan MC, 2018, 'Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 129, pp. 974 - 980, http://dx.doi.org/10.1016/j.clinph.2018.01.061

Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Lera L; Vucic S; Burke D; Kiernan MC, 2018, 'Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS', Neuroscience Letters, vol. 674, pp. 18 - 23, http://dx.doi.org/10.1016/j.neulet.2018.02.065

Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC, 2018, 'Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment', Muscle and Nerve, vol. 57, pp. 848 - 851, http://dx.doi.org/10.1002/mus.26010

Ahmed RM; Ke YD; Vucic S; Ittner LM; Seeley W; Hodges JR; Piguet O; Halliday G; Kiernan MC, 2018, 'Physiological changes in neurodegeneration-mechanistic insights and clinical utility', Nature Reviews Neurology, vol. 14, pp. 259 - 271, http://dx.doi.org/10.1038/nrneurol.2018.23

Van den Bos MAJ; Menon P; Howells J; Geevasinga N; Kiernan MC; Vucic S, 2018, 'Physiological processes underlying short interval intracortical facilitation in the human motor cortex', Frontiers in Neuroscience, vol. 12, http://dx.doi.org/10.3389/fnins.2018.00240

Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CSY; Kiernan MC; Park SB, 2018, 'Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy', Muscle and Nerve, vol. 57, pp. 615 - 621, http://dx.doi.org/10.1002/mus.25968

Nicolas A; Kenna KP; Renton AE; Ticozzi N; Faghri F; Chia R; Dominov JA; Kenna BJ; Nalls MA; Keagle P; Rivera AM; van Rheenen W; Murphy NA; van Vugt JJFA; Geiger JT; Van der Spek RA; Pliner HA; Shankaracharya ; Smith BN; Marangi G; Topp SD; Abramzon Y; Gkazi AS; Eicher JD; Kenna A; Logullo FO; Simone IL; Logroscino G; Salvi F; Bartolomei I; Borghero G; Murru MR; Costantino E; Pani C; Puddu R; Caredda C; Piras V; Tranquilli S; Cuccu S; Corongiu D; Melis M; Milia A; Marrosu F; Marrosu MG; Floris G; Cannas A; Capasso M; Caponnetto C; Mancardi G; Origone P; Mandich P; Conforti FL; Cavallaro S; Mora G; Marinou K; Sideri R; Penco S; Mosca L; Lunetta C; Pinter GL; Corbo M; Riva N; Carrera P; Volanti P; Mandrioli J; Fini N; Fasano A; Tremolizzo L; Arosio A; Ferrarese C; Trojsi F; Tedeschi G; Monsurrò MR; Piccirillo G; Femiano C; Ticca A; Ortu E; La Bella V; Spataro R; Colletti T; Sabatelli M; Zollino M; Conte A; Luigetti M; Lattante S; Santarelli M; Petrucci A; Pugliatti M; Pirisi A; Parish LD; Occhineri P; Giannini F; Battistini S; Ricci C; Benigni M; Cau TB; Loi D; Calvo A; Moglia C; Brunetti M, 2018, 'Genome-wide Analyses Identify KIF5A as a Novel ALS Gene', Neuron, vol. 97, pp. 1268 - 1283.e6, http://dx.doi.org/10.1016/j.neuron.2018.02.027

Howells J; Bostock H; Park SB; Kiernan MC; Burke D, 2018, 'Tracking small sensory nerve action potentials in human axonal excitability studies', Journal of Neuroscience Methods, vol. 298, pp. 45 - 53, http://dx.doi.org/10.1016/j.jneumeth.2018.02.003

Park SB; Kiernan MC, 2018, 'Oxaliplatin and neuropathy: A role for sodium channels', Clinical Neurophysiology, vol. 129, pp. 670 - 671, http://dx.doi.org/10.1016/j.clinph.2017.12.028

Borire AA; Arnold R; Pussell BA; Kwai NC; Visser LH; Simon NG; Kiernan MC; Krishnan AV, 2018, 'Effects of hemodialysis on intraneural blood flow in end-stage kidney disease', Muscle and Nerve, vol. 57, pp. 287 - 293, http://dx.doi.org/10.1002/mus.25704

Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM, 2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies', Brain, vol. 141, pp. 521 - 534, http://dx.doi.org/10.1093/brain/awx328

Kiernan MC, 2018, 'Motor neuron disease in 2017: Progress towards therapy in motor neuron disease', Nature Reviews Neurology, vol. 14, pp. 65 - 66, http://dx.doi.org/10.1038/nrneurol.2017.186

Caga J; Hsieh S; Highton-Williamson E; Zoing MC; Ramsey E; Devenney E; Ahmed RM; Kiernan MC, 2018, 'Apathy and its impact on patient outcome in amyotrophic lateral sclerosis', Journal of Neurology, vol. 265, pp. 187 - 193, http://dx.doi.org/10.1007/s00415-017-8688-4

Burke D; Kiernan MC, 2018, 'Stimulus, response and excitability – What is new?', Clinical Neurophysiology, vol. 129, pp. 333 - 334, http://dx.doi.org/10.1016/j.clinph.2017.10.011

Dharmadasa T; Matamala JM; Huynh W; Zoing MC; Kiernan MC, 2018, 'Motor neurone disease', Handbook of Clinical Neurology, vol. 159, pp. 345 - 357, http://dx.doi.org/10.1016/B978-0-444-63916-5.00022-7

Radakovic R; Puthusseryppady V; Flanagan E; Kiernan MC; Mioshi E; Hornberger M, 2018, 'Frontostriatal grey matter atrophy in amyotrophic lateral sclerosis: A visual rating study', Dementia e Neuropsychologia, vol. 12, pp. 388 - 393, http://dx.doi.org/10.1590/1980-57642018dn12-040008

Garg N; Park SB; Howells J; Yiannikas C; Vucic S; Noto Y-I; Krishnan AV; Spies J; Mathey EK; Pollard JD; Kiernan MC, 2018, '004 Mechanisms of nerve dysfunction in inflammatory neuropathies', Journal of Neurology, Neurosurgery & Psychiatry, vol. 89, pp. A3.1 - A3, http://dx.doi.org/10.1136/jnnp-2018-anzan.4

Garg N; Park SB; Howells J; Noto Y-I; Yiannikas C; Krishnan AV; Spies J; Pollard JD; Vucic S; Bostock H; Kiernan MC, 2018, '1. Axonal function in inflammatory neuropathy: The importance of conduction block', Clinical Neurophysiology, vol. 129, pp. e1 - e1, http://dx.doi.org/10.1016/j.clinph.2017.12.014

Howells J; Makker PGS; Lees JG; Matamala JM; Park SB; Kiernan MC; Burke D; Moalem-Taylor G, 2018, '11. Studying human neurophysiology using the mouse tail!', Clinical Neurophysiology, vol. 129, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2017.12.024

Walker S; Narasimhan M; Matamala JM; Dharmadasa T; Kiernan MC; Huynh W, 2018, '7. Papillary thyroid cancer in a patient with Morvan’s syndrome', Clinical Neurophysiology, vol. 129, pp. e3 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.020

Timmins HC; Li T; Grimison P; Murray JE; Cox KM; Horvath LG; Lewis CR; Goldstein D; Kiernan MC; Park SB, 2018, '5. Neurophysiological dysfunction in chemotherapy-treated patients: Comparison of different platinum analogues', Clinical Neurophysiology, vol. 129, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.018

Li T; Howells J; Lin CSY; Garg N; Kiernan MC; Park SB, 2018, '8. Predicting motor disorders from nerve excitability studies', Clinical Neurophysiology, vol. 129, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.021

Dharmadasa T; Simon NG; Wang C; Vucic S; Kiernan MC, 2018, '021 Clinical implications of cortical dysfunction in motor neuron disease: a combined structural and functional approach', Journal of Neurology, Neurosurgery & Psychiatry, vol. 89, pp. A9.3 - A10, http://dx.doi.org/10.1136/jnnp-2018-anzan.21

Nathani D; Barnett MH; Spies J; Pollard J; Kiernan MC, 2018, '015 Predicting a diagnosis of pathologically confirmed vasculitic neuropathy', Journal of Neurology, Neurosurgery & Psychiatry, vol. 89, pp. A7.2 - A7, http://dx.doi.org/10.1136/jnnp-2018-anzan.15

Dharmadasa T; Matamala JM; Howells J; Vucic S; Kiernan M, 2018, 'S151. Assessing lower limb cortical function with threshold tracking transcranial magnetic stimulation', Clinical Neurophysiology, vol. 129, pp. e198 - e198, http://dx.doi.org/10.1016/j.clinph.2018.04.511

Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Vucic S; Burke D; Kiernan M, 2018, 'F147. Absolute and relative reliability of short-interval intracortical inhibition measured by threshold tracking transcranial magnetic stimulation', Clinical Neurophysiology, vol. 129, pp. e122 - e123, http://dx.doi.org/10.1016/j.clinph.2018.04.310

Noto Y-I; Simon NG; Selby A; Garg N; Vucic S; Kiernan M, 2018, 'T41. Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 129, pp. e17 - e17, http://dx.doi.org/10.1016/j.clinph.2018.04.042

Agarwal S; Highton-Williamson E; Matamala JM; Caga J; Howells J; Vucic S; Ahmed RM; Kiernan MC, 2018, '9. Upper motor neuron dysfunction and neuropsychological profile in PLS: Another entrant on the ALS-FTD spectrum', Clinical Neurophysiology, vol. 129, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.022

Nathani D; Barnett M; Pollard JD; Spies J; Wang M-X; Kiernan MC, 2018, '12. Clinical and neurophysiological predictors of vasculitic neuropathy diagnosed on nerve biopsy', Clinical Neurophysiology, vol. 129, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2017.12.025

Howells J; Trinh T; Burke D; Kiernan MC, 2018, '13. Threshold-tracking TMS without an MEP', Clinical Neurophysiology, vol. 129, pp. e6 - e6, http://dx.doi.org/10.1016/j.clinph.2017.12.026

van den Bos MAJ; Menon P; Geevasinga N; Kiernan MC; Vucic S, 2018, '6. ALS disability is predicted by a shift in the balance between short latency facilitatory and inhibitory circuits', Clinical Neurophysiology, vol. 129, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.019

Tsugawa J; Noto Y-I; Dharmadasa T; Garg N; Kiernan MC, 2018, '4. Median/ulnar nerve ultrasound cross-sectional area ratio in ALS', Clinical Neurophysiology, vol. 129, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2017.12.017

Shimatani Y; Matamala JM; Howells J; Kiernan MC, 2018, '3. Characterization of persistent Na + current in human motor and sensory axons: Exploring the activity at different target levels', Clinical Neurophysiology, vol. 129, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2017.12.016

Dharmadasa T; Matamala JM; Howells J; Vucic S; Kiernan MC, 2018, '10. Phenotypic variability in motor neuron disease: Site of onset and patterns of disease spread', Clinical Neurophysiology, vol. 129, pp. e4 - e5, http://dx.doi.org/10.1016/j.clinph.2017.12.023

Noto YI; Shibuya K; Shahrizaila N; Huynh W; Matamala JM; Dharmadasa T; Kiernan MC, 2017, 'Detection of fasciculations in amyotrophic lateral sclerosis: The optimal ultrasound scan time', Muscle and Nerve, vol. 56, pp. 1068 - 1071, http://dx.doi.org/10.1002/mus.25607

Turner MR; Al-Chalabi A; Chio A; Hardiman O; Kiernan MC; Rohrer JD; Rowe J; Seeley W; Talbot K, 2017, 'Genetic screening in sporadic ALS and FTD', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 1042 - 1044, http://dx.doi.org/10.1136/jnnp-2017-315995

Moalem-Taylor G; Baharuddin B; Bennett B; Krishnan AV; Huynh W; Kiernan MC; Shin-Yi Lin C; Shulruf B; Keoshkerian E; Cameron B; Lloyd A, 2017, 'Immune dysregulation in patients with carpal tunnel syndrome', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/s41598-017-08123-6

Geevasinga N; Korgaonkar MS; Menon P; Van den Bos M; Gomes L; Foster S; Kiernan MC; Vucic S, 2017, 'Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability', European Journal of Neurology, vol. 24, pp. 1507 - 1517, http://dx.doi.org/10.1111/ene.13461

Caldwell C; Kiernan M, 2017, 'The longest sleep', The Lancet Neurology, vol. 16, pp. 961 - 962, http://dx.doi.org/10.1016/S1474-4422(17)30375-7

Cooper-Knock J; Robins H; Niedermoser I; Wyles M; Heath PR; Higginbottom A; Walsh T; Kazoka M; Al Kheifat A; Al-Chalabi A; Basak N; Blair I; Dekker A; Hardiman O; Hide W; Iacoangeli A; Kenna K; Landers J; McLaughlin R; Mill J; Middelkoop B; Moisse M; Pardina JM; Morrison K; Newhouse S; Pulit S; Shatunov A; Shaw C; Sproviero W; Tazelaar G; van Damme P; van den Berg L; van der Spek R; Eijk K; van Es M; van Rheenen W; van Vugt J; Veldink J; Kooyman M; Glass J; Robberecht W; Gotkine M; Drory V; Kiernan M; Neto MM; Ztaz M; Couratier P; Corcia P; Silani V; Chio A; de Carvalho M; Pinto S; Redondo AG; Andersen P; Weber M; Ticozzi N; Ince PG; Hautbergue GM; McDermott CJ; Kirby J; Shaw PJ, 2017, 'Targeted genetic screen in amyotrophic lateral sclerosis reveals novel genetic variants with synergistic effect on clinical phenotype', Frontiers in Molecular Neuroscience, vol. 10, http://dx.doi.org/10.3389/fnmol.2017.00370

McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB, 2017, 'Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey', Supportive Care in Cancer, vol. 25, pp. 3485 - 3493, http://dx.doi.org/10.1007/s00520-017-3772-y

Eisen A; Braak H; Del Tredici K; Lemon R; Ludolph AC; Kiernan MC, 2017, 'Cortical influences drive amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 917 - 924, http://dx.doi.org/10.1136/jnnp-2017-315573

Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM, 2017, 'Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis', Acta neuropathologica communications, vol. 5, pp. 76, http://dx.doi.org/10.1186/s40478-017-0480-2

Garg N; Nguyen T; Mathey E; Park S; Yiannikas C; Vucic S; Spies J; Krishan A; Pollard J; Kiernan M, 2017, 'Autoantibody targets in chronic inflammatory demyelinating polyneuropathy', JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 381, pp. 276 - 277, http://dx.doi.org/10.1016/j.jns.2017.08.788

Timmins HC; Saw W; Cheah BC; Lin CSY; Vucic S; Ahmed RM; Kiernan MC; Park SB, 2017, 'Cardiometabolic health and risk of amyotrophic lateral sclerosis', Muscle and Nerve, vol. 56, pp. 721 - 725, http://dx.doi.org/10.1002/mus.25547

Garg N; Howells J; Yiannikas C; Vucic S; Krishnan AV; Spies J; Bostock H; Mathey EK; Pollard JD; Park SB; Kiernan MC, 2017, 'Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss', Clinical Neurophysiology, vol. 128, pp. 2022 - 2028, http://dx.doi.org/10.1016/j.clinph.2017.07.414

Arnold R; Pianta TJ; Pussell BA; Kirby A; O’Brien K; Sullivan K; Holyday M; Cormack C; Kiernan MC; Krishnan AV, 2017, 'Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD', Clinical Journal of the American Society of Nephrology, vol. 12, pp. 1569 - 1577, http://dx.doi.org/10.2215/CJN.00670117

De Carvalho M; Kiernan MC; Swash M, 2017, 'Fasciculation in amyotrophic lateral sclerosis: Origin and pathophysiological relevance', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 773 - 779, http://dx.doi.org/10.1136/jnnp-2017-315574

Dale RC; Barnett MH; Kiernan MC, 2017, 'Maternal autoimmunity: Risk of neurodevelopmental and neuropsychiatric outcomes', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 713 - 714, http://dx.doi.org/10.1136/jnnp-2017-315724

Coffey JC; Kiernan M, 2017, 'Adipocyte-Epithelial Interactions and Crohn's Disease - An Emerging Drug Target', EBIOMEDICINE, vol. 23, pp. 193 - 194, http://dx.doi.org/10.1016/j.ebiom.2017.08.029

Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC, 2017, 'Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies', Journal of Neuroimmunology, vol. 309, pp. 41 - 46, http://dx.doi.org/10.1016/j.jneuroim.2017.05.002

Matamala JM; Geevasinga N; Huynh W; Dharmadasa T; Howells J; Simon NG; Menon P; Vucic S; Kiernan MC, 2017, 'Cortical function and corticomotoneuronal adaptation in monomelic amyotrophy', Clinical Neurophysiology, vol. 128, pp. 1488 - 1495, http://dx.doi.org/10.1016/j.clinph.2017.05.005

Sillence KA; Halawani AJ; Tounsi WA; Clarke KA; Kiernan M; Madgett TE; Avent ND, 2017, 'Rapid RHD Zygosity Determination Using Digital PCR', CLINICAL CHEMISTRY, vol. 63, pp. 1388 - 1397, http://dx.doi.org/10.1373/clinchem.2016.268698

Noto YI; Simon N; Shibuya K; Matamala JM; Dharmadasa T; Kiernan MC, 2017, 'Dynamic muscle ultrasound identifies upper motor neuron involvement in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 18, pp. 404 - 410, http://dx.doi.org/10.1080/21678421.2017.1286355

Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB, 2017, 'Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer', Clinical Neurophysiology, vol. 128, pp. 1166 - 1175, http://dx.doi.org/10.1016/j.clinph.2017.04.009

Huynh W; Kiernan MC, 2017, 'A man with MS asking about medicinal cannabis', Medicine Today, vol. 18, pp. 56 - 59

Garg N; Park SB; Vucic S; Yiannikas C; Spies J; Howells J; Huynh W; Matamala JM; Krishnan AV; Pollard JD; Cornblath DR; Reilly MM; Kiernan MC, 2017, 'Differentiating lower motor neuron syndromes', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 474 - 483, http://dx.doi.org/10.1136/jnnp-2016-313526

Shibuya K; Simon NG; Geevasinga N; Menon P; Howells J; Park SB; Huynh W; Noto YI; Vucic S; Kiernan MC, 2017, 'The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 128, pp. 1075 - 1082, http://dx.doi.org/10.1016/j.clinph.2017.03.004

Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S, 2017, 'Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis', European Journal of Neurology, vol. 24, pp. 816 - 824, http://dx.doi.org/10.1111/ene.13295

Huynh W; Kwai N; Arnold R; Krishnan AV; Lin CSY; Vucic S; Kiernan MC, 2017, 'The effect of diabetes on cortical function in stroke: Implications for poststroke plasticity', Diabetes, vol. 66, pp. 1661 - 1670, http://dx.doi.org/10.2337/db16-0961

Kiernan MC, 2017, 'Some do not like it hot', Journal of Physiology, vol. 595, pp. 3251 - 3252, http://dx.doi.org/10.1113/JP274183

Simon NG; Lagopoulos J; Paling S; Pfluger C; Park SB; Howells J; Gallagher T; Kliot M; Henderson RD; Vucic S; Kiernan MC, 2017, 'Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS', Journal of Neurology, vol. 264, pp. 882 - 890, http://dx.doi.org/10.1007/s00415-017-8443-x

Dharmadasa T; Henderson RD; Talman PS; Al Macdonell R; Mathers S; Schultz DW; Needham M; Zoing M; Vucic S; Kiernan MC, 2017, 'Motor neurone disease: Progress and challenges', Medical Journal of Australia, vol. 206, pp. 357 - 362, http://dx.doi.org/10.5694/MJA16.01063

Kiernan MC, 2017, 'Transforming the management of stroke', Medical Journal of Australia, vol. 206, pp. 342 - 343, http://dx.doi.org/10.5694/mja17.00028

Bodea LG; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Götz J, 2017, 'Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model', Aging Cell, vol. 16, pp. 377 - 386, http://dx.doi.org/10.1111/acel.12565

Matamala JM; Dharmadasa T; Kiernan MC, 2017, 'Prognostic factors in C9orf72 amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 281, http://dx.doi.org/10.1136/jnnp-2016-314685

McLaughlin RL; Schijven D; Van Rheenen W; Van Eijk KR; O'Brien M; Kahn RS; Ophoff RA; Goris A; Bradley DG; Al-Chalabi A; Van Den Berg LH; Luykx JJ; Hardiman O; Veldink JH; Shatunov A; Dekker AM; Diekstra FP; Pulit SL; Van Der Spek RAA; Van Doormaal PTC; Sproviero W; Jones AR; Nicholson GA; Rowe DB; Pamphlett R; Kiernan MC; Bauer D; Kahlke T; Williams K; Eftimov F; Fogh I; Ticozzi N; Lin K; Millecamps S; Salachas F; Meininger V; Carvalho MD; Pinto S; Mora JS; Rojas-Garcyá R; Polak M; Chandran S; Colville S; Swingler R; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Pittman A; Sidle K; Fratta P; Malaspina A; Petri S; Abdulla S; Drepper C; Sendtner M; Meyer T; Wiedau-Pazos M; Lomen-Hoerth C; Deerlin VMV; Trojanowski JQ; Elman L; McCluskey L; Basak N; Meitinger T; Lichtner P; Blagojevic-Radivojkov M; Andres CR; Maurel C; Bensimon G; Landwehrmeyer B; Brice A; Payan CAM; Saker-Delye S; Durr A; Wood N; Tittmann L; Lieb W; Franke A; Rietschel M; Cichon S; Nothen MM; Amouyel P; Tzourio C; Dartigues JF; Uitterlinden AG; Rivadeneira F; Estrada K; Hofman A; Curtis C; Derkooi AJV; De Visser M; Weber M; Shaw CE; Smith BN; Pansarasa O; Cereda C; Bo RD; Comi GP; D'Alfonso S, 2017, 'Genetic correlation between amyotrophic lateral sclerosis and schizophrenia', Nature Communications, vol. 8, http://dx.doi.org/10.1038/ncomms14774

Ahmed RM; Irish M; van Eersel J; Ittner A; Ke YD; Volkerling A; van der Hoven J; Tanaka K; Karl T; Kassiou M; Kril JJ; Piguet O; Götz J; Kiernan MC; Halliday GM; Hodges JR; Ittner LM, 2017, 'Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology', Neuroscience and Biobehavioral Reviews, vol. 74, pp. 126 - 138, http://dx.doi.org/10.1016/j.neubiorev.2017.01.004

Meininger V; Genge A; van den Berg LH; Robberecht W; Ludolph A; Chio A; Kim SH; Leigh PN; Kiernan MC; Shefner JM; Desnuelle C; Morrison KE; Petri S; Boswell D; Temple J; Mohindra R; Davies M; Bullman J; Rees P; Lavrov A, 2017, 'Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial', The Lancet Neurology, vol. 16, pp. 208 - 216, http://dx.doi.org/10.1016/S1474-4422(16)30399-4

Shibuya K; Park SB; Howells J; Huynh W; Noto YI; Shahrizaila N; Matamala JM; Vucic S; Kiernan MC, 2017, 'Laterality of motor cortical function measured by transcranial magnetic stimulation threshold tracking', Muscle and Nerve, vol. 55, pp. 424 - 427, http://dx.doi.org/10.1002/mus.25372

Farrar MA; Park SB; Vucic S; Carey KA; Turner BJ; Gillingwater TH; Swoboda KJ; Kiernan MC, 2017, 'Emerging therapies and challenges in spinal muscular atrophy', Annals of Neurology, vol. 81, pp. 355 - 368, http://dx.doi.org/10.1002/ana.24864

Van Den Bos MAJ; Geevasinga N; Menon P; Burke D; Kiernan MC; Vucic S, 2017, 'Physiological processes influencing motor-evoked potential duration with voluntary contraction', Journal of Neurophysiology, vol. 117, pp. 1156 - 1162, http://dx.doi.org/10.1152/jn.00832.2016

Matamala JM; Kiernan MC, 2017, 'Natural history and the dawning of a new era for familial ALS', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 95 - 96, http://dx.doi.org/10.1136/jnnp-2016-313898

Vucic S; Kiernan MC, 2017, 'Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease', Neurotherapeutics, vol. 14, pp. 91 - 106, http://dx.doi.org/10.1007/s13311-016-0487-6

Pickering H; Murray J; Lin CSY; Cormack C; Martin A; Kiernan MC; Krishnan AV, 2017, 'Fampridine treatment and walking distance in multiple sclerosis: A randomised controlled trial', Clinical Neurophysiology, vol. 128, pp. 93 - 99, http://dx.doi.org/10.1016/j.clinph.2016.10.088

Borire AA; Visser LH; Padua L; Colebatch JG; Huynh W; Simon NG; Kiernan MC; Krishnan AV, 2017, 'Utility of maximum perfusion intensity as an ultrasonographic marker of intraneural blood flow', Muscle and Nerve, vol. 55, pp. 77 - 83, http://dx.doi.org/10.1002/mus.25200

Shahrizaila N; Noto Y; Simon NG; Huynh W; Shibuya K; Matamala JM; Dharmadasa T; Devenney E; Kennerson ML; Nicholson GA; Kiernan MC, 2017, 'Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy', Clinical Neurophysiology, vol. 128, pp. 227 - 232, http://dx.doi.org/10.1016/j.clinph.2016.11.010

Borire AA; Arnold R; Pussell BA; Kwai NC; Visser LH; Padua L; Simon NG; Kiernan MC; Krishnan AV, 2017, 'Haemodialysis alters peripheral nerve morphology in end-stage kidney disease', Clinical Neurophysiology, vol. 128, pp. 281 - 286, http://dx.doi.org/10.1016/j.clinph.2016.09.010

Park SB; Kiernan MC; Vucic S, 2017, 'Axonal Excitability in Amyotrophic Lateral Sclerosis: Axonal Excitability in ALS', Neurotherapeutics, vol. 14, pp. 78 - 90, http://dx.doi.org/10.1007/s13311-016-0492-9

Devenney EM; Landin-Romero R; Irish M; Hornberger M; Mioshi E; Halliday GM; Kiernan MC; Hodges JR, 2017, 'The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion', NeuroImage: Clinical, vol. 13, pp. 439 - 445, http://dx.doi.org/10.1016/j.nicl.2016.11.028

Ahmed RM; Landin-Romero R; Collet TH; Van Der Klaauw AA; Devenney E; Henning E; Kiernan MC; Piguet O; Farooqi IS; Hodges JR, 2017, 'Energy expenditure in frontotemporal dementia: A behavioural and imaging study', Brain, vol. 140, pp. 171 - 183, http://dx.doi.org/10.1093/brain/aww263

Kukreja JEB; Kiernan M; Schempp B; Siebert A; Hontar A; Nelson B; Dolan J; Noyes K; Dozier A; Ghazi A; Rashid HH; Wu G; Messing EM, 2017, 'Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study', BJU INTERNATIONAL, vol. 119, pp. 38 - 49, http://dx.doi.org/10.1111/bju.13521

Rich JD; Gosev I; Patel CB; Joseph S; Katz JN; Eckman PM; Lee S; Sundareswaran K; Kilic A; Bethea B; Soleimani B; Lima B; Uriel N; Kiernan M, 2017, 'The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device', JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol. 36, pp. 50 - 58, http://dx.doi.org/10.1016/j.healun.2016.08.010

Ahmed RM; Highton-Williamson E; Caga J; Thornton N; Ramsey E; Zoing M; Kim WS; Halliday GM; Piguet O; Hodges JR; Farooqi IS; Kiernan MC, 2017, 'Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition', Journal of Alzheimer's Disease, vol. 61, pp. 773 - 783, http://dx.doi.org/10.3233/JAD-170660

Kiernan M, 2017, 'Tracking neurodegeneration by TMS', Journal of the Neurological Sciences, vol. 381, pp. 40 - 40, http://dx.doi.org/10.1016/j.jns.2017.08.166

Burke D; Howells J; Kiernan MC, 2017, 'Sensory and motor axons are different: implications for neurological disease', Annals of Clinical Neurophysiology, vol. 19, pp. 3 - 3, http://dx.doi.org/10.14253/acn.2017.19.1.3

Geevasinga N; Menon P; Ng K; Van Den Bos M; Byth K; Kiernan MC; Vucic S, 2016, 'Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 17, pp. 580 - 588, http://dx.doi.org/10.1080/21678421.2016.1188961

Ahmed RM; Devenney EM; Irish M; Ittner A; Naismith S; Ittner LM; Rohrer JD; Halliday GM; Eisen A; Hodges JR; Kiernan MC, 2016, 'Neuronal network disintegration: Common pathways linking neurodegenerative diseases', Journal of Neurology, Neurosurgery and Psychiatry, vol. 87, pp. 1234 - 1241, http://dx.doi.org/10.1136/jnnp-2014-308350

Hsieh S; Irish M; Foxe D; Caga J; Devenney E; Ahmed R; Hodges JR; Piguet O; Kiernan MC, 2016, 'My memories are important to me: Changes in autobiographical memory in amyotrophic lateral sclerosis', Neuropsychology, vol. 30, pp. 920 - 930, http://dx.doi.org/10.1037/neu0000291

Farrar MA; Vucic S; Nicholson G; Kiernan MC, 2016, 'Motor cortical dysfunction develops in spinocerebellar ataxia type 3', Clinical Neurophysiology, vol. 127, pp. 3418 - 3424, http://dx.doi.org/10.1016/j.clinph.2016.09.005

Geevasinga N; Menon P; Özdinler PH; Kiernan MC; Vucic S, 2016, 'Pathophysiological and diagnostic implications of cortical dysfunction in ALS', Nature Reviews Neurology, vol. 12, pp. 651 - 661, http://dx.doi.org/10.1038/nrneurol.2016.140

Noto YI; Shibuya K; Vucic S; Kiernan MC, 2016, 'Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis', Expert Review of Neurotherapeutics, vol. 16, pp. 1147 - 1154, http://dx.doi.org/10.1080/14737175.2016.1197774

Dyer WB; Tan JCG; Day T; Kiers L; Kiernan MC; Yiannikas C; Reddel S; Ng K; Mondy P; Dennington PM; Dean MM; Trist HM; dos Remedios C; Hogarth PM; Vucic S; Irving DO, 2016, 'Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy', Brain and Behavior, vol. 6, http://dx.doi.org/10.1002/brb3.516

Kiernan MC, 2016, 'The babinski sign', Practical Neurology, vol. 16, pp. 419 - 420, http://dx.doi.org/10.1136/practneurol-2016-001417

Al-Chalabi A; Hardiman O; Kiernan MC; Chiò A; Rix-Brooks B; van den Berg LH, 2016, 'Amyotrophic lateral sclerosis: moving towards a new classification system', The Lancet Neurology, vol. 15, pp. 1182 - 1194, http://dx.doi.org/10.1016/S1474-4422(16)30199-5

Van Rheenen W; Shatunov A; Dekker AM; McLaughlin RL; Diekstra FP; Pulit SL; Van Der Spek RAA; Võsa U; De Jong S; Robinson MR; Yang J; Fogh I; Van Doormaal PTC; Tazelaar GHP; Koppers M; Blokhuis AM; Sproviero W; Jones AR; Kenna KP; Van Eijk KR; Harschnitz O; Schellevis RD; Brands WJ; Medic J; Menelaou A; Vajda A; Ticozzi N; Lin K; Rogelj B; Vrabec K; Ravnik-Glava M; Koritnik B; Zidar J; Leonardis L; Grošelj LD; Millecamps S; Salachas F; Meininger V; De Carvalho M; Pinto S; Mora JS; Rojas-García R; Polak M; Chandran S; Colville S; Swingler R; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Pittman A; Sidle K; Fratta P; Malaspina A; Topp S; Petri S; Abdulla S; Drepper C; Sendtner M; Meyer T; Ophoff RA; Staats KA; Wiedau-Pazos M; Lomen-Hoerth C; Van Deerlin VM; Trojanowski JQ; Elman L; McCluskey L; Basak AN; Tunca C; Hamzeiy H; Parman Y; Meitinger T; Lichtner P; Radivojkov-Blagojevic M; Andres CR; Maurel C; Bensimon G; Landwehrmeyer B; Brice A; Payan CAM; Saker-Delye S; Dürr A; Wood NW; Tittmann L; Lieb W; Franke A; Rietschel M; Cichon S; Nöthen MM; Amouyel P; Tzourio C; Dartigues JF; Uitterlinden AG; Rivadeneira F; Estrada K; Hofman A; Curtis C; Blauw HM; Van Der Kooi AJ, 2016, 'Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis', Nature Genetics, vol. 48, pp. 1043 - 1048, http://dx.doi.org/10.1038/ng.3622

Burrell JR; Halliday GM; Kril JJ; Ittner LM; Götz J; Kiernan MC; Hodges JR, 2016, 'The frontotemporal dementia-motor neuron disease continuum', The Lancet, vol. 388, pp. 919 - 931, http://dx.doi.org/10.1016/S0140-6736(16)00737-6

Menon P; Geevasinga N; Yiannikas C; Kiernan MC; Vucic S, 2016, 'Cortical contributions to the flail leg syndrome: Pathophysiological insights', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 17, pp. 389 - 396, http://dx.doi.org/10.3109/21678421.2016.1145232

Geevasinga N; Menon P; Scherman DB; Simon N; Yiannikas C; Henderson RD; Kiernan MC; Vucic S, 2016, 'Diagnostic criteria in amyotrophic lateral sclerosis', Neurology, vol. 87, pp. 684 - 690, http://dx.doi.org/10.1212/WNL.0000000000002988

Shibuya K; Park SB; Geevasinga N; Menon P; Howells J; Simon NG; Huynh W; Noto YI; Götz J; Kril JJ; Ittner LM; Hodges J; Halliday G; Vucic S; Kiernan MC, 2016, 'Motor cortical function determines prognosis in sporadic ALS', Neurology, vol. 87, pp. 513 - 520, http://dx.doi.org/10.1212/WNL.0000000000002912

Ahmed RM; Caga J; Devenney E; Hsieh S; Bartley L; Highton-Williamson E; Ramsey E; Zoing M; Halliday GM; Piguet O; Hodges JR; Kiernan MC, 2016, 'Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival', Journal of Neurology, vol. 263, pp. 1593 - 1603, http://dx.doi.org/10.1007/s00415-016-8168-2

Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH, 2016, 'TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia', Journal of the Neurological Sciences, vol. 366, pp. 197 - 201, http://dx.doi.org/10.1016/j.jns.2016.05.005

Huynh W; Pickering H; Howells J; Murray J; Cormack C; Lin CSY; Vucic S; Kiernan MC; Krishnan AV, 2016, 'Effect of fampridine on axonal excitability in multiple sclerosis', Clinical Neurophysiology, vol. 127, pp. 2636 - 2642, http://dx.doi.org/10.1016/j.clinph.2016.04.010

Huynh W; Simon NG; Grosskreutz J; Turner MR; Vucic S; Kiernan MC, 2016, 'Assessment of the upper motor neuron in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 127, pp. 2643 - 2660, http://dx.doi.org/10.1016/j.clinph.2016.04.025

Arnold R; Pussell BA; Kiernan MC; Krishnan AV, 2016, 'Comparative study to evaluate the effects of peritoneal and hemodialysis on peripheral nerve function', Muscle and Nerve, vol. 54, pp. 58 - 64, http://dx.doi.org/10.1002/mus.25016

Geevasinga N; Loy CT; Menon P; de Carvalho M; Swash M; Schrooten M; Van Damme P; Gawel M; Sonoo M; Higashihara M; Noto YI; Kuwabara S; Kiernan MC; Macaskill P; Vucic S, 2016, 'Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data', Clinical Neurophysiology, vol. 127, pp. 2684 - 2691, http://dx.doi.org/10.1016/j.clinph.2016.04.005

Barnett MH; Mathey E; Kiernan MC; Pollard JD, 2016, 'Axonal damage in central and peripheral nervous system inflammatory demyelinating diseases: Common and divergent pathways of tissue damage', Current Opinion in Neurology, vol. 29, pp. 213 - 221, http://dx.doi.org/10.1097/WCO.0000000000000334

Shibuya K; Park SB; Geevasinga N; Huynh W; Simon NG; Menon P; Howells J; Vucic S; Kiernan MC, 2016, 'Threshold tracking transcranial magnetic stimulation: Effects of age and gender on motor cortical function', Clinical Neurophysiology, vol. 127, pp. 2355 - 2361, http://dx.doi.org/10.1016/j.clinph.2016.03.009

Hornberger M; Kiernan MC, 2016, 'Emergence of an imaging biomarker for amyotrophic lateral sclerosis: Is the end point near?', Journal of Neurology, Neurosurgery and Psychiatry, vol. 87, pp. 569, http://dx.doi.org/10.1136/jnnp-2015-312882

Devine MS; Ballard E; Orourke P; Kiernan MC; McCombe PA; Henderson RD, 2016, 'Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 17, pp. 184 - 190, http://dx.doi.org/10.3109/21678421.2015.1125502

Caga J; Turner MR; Hsieh S; Ahmed RM; Devenney E; Ramsey E; Zoing MC; Mioshi E; Kiernan MC, 2016, 'Apathy is associated with poor prognosis in amyotrophic lateral sclerosis', European Journal of Neurology, vol. 23, pp. 891 - 897, http://dx.doi.org/10.1111/ene.12959

Kamminga J; Leslie FVC; Hsieh S; Caga J; Mioshi E; Hornberger M; Ballard KJ; Kiernan MC; Hodges JR; Burrell JR, 2016, 'Syntactic comprehension deficits across the FTD-ALS continuum', Neurobiology of Aging, vol. 41, pp. 11 - 18, http://dx.doi.org/10.1016/j.neurobiolaging.2016.02.002

De Silva D; Hsieh S; Caga J; Leslie FVC; Kiernan MC; Hodges JR; Mioshi E; Burrell JR, 2016, 'Motor function and behaviour across the ALS-FTD spectrum', Acta Neurologica Scandinavica, vol. 133, pp. 367 - 372, http://dx.doi.org/10.1111/ane.12471

Murray L; Butow PN; White K; Kiernan MC; D'Abrew N; Herz H, 2016, 'Advance care planning in motor neuron disease: A qualitative study of caregiver perspectives', Palliative Medicine, vol. 30, pp. 471 - 478, http://dx.doi.org/10.1177/0269216315613902

Kiernan MS; Katz JN, 2016, 'Operating in the Dark When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis?', CIRCULATION-HEART FAILURE, vol. 9, http://dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003141

Simon NG; Lagopoulos J; Gallagher T; Kliot M; Kiernan MC, 2016, 'Peripheral nerve diffusion tensor imaging is reliable and reproducible', Journal of Magnetic Resonance Imaging, vol. 43, pp. 962 - 969, http://dx.doi.org/10.1002/jmri.25056

Bae JS; Ferguson M; Tan R; Mioshi E; Simon N; Burrell J; Vucic S; Hodges JR; Kiernan MC; Hornberger M, 2016, 'Dissociation of structural and functional integrities of the motor system in amyotrophic lateral sclerosis and behavioral-variant frontotemporal dementia', Journal of Clinical Neurology (Korea), vol. 12, pp. 209 - 217, http://dx.doi.org/10.3988/jcn.2016.12.2.209

Huynh W; Vucic S; Krishnan AV; Lin CSY; Kiernan MC, 2016, 'Exploring the evolution of cortical excitability following acute stroke', Neurorehabilitation and Neural Repair, vol. 30, pp. 244 - 257, http://dx.doi.org/10.1177/1545968315593804

Ahmed RM; Irish M; Henning E; Dermody N; Bartley L; Kiernan MC; Piguet O; Farooqi S; Hodges JR, 2016, 'Assessment of eating behavior disturbance and associated neural networks in frontotemporal dementia', JAMA Neurology, vol. 73, pp. 282 - 290, http://dx.doi.org/10.1001/jamaneurol.2015.4478

Grieve SM; Menon P; Korgaonkar MS; Gomes L; Foster S; Kiernan MC; Vucic S, 2016, 'Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 17, pp. 85 - 92, http://dx.doi.org/10.3109/21678421.2015.1074707

Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM, 2016, 'Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions', Annals of Neurology, vol. 79, pp. 295 - 305, http://dx.doi.org/10.1002/ana.24565

Shahrizaila N; Sobue G; Kuwabara S; Kim SH; Birks C; Fan DS; Bae JS; Hu CJ; Gourie-Devi M; Noto Y; Shibuya K; Goh KJ; Kaji R; Tsai CP; Cui L; Talman P; Henderson RD; Vucic S; Kiernan MC, 2016, 'Amyotrophic lateral sclerosis and motor neuron syndromes in Asia', Journal of Neurology, Neurosurgery and Psychiatry, vol. 87, pp. 821 - 830, http://dx.doi.org/10.1136/jnnp-2015-312751

Simon NG; Kiernan MC, 2016, 'Diaphragm ultrasound in amyotrophic lateral sclerosis and other neuromuscular disorders', Clinical Neurophysiology, vol. 127, pp. 28 - 30, http://dx.doi.org/10.1016/j.clinph.2015.04.066

Menezes MP; Farrar MA; Webster R; Antony J; O'Brien K; Ouvrier R; Kiernan MC; Burns J; Vucic S, 2016, 'Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter', Clinical Neurophysiology, vol. 127, pp. 911 - 918, http://dx.doi.org/10.1016/j.clinph.2015.05.012

Hsieh S; Caga J; Leslie FVC; Shibata M; Daveson N; Foxe D; Ramsey E; Lillo P; Ahmed RM; Devenney E; Burrell JR; Hodges JR; Kiernan MC; Mioshi E, 2016, 'Cognitive and Behavioral Symptoms in ALSFTD', Journal of Geriatric Psychiatry and Neurology, vol. 29, pp. 3 - 10, http://dx.doi.org/10.1177/0891988715598232

Ahmed RM; Irish M; Piguet O; Halliday GM; Ittner LM; Farooqi S; Hodges JR; Kiernan MC, 2016, 'Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism', The Lancet Neurology, vol. 15, pp. 332 - 342, http://dx.doi.org/10.1016/S1474-4422(15)00380-4

Kiernan MC, 2016, '35,000 Days on Earth', Journal of Neurology, Neurosurgery and Psychiatry, vol. 87, pp. 1 - 2, http://dx.doi.org/10.1136/jnnp-2015-312686

Garg N; Yuki N; Park SB; Barnett MH; Kiernan MC, 2016, 'Acute bulbar, neck and limb weakness with monospecific anti-GT1a antibody: A rare localized subtype of Guillain-Barré sydnrome', Muscle and Nerve, vol. 53, pp. 143 - 146, http://dx.doi.org/10.1002/mus.24935

Dharmadasa T; Matamala JM; Kiernan MC, 2016, 'Treatment approaches in motor neurone disease', Current Opinion in Neurology, vol. 29, pp. 581 - 591, http://dx.doi.org/10.1097/WCO.0000000000000369

Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M, 2016, 'Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort', BMJ Open, vol. 6, pp. e012054, http://dx.doi.org/10.1136/BMJOPEN-2016-012054

Kwai NCG; Arnold R; Poynten AM; Howells J; Kiernan MC; Lin CSY; Krishnan AV, 2016, 'In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes', Clinical Neurophysiology, vol. 127, pp. 1700 - 1706, http://dx.doi.org/10.1016/j.clinph.2015.11.047

Farrar MA; Vucic S; Nicholson G; Kiernan MC, 2016, '3. Cortical dysfunction in Machado–Jospeh disease', Clinical Neurophysiology, vol. 127, pp. e11 - e11, http://dx.doi.org/10.1016/j.clinph.2015.11.023

Shibuya K; Park SB; Geevasinga N; Huynh W; Simon NG; Menon P; Howells J; Garg N; Noto Y-I; Iwai Y; Nicholson GA; Vucic S; Kuwabara S; Kiernan MC, 2016, '7. Pathophysiological basis of motor neuronal hyperexcitability in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 127, pp. e12 - e12, http://dx.doi.org/10.1016/j.clinph.2015.11.027

Garg N; Park SB; Pollard JD; Yiannikas C; Kiernan MC, 2016, '10. Neurophysiological profile of multifocal motor neuropathy', Clinical Neurophysiology, vol. 127, pp. e13 - e13, http://dx.doi.org/10.1016/j.clinph.2015.11.030

Timmins HC; Cheah BC; Lin CSY; Vucic S; Kiernan MC; Park SB, 2016, '5. Neurophysiological measures correlate with functional outcomes in ALS', Clinical Neurophysiology, vol. 127, pp. e11 - e11, http://dx.doi.org/10.1016/j.clinph.2015.11.025

Howells J; Park SB; Burke D; Kiernan MC, 2016, '18. Dysfunctional properties of single motor units in ALS', Clinical Neurophysiology, vol. 127, pp. e16 - e16, http://dx.doi.org/10.1016/j.clinph.2015.11.038

Geevasinga N; Menon P; Ng K; Kiernan MC; Vucic S, 2016, '12. Riluzole exerts short-term effects on cortical hyperexcitability in sporadic ALS', Clinical Neurophysiology, vol. 127, pp. e14 - e14, http://dx.doi.org/10.1016/j.clinph.2015.11.032

Geevasinga N; Menon P; Loy C; Yiannikas C; Simon NG; Kiernan MC; Vucic S, 2016, '11. Revisiting early diagnosis in ALS', Clinical Neurophysiology, vol. 127, pp. e13 - e14, http://dx.doi.org/10.1016/j.clinph.2015.11.031

J. van den Bos MA; Menon P; Geevasinga N; Kiernan MC; Vucic S, 2016, '19. Cortical hyperexcitability in ALS: A heterogeneous process', Clinical Neurophysiology, vol. 127, pp. e17 - e17, http://dx.doi.org/10.1016/j.clinph.2015.11.039

Devenney E; Bartley L; Hoon C; O'Callaghan C; Kumfor F; Hornberger M; Kwok JB; Halliday GM; Kiernan MC; Piguet O; Hodges JR, 2015, 'Progression in behavioral variant frontotemporal dementia: A longitudinal study', JAMA Neurology, vol. 72, pp. 1501 - 1509, http://dx.doi.org/10.1001/jamaneurol.2015.2061

Park SB; Vucic S; Cheah BC; Lin CSY; Kirby A; Mann KP; Zoing MC; Winhammar J; Kiernan MC, 2015, 'Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial', EBioMedicine, vol. 2, pp. 1916 - 1922, http://dx.doi.org/10.1016/j.ebiom.2015.11.022

Arnold R; Huynh W; Kiernan MC; Krishnan AV, 2015, 'Ion channel modulation as a therapeutic approach in multiple sclerosis', Current Medicinal Chemistry, vol. 22, pp. 4366 - 4378, http://dx.doi.org/10.2174/0929867322666151029104452

Kiernan MC; Turner MR, 2015, 'Lou Gehrig and the ALS split hand', Neurology, vol. 85, pp. 1995, http://dx.doi.org/10.1212/WNL.0000000000002172

Lu R; Kiernan MC; Murray A; Rosner MH; Ronco C, 2015, 'Kidney-brain crosstalk in the acute and chronic setting', Nature Reviews Nephrology, vol. 11, pp. 707 - 719, http://dx.doi.org/10.1038/nrneph.2015.131

Simon NG; Kiernan MC, 2015, 'Precise correlation between structural and electrophysiological disturbances in MADSAM neuropathy', Neuromuscular Disorders, vol. 25, pp. 904 - 907, http://dx.doi.org/10.1016/j.nmd.2015.07.012

Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM, 2015, 'Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS', Acta Neuropathologica, vol. 130, pp. 661 - 678, http://dx.doi.org/10.1007/s00401-015-1486-0

Geevasinga N; Menon P; Nicholson GA; Ng K; Howells J; Kril JJ; Yiannikas C; Kiernan MC; Vucic S, 2015, 'Cortical function in asymptomatic carriers and patients with C9Orf72 amyotrophic lateral sclerosis', JAMA Neurology, vol. 72, pp. 1268 - 1274, http://dx.doi.org/10.1001/jamaneurol.2015.1872

Ahmed RM; Latheef S; Bartley L; Irish M; Halliday GM; Kiernan MC; Hodges JR; Piguet O, 2015, 'Eating behavior in frontotemporal dementia', Neurology, vol. 85, pp. 1310 - 1317, http://dx.doi.org/10.1212/WNL.0000000000002018

Linnane B; Kearse L; O'Connell NH; Fenton J; Kiernan MG; Dunne CP, 2015, 'A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa', BMC PULMONARY MEDICINE, vol. 15, http://dx.doi.org/10.1186/s12890-015-0113-0

Hogden A; Greenfield D; Nugus P; Kiernan MCS, 2015, 'Development of a model to guide decision making in amyotrophic lateral sclerosis multidisciplinary care', Health Expectations, vol. 18, pp. 1769 - 1782, http://dx.doi.org/10.1111/hex.12169

Simon NG; Huynh W; Vucic S; Talbot K; Kiernan MC, 2015, 'Motor neuron disease: Current management and future prospects', Internal Medicine Journal, vol. 45, pp. 1005 - 1013, http://dx.doi.org/10.1111/imj.12874

Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JBJ; Hodges JR; Kiernan MC; Halliday GM, 2015, 'TDP-43 proteinopathies: Pathological identification of brain regions differentiating clinical phenotypes', Brain, vol. 138, pp. 3110 - 3122, http://dx.doi.org/10.1093/brain/awv220

Mathey EK; Park SB; Hughes RAC; Pollard JD; Armati PJ; Barnett MH; Taylor BV; Dyck PJB; Kiernan MC; Lin CSY, 2015, 'Chronic inflammatory demyelinating polyradiculoneuropathy: From pathology to phenotype', Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, pp. 973 - 985, http://dx.doi.org/10.1136/jnnp-2014-309697

Ahmed RM; Iodice V; Daveson N; Kiernan MC; Piguet O; Hodges JR, 2015, 'Autonomic dysregulation in frontotemporal dementia', Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, pp. 1048 - 1049, http://dx.doi.org/10.1136/jnnp-2014-309424

Caga J; Ramsey E; Hogden A; Mioshi E; Kiernan MC, 2015, 'A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis', Palliative and Supportive Care, vol. 13, pp. 1019 - 1024, http://dx.doi.org/10.1017/S1478951514000881

Simon NG; Ralph JW; Lomen-Hoerth C; Poncelet AN; Vucic S; Kiernan MC; Kliot M, 2015, 'Quantitative ultrasound of denervated hand muscles', Muscle and Nerve, vol. 52, pp. 221 - 230, http://dx.doi.org/10.1002/mus.24519

Devenney E; Foxe D; Dobson-Stone C; Kwok JB; Kiernan MC; Hodges JR, 2015, 'Clinical heterogeneity of the C9orf72 genetic mutation in frontotemporal dementia', Neurocase, vol. 21, pp. 535 - 541, http://dx.doi.org/10.1080/13554794.2014.951058

Kiernan M; Bhogal M; Wong K; Sivaprakasam R; Ashman N; Ali N, 2015, 'Sight-threatening intraocular pressure due to an upper arm dialysis fistula', LANCET, vol. 386, pp. 101 - 102, http://dx.doi.org/10.1016/S0140-6736(15)61003-0

Huynh W; Kiernan MC, 2015, 'A unique account of ALS in China: Exploring ethnic heterogeneity', Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, pp. 1051 - 1052, http://dx.doi.org/10.1136/jnnp-2015-311293

Eisen A; Lemon R; Kiernan MC; Hornberger M; Turner MR, 2015, 'Does dysfunction of the mirror neuron system contribute to symptoms in amyotrophic lateral sclerosis?', Clinical Neurophysiology, vol. 126, pp. 1288 - 1294, http://dx.doi.org/10.1016/j.clinph.2015.02.003

Ahmed RM; Kaizik C; Irish M; Mioshi E; Dermody N; Kiernan MC; Piguet O; Hodges JR, 2015, 'Characterizing sexual behavior in frontotemporal dementia', Journal of Alzheimer's Disease, vol. 46, pp. 677 - 686, http://dx.doi.org/10.3233/JAD-150034

Simon NG; Lee M; Bae JS; Mioshi E; Lin CSY; Pfluger CM; Henderson RD; Vucic S; Swash M; Burke D; Kiernan MC, 2015, 'Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis', Journal of Neurology, vol. 262, pp. 1424 - 1432, http://dx.doi.org/10.1007/s00415-015-7721-8

Ittner LM; Halliday GM; Kril JJ; Götz J; Hodges JR; Kiernan MC, 2015, 'FTD and ALS-translating mouse studies into clinical trials', Nature Reviews Neurology, vol. 11, pp. 360 - 366, http://dx.doi.org/10.1038/nrneurol.2015.65

Wang C; Paling D; Chen L; Hatton SN; Lagopoulos J; Aw ST; Kiernan MC; Barnett MH, 2015, 'Axonal conduction in multiple sclerosis: A combined magnetic resonance imaging and electrophysiological study of the medial longitudinal fasciculus', Multiple Sclerosis, vol. 21, pp. 905 - 915, http://dx.doi.org/10.1177/1352458514556301

Menon P; Geevasinga N; Yiannikas C; Howells J; Kiernan MC; Vucic S, 2015, 'Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study (vol 14, pg 478, 2015)', LANCET NEUROLOGY, vol. 14, pp. 566 - 566, http://dx.doi.org/10.1016/S1474-4422(15)00014-9

Borden M; Kiernan MS; Duc TP; DeNofrio D; Sylvia L, 2015, 'Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic international normalized ratios', JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol. 34, pp. 860 - 862, http://dx.doi.org/10.1016/j.healun.2015.01.981

Swash M; Kiernan MC, 2015, 'Measuring change in amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, pp. 1169 - 1170, http://dx.doi.org/10.1136/jnnp-2015-311051

Geevasinga N; Menon P; Sue CM; Kumar KR; Ng K; Yiannikas C; Kiernan MC; Vucic S, 2015, 'Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia', European Journal of Neurology, vol. 22, pp. 826 - e58, http://dx.doi.org/10.1111/ene.12669

Menon P; Geevasinga N; Yiannikas C; Howells J; Kiernan MC; Vucic S, 2015, 'Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: A prospective study', The Lancet Neurology, vol. 14, pp. 478 - 484, http://dx.doi.org/10.1016/S1474-4422(15)00014-9

Devenney E; Vucic S; Hodges JR; Kiernan MC, 2015, 'Motor neuron disease-frontotemporal dementia: A clinical continuum', Expert Review of Neurotherapeutics, vol. 15, pp. 509 - 522, http://dx.doi.org/10.1586/14737175.2015.1034108

Lee M; Kiernan MC; Macefield VG; Lee BB; Lin CSY, 2015, 'Short-term peripheral nerve stimulation ameliorates axonal dysfunction after spinal cord injury', Journal of Neurophysiology, vol. 113, pp. 3209 - 3218, http://dx.doi.org/10.1152/jn.00839.2014

Turner MR; Kiernan MC, 2015, 'The standard of care in amyotrophic lateral sclerosis:A centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder', Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, pp. 481 - 482, http://dx.doi.org/10.1136/jnnp-2014-309829

Simon NG; Lin CSY; Lee M; Howells J; Vucic S; Burke D; Kiernan MC, 2015, 'Segmental motoneuronal dysfunction is a feature of amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 126, pp. 828 - 836, http://dx.doi.org/10.1016/j.clinph.2014.07.029

Menon P; Kiernan MC; Vucic S, 2015, 'Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS', Clinical Neurophysiology, vol. 126, pp. 803 - 809, http://dx.doi.org/10.1016/j.clinph.2014.04.023

Farrar MA; Kiernan MC, 2015, 'The Genetics of Spinal Muscular Atrophy: Progress and Challenges', Neurotherapeutics, vol. 12, pp. 290 - 302, http://dx.doi.org/10.1007/s13311-014-0314-x

Kiernan MC, 2015, 'Palliative care in amyotrophic lateral sclerosis', The Lancet Neurology, vol. 14, pp. 347 - 348, http://dx.doi.org/10.1016/S1474-4422(14)70289-3

Huynh W; Kiernan MC, 2015, 'Peripheral nerve axonal excitability studies: Expanding the neurophysiologist's armamentarium', Cerebellum and Ataxias, vol. 2, pp. 4, http://dx.doi.org/10.1186/s40673-015-0022-2

Park SB; Sung JY; Tani J; Kiernan MC; Lin CSY, 2015, 'Reply: Biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy', Brain, vol. 138, pp. e336, http://dx.doi.org/10.1093/brain/awu254

Ahmed RM; Newcombe REA; Piper AJ; Lewis SJ; Yee BJ; Kiernan MC; Grunstein RR, 2015, 'Sleep disorders and respiratory function in amyotrophic lateral sclerosis', Sleep Medicine Reviews, vol. 26, pp. 33 - 42, http://dx.doi.org/10.1016/j.smrv.2015.05.007

Kwai N; Arnold R; Poynten AM; Lin CSY; Kiernan MC; Krishnan AV, 2015, 'Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus', Diabetes/Metabolism Research and Reviews, vol. 31, pp. 175 - 182, http://dx.doi.org/10.1002/dmrr.2583

Kiernan MC, 2015, 'Tragic choices', Journal of Medical Ethics, vol. 41, pp. 950 - 951, http://dx.doi.org/10.1136/medethics-2013-101652

Geevasinga N; Menon P; Howells J; Nicholson GA; Kiernan MC; Vucic S, 2015, 'Axonal ion channel dysfunction in C9orf72 familial amyotrophic lateral sclerosis', JAMA Neurology, vol. 72, pp. 49 - 57, http://dx.doi.org/10.1001/jamaneurol.2014.2940

Tan RH; Devenney E; Kiernan MC; Halliday GM; Hodges JR; Hornberger M, 2015, 'Terra incognita-cerebellar contributions to neuropsychiatric and cognitive dysfunction in behavioral variant frontotemporal dementia', Frontiers in Aging Neuroscience, vol. 7, http://dx.doi.org/10.3389/fnagi.2015.00121

Hsieh S; Leyton CE; Caga J; Flanagan E; Kaizik C; OConnor CM; Kiernan MC; Hodges JR; Piguet O; Mioshi E, 2015, 'The evolution of caregiver burden in frontotemporal dementia with and without amyotrophic lateral sclerosis', Journal of Alzheimer's Disease, vol. 49, pp. 875 - 885, http://dx.doi.org/10.3233/JAD-150475

Carswell C; Northey LC; Davies L; Yuki N; Kiernan MC, 2015, 'Progressive bilateral facial weakness', Practical Neurology, vol. 15, pp. 76 - 79, http://dx.doi.org/10.1136/practneurol-2014-000989

Kiernan MC, 2015, 'A fine neuroscience vintage', Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, pp. 1 - 2, http://dx.doi.org/10.1136/jnnp-2014-309899

Simon NG; Ralph JW; Lomen-Hoerth C; Poncelet AN; Vucic S; Kiernan MC; Kliot M, 2015, 'Quantitative ultrasound of denervated hand muscles', Muscle and Nerve, http://dx.doi.org/10.1002/mus.24519

Ahmed RM; Iodice V; Daveson N; Kiernan MC; Piguet O; Hodges JR, 2014, 'Autonomic dysregulation in frontotemporal dementia', Journal of Neurology, Neurosurgery and Psychiatry, http://dx.doi.org/10.1136/jnnp-2014-309424

Park SB; Kwok JB; Loy CT; Friedlander ML; Lin CSY; Krishnan AV; Lewis CR; Kiernan MC, 2014, 'Paclitaxel-induced neuropathy: Potential association of MAPT and GSK3B genotypes', BMC Cancer, vol. 14, http://dx.doi.org/10.1186/1471-2407-14-993

Devine MS; Kiernan MC; Heggie S; McCombe PA; Henderson RD, 2014, 'Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, pp. 481 - 487, http://dx.doi.org/10.3109/21678421.2014.906617

Simon NG; Lomen-Hoerth C; Kiernan MC, 2014, 'Patterns of clinical and electrodiagnostic abnormalities in early amyotrophic lateral sclerosis', Muscle and Nerve, vol. 50, pp. 894 - 899, http://dx.doi.org/10.1002/mus.24244

Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S, 2014, 'Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis', European Journal of Neurology, vol. 21, pp. 1451 - 1457, http://dx.doi.org/10.1111/ene.12422

Huynh W; Lin CSY; Krishnan AV; Vucic S; Kiernan MC, 2014, 'Transynaptic Changes Evident in Peripheral Axonal Function After Acute Cerebellar Infarct', Cerebellum, vol. 13, pp. 669 - 676, http://dx.doi.org/10.1007/s12311-014-0577-0

Simon NG; Turner MR; Vucic S; Al-Chalabi A; Shefner J; Lomen-Hoerth C; Kiernan MC, 2014, 'Quantifying disease progression in amyotrophic lateral sclerosis', Annals of Neurology, vol. 76, pp. 643 - 657, http://dx.doi.org/10.1002/ana.24273

Ahmed RM; MacMillan M; Bartley L; Halliday GM; Kiernan MC; Hodges JR; Piguet O, 2014, 'Systemic metabolism in frontotemporal dementia', Neurology, vol. 83, pp. 1812 - 1818, http://dx.doi.org/10.1212/WNL.0000000000000993

Eisen A; Kiernan M; Mitsumoto H; Swash M, 2014, 'Amyotrophic lateral sclerosis: A long preclinical period?', Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, pp. 1232 - 1238, http://dx.doi.org/10.1136/jnnp-2013-307135

Rowin EJ; Maron BJ; Kiernan MS; Casey SA; Feldman DS; Hryniewicz KM; Chan RH; Harris KM; Udelson JE; DeNofrio D; Roberts WC; Maron MS, 2014, 'Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy Under-Recognized Subset of Candidates for Heart Transplant', CIRCULATION-HEART FAILURE, vol. 7, pp. 967 - U148, http://dx.doi.org/10.1161/CIRCHEARTFAILURE.114.001435

Ahmed RM; Mioshi E; Caga J; Shibata M; Zoing M; Bartley L; Piguet O; Hodges JR; Kiernan MC, 2014, 'Body mass index delineates ALS from FTD: implications for metabolic health', Journal of Neurology, vol. 261, pp. 1774 - 1780, http://dx.doi.org/10.1007/s00415-014-7416-6

Tan RH; Devenney E; Dobson-Stone C; Kwok JB; Hodges JR; Kiernan MC; Halliday GM; Hornberger M, 2014, 'Cerebellar integrity in the amyotrophic lateral sclerosis - Frontotemporal dementia continuum', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0105632

Menon P; Kiernan MC; Vucic S, 2014, 'Cortical hyperexcitability of the thenar group of intrinsic hand muscles may contribute to the split-hand sign in ALS', Clinical Neurophysiology, vol. 125, http://dx.doi.org/10.1016/j.clinph.2013.10.023

Menon P; Kiernan MC; Vucic S, 2014, 'Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0087124

Mioshi E; Caga J; Lillo P; Hsieh S; Ramsey E; Devenney E; Hornberger M; Hodges JR; Kiernan MC, 2014, 'Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival', Neurology, vol. 82, pp. 149 - 154, http://dx.doi.org/10.1212/WNL.0000000000000023

Arnold R; Pussell BA; Howells J; Grinius V; Kiernan MC; Lin CSY; Krishnan AV, 2014, 'Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease', Clinical Neurophysiology, vol. 125, pp. 179 - 185, http://dx.doi.org/10.1016/j.clinph.2013.06.022

Menon P; Kiernan MC; Vucic S, 2014, 'ALS pathophysiology: Insights from the split-hand phenomenon', Clinical Neurophysiology, vol. 125, pp. 186 - 193, http://dx.doi.org/10.1016/j.clinph.2013.07.022

Simon NG; Vucic S; Joffe R; Kiernan MC, 2014, 'Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase', Journal of Neurology, vol. 261, pp. 238 - 239, http://dx.doi.org/10.1007/s00415-013-7197-3

Huynh W; Kiernan MC, 2014, 'Reply: Botulinum toxin injection for post-stroke spasticity', Muscle and Nerve, vol. 49, pp. 932 - 933, http://dx.doi.org/10.1002/mus.24221

Farrar MA; Park SB; Krishnan AV; Kiernan MC; Lin CSY, 2014, 'Axonal dysfunction, dysmyelination, and conduction failure in hereditary neuropathy with liability to pressure palsies', Muscle and Nerve, vol. 49, pp. 858 - 865, http://dx.doi.org/10.1002/mus.24085

Menon P; Kiernan MC; Vucic S, 2014, 'Cortical excitability differences in hand muscles follow a split-hand pattern in healthy controls', Muscle and Nerve, vol. 49, pp. 836 - 844, http://dx.doi.org/10.1002/mus.24072

Mioshi E; Hsieh S; Caga J; Ramsey E; Chen K; Lillo P; Simon N; Vucic S; Hornberger M; Hodges JR; Kiernan MC, 2014, 'A novel tool to detect behavioural symptoms in ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, pp. 298 - 304, http://dx.doi.org/10.3109/21678421.2014.896927

Ambikairajah A; Devenney E; Flanagan E; Yew B; Mioshi E; Kiernan MC; Hodges JR; Hornberger M, 2014, 'A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, pp. 226 - 234, http://dx.doi.org/10.3109/21678421.2014.880180

Bae JS; Menon P; Mioshi E; Kiernan MC; Vucic S, 2014, 'Cortical hyperexcitability and the split-hand plus phenomenon: Pathophysiological insights in ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, pp. 250 - 256, http://dx.doi.org/10.3109/21678421.2013.872150

Savage SA; Lillo P; Kumfor F; Kiernan MC; Piguet O; Hodges JR, 2014, 'Emotion processing deficits distinguish pure amyotrophic lateral sclerosis from frontotemporal dementia', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, pp. 39 - 46, http://dx.doi.org/10.3109/21678421.2013.809763

Sung JY; Tani J; Park SB; Kiernan MC; Lin CSY, 2014, 'Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy', Brain, vol. 137, pp. 2155 - 2163, http://dx.doi.org/10.1093/brain/awu158

Park SB; Lin CSY; Krishnan AV; Simon NG; Bostock H; Vincent A; Kiernan MC, 2014, 'Axonal dysfunction with voltage gated potassium channel complex antibodies', Experimental Neurology, vol. 261, pp. 337 - 342, http://dx.doi.org/10.1016/j.expneurol.2014.06.002

Bae JS; Yuki N; Kuwabara S; Kim JK; Vucic S; Lin CS; Kiernan MC, 2014, 'Guillain-Barré syndrome in Asia', Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, pp. 905 - 911, http://dx.doi.org/10.1136/jnnp-2013-306212

Vucic S; Rothstein JD; Kiernan MC, 2014, 'Advances in treating amyotrophic lateral sclerosis: Insights from pathophysiological studies', Trends in Neurosciences, vol. 37, pp. 433 - 442, http://dx.doi.org/10.1016/j.tins.2014.05.006

Menon P; Kiernan MC; Vucic S, 2014, 'Biomarkers and future targets for development in amyotrophic lateral sclerosis', Current Medicinal Chemistry, vol. 21, pp. 3535 - 3550, http://dx.doi.org/10.2174/0929867321666140601161148

Kiernan MC; Maxwell I, 2014, 'Corrigendum to "Proceedings of the 15th Biennial Clinical Neurophysiology Workshop of the Australian and New Zealand Association of Neurologists, Sheraton Mirage Resort, Gold Coast, Queensland, Australia, 29th September-2nd October, 2013" [Clin. Neurophysiol. 125 (2014) e1-e7]', Clinical Neurophysiology, vol. 125, pp. 2454, http://dx.doi.org/10.1016/j.clinph.2014.09.005

Kiernan MC, 2014, 'ALS and neuromuscular disease: In search of the Holy Grail', The Lancet Neurology, vol. 13, pp. 13 - 14, http://dx.doi.org/10.1016/S1474-4422(13)70226-6

Kiernan MC, 2014, 'Remembrance of things future', Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, pp. 1, http://dx.doi.org/10.1136/jnnp-2013-307129

Geevasinga N; Menon P; Kiernan MC; Vucic S, 2014, 'Motor cortical function and the precision grip', Physiological Reports, vol. 2, http://dx.doi.org/10.14814/phy2.12120

Devenney E; Hornberger M; Irish M; Mioshi E; Burrell J; Tan R; Kiernan MC; Hodges JR, 2014, 'Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile', JAMA neurology, vol. 71, pp. 331 - 339, http://dx.doi.org/10.1001/jamaneurol.2013.6002

Burrell JR; Hornberger M; Vucic S; Kiernan MC; Hodges JR, 2014, 'Apraxia and motor dysfunction in corticobasal syndrome', PloS One, vol. 9, pp. e92944 - e92944, http://dx.doi.org/10.1371/journal.pone.0092944

Leslie FVC; Hsieh S; Caga J; Savage SA; Mioshi E; Hornberger M; Kiernan MC; Hodges JR; Burrell JR, 2014, 'Semantic deficits in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 16, pp. 1 - 8, http://dx.doi.org/10.3109/21678421.2014.987301

Huynh W; Vucic S; Krishnan AV; Lin CS-Y; Kiernan MC, 2014, '8. Evolution and recovery of motor function post-stroke', Clinical Neurophysiology, vol. 125, pp. e3 - e4, http://dx.doi.org/10.1016/j.clinph.2013.10.030

Murray JE; Pickering HR; Lin CS-Y; Goldstein D; Friedlander ML; Kiernan MC; Krishnan AV, 2014, '6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy', Clinical Neurophysiology, vol. 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.028

Pickering H; Lin CS-Y; Murray J; Kiernan MC; Krishnan AV, 2014, '7. Effects of fampridine PR on axonal function in multiple sclerosis', Clinical Neurophysiology, vol. 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.029

Devenney E; Hoon C; Kiernan M; Hodges J, 2014, '14.', Journal of Clinical Neuroscience, vol. 21, pp. 2037 - 2037, http://dx.doi.org/10.1016/j.jocn.2014.06.028

Devine M; Kiernan M; Pannek K; Rose S; McCombe P; Henderson R, 2014, '28.', Journal of Clinical Neuroscience, vol. 21, pp. 2042 - 2042, http://dx.doi.org/10.1016/j.jocn.2014.06.042

Geevasinga N; Menon P; Yiannikas C; Kiernan M; Vucic S, 2014, 'O54: Diagnostic utility of cortical hyperexcitability in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 125, pp. S44 - S44, http://dx.doi.org/10.1016/s1388-2457(14)50157-5

Ahmed R; Irish M; Bartley L; Samaras K; Piguet O; Hodges J; Kiernan M, 2014, '30.', Journal of Clinical Neuroscience, vol. 21, pp. 2042 - 2043, http://dx.doi.org/10.1016/j.jocn.2014.06.044

Geevasinga N; Menon P; Kiernan MC; Vucic S, 2014, '3. Diagnostic utility of threshold tracking TMS in ALS: Comparative study to Awaji criteria', Clinical Neurophysiology, vol. 125, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2013.10.025

Wang C; Paling D; Chen L; Hatton S; Lagopoulos J; Aw S; Kiernan M; Barnett M, 2014, '66.', Journal of Clinical Neuroscience, vol. 21, pp. 2053 - 2054, http://dx.doi.org/10.1016/j.jocn.2014.06.080

Sung J-Y; Lin Y-C; Lin S-Y; Kiernan MC; Lin CS-Y, 2014, '14. Sensory axonal dysfunction in asymptomatic diabetic patients', Clinical Neurophysiology, vol. 125, pp. e5 - e6, http://dx.doi.org/10.1016/j.clinph.2013.10.036

Geevasinga N; Menon P; Nicholson G; Ng K; Kiernan M; Vucic S, 2014, '16.', Journal of Clinical Neuroscience, vol. 21, pp. 2038 - 2038, http://dx.doi.org/10.1016/j.jocn.2014.06.030

Leslie FVC; Hsieh S; Caga J; Mioshi E; Hornberger M; Kiernan MC; Hodges JR; Burrell JR, 2014, '13.', Journal of Clinical Neuroscience, vol. 21, pp. 2037 - 2037, http://dx.doi.org/10.1016/j.jocn.2014.06.027

Garg N; Barnett MH; Yuki N; Kiernan MC, 2014, '60.', Journal of Clinical Neuroscience, vol. 21, pp. 2052 - 2052, http://dx.doi.org/10.1016/j.jocn.2014.06.074

Menon P; Geevasingha N; Yiannikas C; Kiernan M; Vucic S, 2014, '15.', Journal of Clinical Neuroscience, vol. 21, pp. 2037 - 2038, http://dx.doi.org/10.1016/j.jocn.2014.06.029

Geevasinga N; Menon P; Sue CM; Kumar KR; Ng K; Kiernan M; Vucic S, 2014, '63.', Journal of Clinical Neuroscience, vol. 21, pp. 2052 - 2053, http://dx.doi.org/10.1016/j.jocn.2014.06.077

Huynh W; Krishnan AV; Vucic S; Lin CSY; Kiernan MC, 2013, 'Motor cortex excitability in acute cerebellar infarct', Cerebellum, vol. 12, pp. 826 - 834, http://dx.doi.org/10.1007/s12311-013-0493-8

Simon NG; vucic S; Joffe R; Kiernan MC, 2013, 'Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase.', Journal of Neurology, vol. 261, pp. 238 - 239, http://dx.doi.org/10.1007/s00415-013-7197-3

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, http://dx.doi.org/10.1002/caac.21204

Simon NG; Reddel SW; Kiernan MC; Layzer R, 2013, 'Muscle-specific kinase antibodies: A novel cause of peripheral nerve hyperexcitability?', Muscle and Nerve, vol. 48, pp. 819 - 823, http://dx.doi.org/10.1002/mus.23907

Sahebally SM; Burke JP; Chang KH; Kiernan MG; O'Connell PR; Coffey JC, 2013, 'Circulating fibrocytes and Crohn's disease', BRITISH JOURNAL OF SURGERY, vol. 100, pp. 1549 - 1556, http://dx.doi.org/10.1002/bjs.9302

Cudkowicz ME; van den Berg LH; Shefner JM; Mitsumoto H; Mora JS; Ludolph A; Hardiman O; Bozik ME; Ingersoll EW; Archibald D; Meyers AL; Dong Y; Farwell WR; Kerr DA, 2013, 'Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial', LANCET NEUROLOGY, vol. 12, pp. 1059 - 1067, http://dx.doi.org/10.1016/S1474-4422(13)70221-7

Arnold R; Pussell BA; Pianta TJ; Lin CSY; Kiernan MC; Krishnan AV, 2013, 'Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients', American Journal of Transplantation, vol. 13, pp. 2426 - 2432, http://dx.doi.org/10.1111/ajt.12324

Kiernan MC; Kaji R, 2013, 'Physiology and pathophysiology of myelinated nerve fibers', Handbook of Clinical Neurology, vol. 115, pp. 43 - 53, http://dx.doi.org/10.1016/B978-0-444-52902-2.00004-7

Williams KL; Fifita JA; Vucic S; Durnall JC; Kiernan MC; Blair IP; Nicholson GA, 2013, 'Pathophysiological insights into ALS with C9ORF72 expansions', Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, pp. 931 - 935, http://dx.doi.org/10.1136/jnnp-2012-304529

Vucic S; Kiernan MC, 2013, 'Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology', Handbook of Clinical Neurology, vol. 116, pp. 561 - 575, http://dx.doi.org/10.1016/B978-0-444-53497-2.00045-0

Vucic O; Lin CS-Y; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC, 2013, 'Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis', Brain, vol. 136, pp. 1361 - 1370, http://dx.doi.org/10.1093/brain/awt085

Kwai NCG; Arnold R; Wickremaarachchi C; Lin CS-Y; Poynten AM; Kiernan MC; Krishnan AV, 2013, 'Effects of Axonal Ion-Channel Dysfunction on Quality of Life in Type 2 Diabetes.', Diabetes Care, vol. 36, pp. 1272 - 1277, http://dx.doi.org/10.2337/dc12-1310

Arnold R; Pussell B; Pianta T; Grinius V; Lin CS-Y; Kiernan MC; Howells J; Jardine MJ; Krishnan AV, 2013, 'Effects of Hemodiafiltration and High Flux Hemodialysis on Nerve Excitability in End-Stage Kidney Disease', PLoS ONE, vol. 8, pp. Article number e59055, http://dx.doi.org/10.1371/journal.pone.0059055

Farrar MA; Park SB; Lin CS-Y; Kiernan MC, 2013, 'Evolution of peripheral nerve function in humans: Novel insights from motor nerve excitability', The Journal of Physiology, vol. 591, pp. 273 - 286, http://dx.doi.org/10.1113/jphysiol.2012.240820

Arnold R; Kwai NCG; Lin CS-Y; Poynten AM; Kiernan MC; Krishnan AV, 2013, 'Axonal dysfunction prior to neuropathy onset in type 1 diabetes', Diabetes - Metabolism Research and Reviews, vol. 29, pp. 53 - 59, http://dx.doi.org/10.1002/dmrr.2360

Huynh W; Vucic O; Krishnan AV; Lin CS-Y; Hornberger M; Kiernan MC, 2013, 'Longitudinal Plasticity Across the Neural Axis in Acute Stroke.', Neurorehabilitation and Neural Repair, vol. 27, pp. 219 - 229, http://dx.doi.org/10.1177/1545968312462071

Cheah BC; Lin CS-Y; Park SB; Vucic O; Krishnan AV; Kiernan MC, 2013, 'Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 123, pp. 2460 - 2467, http://dx.doi.org/10.1016/j.clinph.2012.06.020

Menon P; Kiernan MC; Yannikas C; Stroud J; Vucic O, 2013, 'Split-hand index for the diagnosis of amyotrophic lateral sclerosis.', Clinical Neurophysiology, vol. 124, pp. 410 - 416, http://dx.doi.org/10.1016/j.clinph.2012.07.025

Burrell JR; Carpenter RHS; Hodges JR; Kiernan MC, 2013, 'Early saccades in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 14, pp. 294 - 301, http://dx.doi.org/10.3109/21678421.2013.783077

Mioshi E; Lillo P; Yew B; Hsieh S; Savage S; Hodges JR; Kiernan MC; Hornberger M, 2013, 'Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes', Neurology, vol. 80, pp. 1117 - 1123, http://dx.doi.org/10.1212/WNL.0b013e31828869da

Menon P; Bae JS; Mioshi E; Kiernan MC; Vucic O, 2013, 'Split-hand plus sign in ALS: Differential involvement of the flexor pollicis longus and intrinsic hand muscles', Amyotroph Lateral Scler Frontotemporal Degener, vol. 14, pp. 315 - 318, http://dx.doi.org/10.3109/21678421.2012.734521

Bae JS; Menon P; Kiernan MC; Vucic O, 2013, 'Cortical excitability differences between flexor pollicis longus and APB', Neuroscience Letters, vol. 541, pp. 150 - 154, http://dx.doi.org/10.1016/j.neulet.2013.03.003

Vucic S; Nicholson G; Chio A; Kiernan MC, 2013, 'Apparent anticipation in SOD1 familial amyotrophic lateral sclerosis', Amyotroph Lateral Scler Frontotemporal Degener, vol. 14, pp. 452 - 456, http://dx.doi.org/10.3109/21678421.2013.764569

Krishnan AV; Kiernan MC, 2013, 'Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.', Multiple Sclerosis, vol. 19, pp. 385 - 391, http://dx.doi.org/10.1177/1352458512463769

Brodtmann A; Kiernan MC, 2013, 'Diagnostic shifts in ALS?: From clinical specter to imaging spectra.', Neurology, vol. 80, pp. 606 - 607, http://dx.doi.org/10.1212/WNL.0b013e318281cd27

Simon N; Kiernan MC, 2013, 'Fasciculation anxiety syndrome in clinicians', Journal of Neurology, vol. EPUB ahead of print, pp. 1743 - 1747, http://dx.doi.org/10.1007/s00415-013-6856-8

Bae JS; Simon NG; Menon P; Vucic O; Kiernan MC, 2013, 'The puzzling case of hyperexcitability in amyotrophic lateral sclerosis', Journal of Clinical Neurology (Korea), vol. 9, pp. 65 - 74, http://dx.doi.org/10.3988/jcn.2013.9.2.65

Kiernan MC, 2013, 'Lies, damned lies... and citation metrics.', Journal of Neurology Neurosurgery and Psychiatry, vol. 84, pp. 1 - 1, http://dx.doi.org/10.1136/jnnp-2012-304488

Farrar M; Vucic O; Johnston H; du Sart D; Kiernan MC, 2013, 'Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy.', Journal of Pediatrics, vol. 162, pp. 155 - 159, http://dx.doi.org/10.1016/j.jpeds.2012.05.067

Vucic O; Ziemann U; Eisen A; Hallett M; Kiernan MC, 2013, 'Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights', Journal of Neurology Neurosurgery and Psychiatry, vol. epub, pp. 1161 - 1170, http://dx.doi.org/10.1136/jnnp-2012-304019

Hsieh S; Lillo P; Kiernan MC; Hodges JR; Mioshi E, 2013, 'When more is needed: The utility of the frontotemporal dementia scale in ALS.', Amyotroph Lateral Scler Frontotemporal Degener, vol. 14, pp. 169 - 171, http://dx.doi.org/10.3109/2167842.2013.764899

Turner M; Hardiman O; Benatar ; Brooks BR; Chio A; De carvalho M; Ince PG; Lin CS-Y; Miller RG; Mitsumoto H; Nicholson G; Ravits J; Shaw P; Swash M; Talbot K; Traynor BJ; Van den berg LH; Veldink JH; Vucic S; Kiernan MC, 2013, 'Controversies and priorities in amyotrophic lateral sclerosis.', Lancet Neurology, vol. 12, pp. 310 - 322, http://dx.doi.org/10.1016/S1474-4422(13)70036-X

Hogden A; Greenfield D; Nugus P; Kiernan MC, 2013, 'Development of a model to guide decision-making in amyotrophic lateral sclerosis multidisciplinary care', Health Expectations, vol. Early online published 23 December 2013: doi: 10.1111/hex.12169, http://dx.doi.org/10.1111/hex.12169

Park SB; Lin CSY; Kiernan MC, 2012, 'Nerve excitability assessment in chemotherapy-induced neurotoxicity.', Journal of visualized experiments : JoVE

Park SB; Lin CSY; Kiernan MC, 2012, 'Nerve excitability assessment in chemotherapy-induced neurotoxicity', Journal of Visualized Experiments, http://dx.doi.org/10.3791/3439

Kiernan MC; Lin CSY, 2012, 'Nerve Excitability: A Clinical Translation', Aminoff's Electrodiagnosis in Clinical Neurology, pp. 345 - 365, http://dx.doi.org/10.1016/B978-1-4557-0308-1.00015-7

Park SB, 2012, 'WriteClick: Longitudinal assessment of oxaliplatin-induced neuropathy (Neurology (2012) 78 (152))', Neurology, vol. 78, pp. 515, http://dx.doi.org/10.1212/WNL.0b013e31824b2f5c

Kim S; Vucic O; Mahant N; Kiernan MC; Fung VS, 2012, 'The relationship between cortical and spinal hyperexcitability and clinical disease severity in stiff-man syndrome.', Parkinsonism and Related Disorders, vol. 18, pp. 1045 - 1047, http://dx.doi.org/10.1016/j.parkreldis.2012.04.022

Krishnan AV; Park SB; Huynh W; Lin CS-Y; Henderson RD; Kiernan MC, 2012, 'Impaired energy-dependent processes underlie acute lead neuropathy', Muscle and Nerve, vol. 46, pp. 961 - 964, http://dx.doi.org/10.1002/mus.23425

Bennett BK; Park SB; Lin CS-Y; Friedlander M; Kiernan MC; Goldstein D, 2012, 'Impact of Oxaliplatin-induced Neuropathy: A Patient Perspective', Supportive Care in Cancer, vol. 20, pp. 2959 - 2967, http://dx.doi.org/10.1007/s00520-012-1428-5

Park SB; Lin CS-Y; Kiernan MC, 2012, 'Nerve excitability assessment in chemotherapy-induced neurotoxicity', Journal of Visualized Experiments, vol. 62, pp. 1 - 5, http://dx.doi.org/10.3791/3439

Lillo P; Mioshi E; Burrell JR; Kiernan MC; Hodges JR; Hornberger M, 2012, 'Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum', PloS One, vol. 7, pp. e43993 - e43993, http://dx.doi.org/10.1371/journal.pone.0043993

Burrell JR; Hornberger M; Carpenter RHS; Kiernan MC; Hodges JR, 2012, 'Saccadic abnormalities in frontotemporal dementia', Neurology, vol. 78, pp. 1816 - 1823, http://dx.doi.org/10.1212/WNL.0b013e318258f75c

Burrell JR; Vucic S; Kiernan MC, 2012, 'Response to Karam et al', Amyotrophic Lateral Sclerosis, vol. 13, pp. 159 - 160, http://dx.doi.org/10.3109/17482968.2011.613573

Lillo P; Savage S; Mioshi E; Kiernan MC; Hodges JR, 2012, 'Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum', Amyotrophic Lateral Sclerosis, vol. 13, pp. 102 - 109, http://dx.doi.org/10.3109/17482968.2011

Mioshi E; Lillo P; Kiernan MC; Hodges JR, 2012, 'Activities of daily living in motor neuron disease: Role of behavioural and motor changes', Journal of Clinical Neuroscience, vol. 19, pp. 552 - 556, http://dx.doi.org/10.1016/j.jocn.2011.07.042

Amirjani N; Kiernan MC; Mckenzie DK; Butler JE; Gandevia SC, 2012, 'Is there a case for diaphragm pacing for amyotrophic lateral sclerosis patients?', Amyotrophic Lateral Sclerosis, vol. 13, pp. 521 - 527, http://dx.doi.org/10.3109/17482968.2012.673169

Tomlinson SE; Bostock H; Grinton BE; Hanna M; Kullmann DM; Kiernan MC; Scheffer I; Berkovic S; Burkey D, 2012, 'In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission', Brain, vol. 135, pp. 3144 - 3152, http://dx.doi.org/10.1093/brain/aws241

Vucic O; Hedley-Whyte ET; Reddel SR; Tisch S; Kotschet K; Cros D; Kiernan MC, 2012, 'FOSMN Syndrom : novel insight into diease pathophysiology', Neurology, vol. 79, pp. 73 - 79, http://dx.doi.org/10.1212/WNL.0b013e31825dce13

Simon N; Kiernan MC, 2012, 'Common peroneal neuropathy and cancer', Internal Medicine Journal, vol. 42, pp. 837 - 840, http://dx.doi.org/10.1111/j.1445-5994.2012.02836.x

Hunter M; Kiernan MC; Post J, 2012, 'Human T-lymphotropic virus seroconversion associated with pooled human intravenous immunoglobulin therapy.', Internal Medicine Journal, vol. 42, pp. 729 - 730, http://dx.doi.org/10.1111/j.1445-5994.2012.02803.x

Kiernan MC, 2012, 'Emergence of a predictive clinical biomarker for diabetic neuropathy', Diabetes, vol. 61, pp. 1346 - 1347, http://dx.doi.org/10.2337/db12-0193

Kiernan MC; Petri S, 2012, 'Hyperexcitability and amyotrophic lateral sclerosis', Neurology, vol. 78, pp. 1544 - 1545, http://dx.doi.org/10.1212/WNL.0b013e3182563c0a

Turner M; Kiernan MC, 2012, 'Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?', Amyotrophic Lateral Sclerosis, vol. 13, pp. 245 - 250, http://dx.doi.org/10.3109/17482968.2011.636050

Farrar M; Vucic O; Johnston H; Kiernan MC, 2012, 'Corticomotoneuronal Integrity and Adaption in Spinal Muscular Atrophy', Archives of Neurology, vol. 69, pp. 467 - 473, http://dx.doi.org/10.1001/archneurol.2011.1697

Kiernan MC, 2012, 'Amyotrophic lateral sclerosis and frontotemporal dementia', Journal of Neurology Neurosurgery and Psychiatry, vol. 83, pp. 355 - 355, http://dx.doi.org/10.1136/jnnp-2012-302357

Vucic S; Burke T; Lenton K; Ramanathan S; Gomes L; Yannikas C; Kiernan MC, 2012, 'Cortical dysfunction underlies disability in multiple sclerosis', Multiple Sclerosis, vol. 18, pp. 425 - 432, http://dx.doi.org/10.1177/1352458511424308

Ahmadzai ; Kiernan MC; Wakefield D; Thomas PS, 2012, 'Treatment of refractory neurosarcoidosis with TNF-inhibitors: what lies ahead?', Internal Medicine Journal, vol. 42, pp. 232 - 232, http://dx.doi.org/10.1111/j.1445-5994.2011.02576.x

Hogden A; Greenfield DR; Nugus PI; Kiernan MC, 2012, 'Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals', Patient Preference and Adherence, vol. 6, pp. 691 - 701, http://dx.doi.org/10.2147/PPA.S36759

Hogden A; Greenfield DR; Nugus PI; Kiernan MC, 2012, 'What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives.', Patient Preference and Adherence, vol. 2, pp. 829 - 838, http://dx.doi.org/10.2147/PPA.S37851

Kiernan MC, 2012, 'Movement disorders: what lies beneath?', Journal of Neurology Neurosurgery and Psychiatry, vol. 83, pp. 949 - 949, http://dx.doi.org/10.1136/jnnp-2012-303758

Kiernan MC, 2012, 'What is impact?', Journal of Neurology Neurosurgery and Psychiatry, vol. 83, pp. 1 - 2, http://dx.doi.org/10.1136/jnnp-2011-301738

Park SB; Koltzenburg M, 2012, 'Longitudinal Assessment of Oxaliplatin-induced Neuropathy', Neurology, vol. 78, pp. 152 - 152, http://dx.doi.org/10.1212/01.wnl.0000410913.88642.bf

Huynh W; Krishnan AV; Vucic S; Lin CS-Y; Hornberger M; Kiernan MC, 2012, '4. Unmasking the mechanisms of neuroplasticity in stroke: A study of the entire neural axis', Clinical Neurophysiology, vol. 123, pp. e70 - e70, http://dx.doi.org/10.1016/j.clinph.2011.11.013

Kwai N; Arnold R; Wickrema C; Poynten A; Kiernan M; Krishnan A, 2012, '20. Effects of altered axonal biophysical properties on quality of life in diabetic peripheral neuropathy', Clinical Neurophysiology, vol. 123, pp. e75 - e75, http://dx.doi.org/10.1016/j.clinph.2011.11.029

Menon P; Cheah B; Kiernan MC; Stroud J; Yiannikas C; Vucic S, 2012, '11. A novel diagnostic test for ALS – the split-hand index', Clinical Neurophysiology, vol. 123, pp. e72 - e72, http://dx.doi.org/10.1016/j.clinph.2011.11.020

Cheah BCC; Vucic S; Kiernan MC, 2012, 'Potential utility of biomarkers in the diagnosis and treatment of amyotrophic lateral sclerosis', Clinical Investigation, vol. 2, pp. 107 - 117, http://dx.doi.org/10.4155/cli.11.172

Murray JE; Pickering HR; Kiernan MC; Lin CS-Y, 2012, '12. All axons are not equal', Clinical Neurophysiology, vol. 123, pp. e72 - e73, http://dx.doi.org/10.1016/j.clinph.2011.11.021

Simon NG; Kiernan MC, 2012, '6. Electrodiagnostic abnormalities and patterns of spread in early amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 123, pp. e71 - e71, http://dx.doi.org/10.1016/j.clinph.2011.11.015

Burrell JR; Hornberger M; Carpenter RHS; Kiernan MC; Hodges JR, 2012, '18. Abnormal saccades detect frontal dysfunction in motor neuron disease', Clinical Neurophysiology, vol. 123, pp. e74 - e74, http://dx.doi.org/10.1016/j.clinph.2011.11.027

Herz H; Yang L; d'Abrew N; White K; Kiernan M; Butow P, 2012, 'Letter on future care; an individualised disease-specific future care plan for people with ALS', BMJ Supportive & Palliative Care, vol. 2, pp. 190.4 - 191, http://dx.doi.org/10.1136/bmjspcare-2012-000250.77

Menon P; Kiernan MC; Vucic S, 2011, 'Appearance, phenomenology and diagnostic utility of the split hand in amyotrophic lateral sclerosis', NEURODEGENERATIVE DISEASE MANAGEMENT, vol. 1, pp. 457 - 462, http://dx.doi.org/10.2217/NMT.11.60

Vucic S; Cheah BC; Yiannikas C; Kiernan MC, 2011, 'Cortical excitability distinguishes ALS from mimic disorders', CLINICAL NEUROPHYSIOLOGY, vol. 122, pp. 1860 - 1866, http://dx.doi.org/10.1016/j.clinph.2010.12.062

Toprak D; Friedlander P; Kiernan MP, 2011, 'A Teenager With Neck Pain', CLINICAL PEDIATRICS, vol. 50, pp. 79 - 80, http://dx.doi.org/10.1177/0009922810378740

Boland R; Lin CS-Y; Engel S; Kiernan MC, 2011, 'Adaption of motor function after spinal cord injury: Novel insights into spinal shock', Brain, vol. 134, pp. 495 - 505, http://dx.doi.org/10.1093/brain/awq289

Lin CS-Y; Lee M; Park SB; Kiernan MC, 2011, 'Purple pigments: the pathophysiology of acute porphyric neuropathy', Clinical Neurophysiology, vol. 122, pp. 2336 - 2344, http://dx.doi.org/10.1016/j.clinph.2011.07.036

Huynh W; Krishnan AV; Lin CS-Y; Vucic S; Kiernan MC, 2011, 'The effects of large artery ischemia and subsequent recanalization on nerve excitability', Muscle and Nerve, vol. 44, pp. 841 - 841, http://dx.doi.org/10.1002/mus.22209

Farrar M; Vucic O; Lin CS-Y; Park SB; Johnston H; Bostock H; Kiernan MC, 2011, 'Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy', Brain, vol. 134, pp. 3185 - 3197, http://dx.doi.org/10.1093/brain/awr229

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Long-term neuropathy after Oxaliplatin treatment: Challenging the dictum of reversibility', Oncologist, vol. 16, pp. 708 - 716, http://dx.doi.org/10.1634/theoncologist.2010-0248

Park SB; Lin CS-Y; Krishnan AV; Kiernan MC, 2011, 'The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?', Cancer Chemotherapy and Pharmacology, vol. 67, pp. 1189 - 1190, http://dx.doi.org/10.1007/s00280-011-1579-y

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Dose effects of Oxaliplatin on persistent and transient na+ conductances and the development of neurotoxicity', PLoS One, vol. 6, pp. 1 - 7, http://dx.doi.org/10.1371/journal.pone.0018469

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Lewis C; Kiernan MC, 2011, 'Early Progressive and Sustained Dysfunction of Sensory Axons Underlies Paclitaxel-induced Neuropathy', Muscle and Nerve, vol. 43, pp. 367 - 374, http://dx.doi.org/10.1002/mus.21874

Park SB; Lin CS-Y; Burke DJ; Kiernan MC, 2011, 'Activity-dependent conduction failure: Molecular insights', Journal of the Peripheral Nervous System, vol. 16, pp. 159 - 168, http://dx.doi.org/10.1111/j.1529-8027.2011.00358.x

Han SE; Lin CS-Y; Boland RA; Kiernan MC; Boland R, 2011, 'Nerve compression, membrane excitability, and symptoms of carpal tunnel syndrome', Muscle and Nerve, vol. 44, pp. 402 - 409, http://dx.doi.org/10.1002/mus.22078

Boland R; Lin CS-Y; Engel S; Kiernan MC, 2011, 'Adaptation of motor function after spinal cord injury: novel insights into spinal shock', Brain, vol. 134, pp. 495 - 505, http://dx.doi.org/10.1093/brain/awq289

Krishnan AV; Park SB; Payne ; Lin C; Vucic S; Kiernan MC, 2011, 'Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy', Clinical Neurophysiology, vol. 122, pp. 194 - 198, http://dx.doi.org/10.1016/j.clinph.2010.04.038

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy', Experimental Neurology, vol. 227, pp. 120 - 127, http://dx.doi.org/10.1016/j.expneurol.2010.10.002

Burrell JR; Yiannikas C; Rowe D; Kiernan MC, 2011, 'Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes', PloS One, vol. 6, pp. e27041 - e27041, http://dx.doi.org/10.1371/journal.pone.0027041

Burrell JR; Kiernan MC; Vucic S; Hodges JR, 2011, 'Motor neuron dysfunction in frontotemporal dementia', Brain: A Journal of Neurology, vol. 134, pp. 2582 - 2594, http://dx.doi.org/10.1093/brain/awr195

Burrell JR; Vucic S; Kiernan MC, 2011, 'Isolated bulbar phenotype of amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, vol. 12, pp. 283 - 289, http://dx.doi.org/10.3109/17482968.2011.551940

Kiernan MC; Vucic S; Cheah BC; Turner MR; Eisen A; Hardiman O; Burrell JR; Zoing MC, 2011, 'Amyotrophic lateral sclerosis', Lancet, vol. 377, pp. 942 - 955, http://dx.doi.org/10.1016/S0140-6736(10)61156-7

Huynh W; Kiernan MC, 2011, 'Nerve conduction studies', Australian Family Physician, vol. 40, pp. 693 - 697

Lillo P; Mioshi E; Zoing M; Kiernan MC; Hodges JR, 2011, 'How common are behavioural changes in amyotrophic lateral sclerosis?', Amyotrophic Lateral Sclerosis, vol. 12, pp. 45 - 51, http://dx.doi.org/10.3109/17482968.2010.520718

Carson A; Kiernan MC, 2011, 'Who is really the world's best known neurologist?', Practical Neurology, vol. 11, pp. 380 - 381, http://dx.doi.org/10.1136/practneurol-2011-000141

Hardiman O; Van den berg L; Kiernan MC, 2011, 'Clinical diagnosis and management of amyotrophic lateral sclerosis', Nature Reviews Neurology, vol. 7, pp. 639 - 649, http://dx.doi.org/10.1038/nrneurol.2011.153

Vucic S; Cheah BC; Kiernan MC, 2011, 'Maladaptation of cortical circuits underlies fatigue and weakness in ALS.', Amyotrophic Lateral Sclerosis, vol. 12, pp. 414 - 420, http://dx.doi.org/10.3109/17482968.2011.597403

Vucic O; Cheah BC; Yiannikas C; Kiernan MC, 2011, 'Cortical excitability distinguishes ALS from mimic disorders', Clinical Neurophysiology, vol. 122, pp. 1860 - 1866, http://dx.doi.org/10.1016/j.clinph.2010.12.062

Kiernan MC; Steve V, 2011, 'Clarifying variability of corticomotoneuronal function in kennedy disease', Muscle and Nerve, vol. 44, pp. 197 - 201, http://dx.doi.org/10.1002/mus.22017

Kiernan MC, 2011, 'Freud, Neurology and the Emergence of Dynamic Neural Networks', Journal of Neurology Neurosurgery and Psychiatry, vol. 82, pp. 120 - 120, http://dx.doi.org/10.1136/jnnp.2010.224998

Cheah BC; Vucic S; Krishnan AV; Boland R; Kiernan MC, 2011, 'Neurophysiological index as a biomarker for ALS progression: Validity of mixed effects models', Amyotrophic Lateral Sclerosis, vol. 12, pp. 33 - 38, http://dx.doi.org/10.3109/17482968.2010.531742

Vucic S; Cheah BC; Kiernan MC, 2011, 'Dissecting the Mechanisms Underlying Short-Interval Intracortical Inhibition Using Exercise', Cerebral Cortex, vol. 21, pp. 1639 - 1644, http://dx.doi.org/10.1093/cercor/bhq235

Kiernan MC, 2011, 'The Realm of Neurology – Past, Present and Future', Journal of Neurology Neurosurgery and Psychiatry, vol. 82, pp. 1 - 1, http://dx.doi.org/10.1136/jnnp.2010.234344

Zoing M; Kiernan MC, 2011, 'Motor neurone disease Caring for the patient in general practice', Australian Family Physician, vol. 40, pp. 962 - 966, http://search.informit.com.au/documentSummary;dn=686583020346040;res=IELHEA

Arnold R; Pianta T; Pussell B; Grinius V; Lin C; Kiernan M; Jardine M; Krishnan A, 2010, 'DIFFERENTIAL EFFECTS OF HAEMODIAFILTRATION ON HIGH FLUX HAEMODIALYSIS ON NERVE FUNCTION IN VITRO', NEPHROLOGY, vol. 15, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vucic S; Cheah BC; Yiannikas C; Vincent A; Kiernan MC, 2010, 'Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia', Brain, vol. 133, pp. 2727 - 2733, http://dx.doi.org/10.1093/brain/awq188

Farrar M; Lin CS-Y; Krishnan AV; Park SB; Andrews PI; Kiernan MC, 2010, 'Acute, reversible axonal energy failure during stroke-like episodes in MELAS', Pediatrics, vol. 126, pp. e734 - e739, http://dx.doi.org/10.1542/peds.2009-2930

Han SH; Lin CS-Y; Boland R; Bilston LE; Kiernan MC, 2010, 'Changes in human sensory axonal excitability induced by focal nerve compression', The Journal of Physiology, vol. 588, pp. 1737 - 1745, http://dx.doi.org/10.1113/jphysiol.2010.188169

He EY; Wang L; Kiernan MC, 2010, 'Scurvy and stroke - is there an association?', Medical Journal of Australia, vol. 193, pp. 555 - 556

Huynh W; Lam A; Vucic S; Cheah BC; Clouston P; Kiernan MC, 2010, 'Corticospinal tract dysfunction and development of Amyotrophic Lateral Sclerosis following electrical injury', Muscle and Nerve, vol. 42, pp. 288 - 292, http://dx.doi.org/10.1002/mus.21681

Loy CT; Jillian JK; Trollor JN; Kiernan MC; Kwok J; Vucic O; Halliday GM; Hodges JR, 2010, 'The case of a 48 year-old woman with bizarre and complex delusions', Nature Reviews Neurology, vol. 6, pp. 175 - 179, http://dx.doi.org/10.1038/nrneurol.2010.3

Cheah B; Kiernan MC, 2010, 'Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis', Idrugs, vol. 13, pp. 911 - 920

Inam S; Vucic S; Brodaty NE; Zoing M; Kiernan MC, 2010, 'The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis, vol. 11, pp. 558 - 561, http://dx.doi.org/10.3109/17482961003792958

Vucic O; Winhammar J; Rowe DB; Kiernan MC, 2010, 'Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers', Clinical Neurophysiology, vol. 121, pp. 1781 - 1785, http://dx.doi.org/10.1016/j.clinph.2010.02.164

Cheah B; Vucic O; Krishnan AV; Kiernan MC, 2010, 'Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, vol. 17, pp. 1942 - 1959, http://dx.doi.org/10.2174/092986710791163939

Vucic O; Burke DJ; Kiernan MC, 2010, 'Fatigue in multiple sclerosis: Mechanisms and management', Clinical Neurophysiology, vol. 121, pp. 809 - 817, http://dx.doi.org/10.1016/j.clinph.2009.12.013

Blair IP; Williams KL; Warraich S; Durnall J; Theong A; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA, 2010, 'FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis', Journal of Neurology Neurosurgery and Psychiatry, vol. 81, pp. 639 - 645, http://dx.doi.org/10.1136/jnnp.2009.194399

Kiernan MC, 2010, 'Why an Australian Editor for JNNP?', Journal of Neurology Neurosurgery and Psychiatry, vol. 81, pp. 1 - 1, http://dx.doi.org/10.1136/jnnp.2009.200063

Vucic O; Nicholson GA; Kiernan MC, 2010, 'Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS', Journal of Neurology Neurosurgery and Psychiatry, vol. 81, pp. 97 - 100, http://dx.doi.org/10.1136/jnnp.2008.157537

Vucic O; Kiernan MC, 2010, 'Upregulation of persistent sodium conductances in familial ALS', Journal of Neurology Neurosurgery and Psychiatry, vol. 81, pp. 222 - 227, http://dx.doi.org/10.1136/jnnp.2009.183079

Cheah B; Kiernan MC, 2010, 'Neurophysiological methodolgies: Diagnosis of peripheral nerve disease and assessment of pharmacological agents', Current Opinion in Investigational Drugs, vol. 11, pp. 72 - 79

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2010, '5. A novel biomarker of axonal dysfunction in oxaliplatin-induced neurotoxicity', Clinical Neurophysiology, vol. 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.025

Farrar MA; Lin CS-Y; Krishnan A; Park SB; Andrews PI; Kiernan MC, 2010, '6. Axonal energy failure during a stroke-like episode in MELAS', Clinical Neurophysiology, vol. 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.026

Talman PS; Kiernan M; Rowe D; Henderson R; Edis R; Thyagarajan D; Mathers S; Mcombe P, 2010, '13. Australian motor neuron disease registry 5 year follow-up', Journal of Clinical Neuroscience, vol. 17, pp. 1613 - 1614, http://dx.doi.org/10.1016/j.jocn.2010.07.014

Huynh W; Lam A; Cheah B; Vucic S; Kiernan MC, 2010, '2. Corticospinal dysfunction and the development of amyotrophic lateral sclerosis following electrical injury', Clinical Neurophysiology, vol. 121, pp. e1 - e1, http://dx.doi.org/10.1016/j.clinph.2009.10.022

Tomlinson SE; Grinton BE; Bostock H; Hanna MG; Kiernan MC; Berkovic SF; Burke D; Scheffer IE, 2010, '35. Peripheral nerve excitability testing shows distinctive ion channel dysfunction in patients with KCNQ2 mutations and epilepsy', Journal of Clinical Neuroscience, vol. 17, pp. 1621 - 1621, http://dx.doi.org/10.1016/j.jocn.2010.07.036

Burrell JR; Vucic S; Kiernan MC, 2010, '15. Distinct, isolated bulbar palsy presentations of amyotrophic lateral sclerosis', Journal of Clinical Neuroscience, vol. 17, pp. 1614 - 1614, http://dx.doi.org/10.1016/j.jocn.2010.07.016

Vucic S; Cheah BC; Kiernan MC, 2010, '14. Central mechanisms underlying fatigue in amyotrophic lateral sclerosis', Journal of Clinical Neuroscience, vol. 17, pp. 1614 - 1614, http://dx.doi.org/10.1016/j.jocn.2010.07.015

Farrar MA; Johnston HM; Grattan-Smith P; Turner A; Kiernan MC, 2009, 'Spinal muscular atrophy: Molecular mechanisms', Current Molecular Medicine, vol. 9, pp. 851 - 862, http://dx.doi.org/10.2174/156652409789105516

Cheah B; Boland R; Brodaty NE; Zoing M; Jeffrey S; Mckenzie DK; Kiernan MC, 2009, 'INSPIRATIonAL--INSPIRAtory muscle training in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis, vol. 10, pp. 384 - 392, http://dx.doi.org/10.3109/17482960903082218

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced Lhermitte’s phenomenon as a manifestation of severe generalized nerve dysfunction', Oncology, vol. 77, pp. 342 - 348, http://dx.doi.org/10.1159/000265940

Krishnan AV; Lin CS; Reddel SW; Mcgrath R; Kiernan MC, 2009, 'Conduction block and impaired axonal function in tick paralysis', Muscle and Nerve, vol. 40, pp. 358 - 362, http://dx.doi.org/10.1002/mus.21395

Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, vol. 27, pp. 1243 - 1249, http://dx.doi.org/10.1200/JCO.2008.19.3425

Krishnan AV; Lin CS-Y; Park SB; Kiernan MC, 2009, 'Axonal ion channels from bench to bedside: A translational neuroscience', Progress in Neurobiology, vol. 89, pp. 288 - 313, http://dx.doi.org/10.1016/j.pneurobio.2009.08.002

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, vol. 132, pp. 2712 - 2723, http://dx.doi.org/10.1093/brain/awp219

Burke D; Howells J; Trevillion L; McNulty PA; Jankelowitz SK; Kiernan MC, 2009, 'Threshold behaviour of human axons explored using subthreshold perturbations to membrane potential', The Journal of Physiology, vol. 587, pp. 491 - 504, http://dx.doi.org/10.1113/jphysiol.2008.163170

Krishnan AV; Pussell BA; Kiernan MC, 2009, 'Neuromuscular Disease in the Dialysis Patient: An Update for the Nephrologist', Seminars in Dialysis, vol. 22, pp. 267 - 278, http://dx.doi.org/10.1111/j.1525-139X.2008.00555.x

Nogajski J; Kiernan MC; Ouvrier R; Andrews PI, 2009, 'Congenital myasthenic syndromes', Journal of Clinical Neuroscience, vol. 16, pp. 1 - 11, http://dx.doi.org/10.1016/j.jocn.2008.05.001

Vucic O; Cheah BC; Kiernan MC, 2009, 'Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis', Experimental Neurology, vol. 220, pp. 177 - 182, http://dx.doi.org/10.1016/j.expneurol.2009.08.017

Krishnan AV; Kiernan MC, 2009, 'Neurological complications of chronic kidney disease', Nature Reviews Neurology, vol. 5, pp. 542 - 551, http://dx.doi.org/10.1038/nrneurol.2009.138

Kiernan MC, 2009, 'Amyotrophic lateral sclerosis and the neuroprotective potential of exercise', The Journal of Physiology, vol. 587, pp. 3759 - 3760, http://dx.doi.org/10.1113/jphysiol.2009.177022

Kiernan MC, 2009, 'Hyperexcitability, persistent Na+ conductances and neurodegeneration in amyotrophic lateral sclerosis', Experimental Neurology, vol. 218, pp. 1 - 4, http://dx.doi.org/10.1016/j.expneurol.2009.03.039

Boland R; Kiernan MC, 2009, 'Assessing the accuracy of a combination of clinical tests for identifying carpal tunnel syndrome', Journal of Clinical Neuroscience, vol. 16, pp. 929 - 933, http://dx.doi.org/10.1016/j.jocn.2008.09.004

Vucic O; Kiernan MC; Cornblath D, 2009, 'Guillain-Barré syndrome: an update', Journal of Clinical Neuroscience, vol. 16, pp. 733 - 741, http://dx.doi.org/10.1016/j.jocn.2008.08.033

Vucic O; Cheah B; Krishnan AV; Burke DJ; Kiernan MC, 2009, 'The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition', Brain Research, vol. 1, pp. 39 - 47, http://dx.doi.org/10.1016/j.brainres.2009.03.043

Vucic O; Kiernan MC, 2009, 'Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis', Current Molecular Medicine, vol. 9, pp. 255 - 272, http://dx.doi.org/10.2174/156652409787847173

Kiernan MC, 2009, 'Identification of cognitive deficits in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 120, pp. 645 - 646, http://dx.doi.org/10.1016/j.clinph.2009.02.156

Krishnan AV; Fulham MJ; Kiernan MC, 2009, 'Another Cause of Occupational Entrapment Neuropathy: La Main Du Cuisinier (The Chef's Hand)', Journal of Clinical Neurophysiology, vol. 26, pp. 129 - 131, http://dx.doi.org/10.1097/WNP.0b013e31819b3a5b

Boland R; Bostock H; Kiernan MC, 2009, 'Plasticity of lower limb motor axons after cervical cord injury', Clinical Neurophysiology, vol. 120, pp. 204 - 209, http://dx.doi.org/10.1016/j.clinph.2008.10.009

Turner M; Kiernan MC; Leigh P; Talbot K, 2009, 'Biomarkers in amyotrophic lateral sclerosis', Lancet Neurology, vol. 8, pp. 94 - 109, http://dx.doi.org/10.1016/S1474-4422(08)70293-X

Han SH; Boland R; Krishnan AV; Vucic S; Lin CS-Y; Kiernan MC, 2009, 'Ischaemic sensitivity of axons in carpal tunnel syndrome', Journal of the Peripheral Nervous System, vol. 14, pp. 190 - 200, http://dx.doi.org/10.1111/j.1529-8027.2009.00231.x

Barritt A; Bacsi AM; Tschuchnigg M; Sharpe D; Kiernan MC, 2009, 'Myasthenia gravis seven years after removal of an invasive thymoma', Journal of Clinical Neuroscience, vol. 16, pp. 966 - 968, http://dx.doi.org/10.1016/j.jocn.2008.09.016

Lin CS-Y; Krishnan AV; Park S; Kiernan MC, 2009, 'Effects of Immunotherapy on Nerve Excitability in Patients with Chronic Inflammatory Demyelinating Polyneuropathy', Journal of Clinical Neuroscience, vol. 16, pp. 1519 - 1520, http://dx.doi.org/10.1016/j.jocn.2009.07.019

Krishnan AV; Lin CS; Kiernan MC, 2009, '125. Conduction failure and fatigue in diabetic neuropathy', Journal of Clinical Neuroscience, vol. 16, pp. 468 - 469, http://dx.doi.org/10.1016/j.jocn.2008.07.025

Burrell JR; Yiannikas C; Rowe D; Kiernan MC, 2009, 'Predicting Response to Intravenous Immunoglobulin in Lower Motor Neuron Syndromes', Journal of Clinical Neuroscience, vol. 16, pp. 1515 - 1516, http://dx.doi.org/10.1016/j.jocn.2009.07.008

Winhammar JM; Vucic S; Kiernan M; Rowe DB, 2009, '231. Analysis of UMN Abnormalities in Parry-Romberg Syndrome', Journal of Clinical Neuroscience, vol. 16, pp. 479 - 479, http://dx.doi.org/10.1016/j.jocn.2008.07.058

Winhammar JM; Vucic S; Joffe D; Kiernan M; Rowe DB, 2009, '109. An Algorithm to Quantify UMN Involvement in ALS', Journal of Clinical Neuroscience, vol. 16, pp. 464 - 464, http://dx.doi.org/10.1016/j.jocn.2008.07.008

Cheah B; Boland R; Brodaty N; Zoing M; Jeffery S; McKenzie D; Kiernan M, 2009, 'INSPIRATIonAL - INSPIRAtory muscle Training In Amyotrophic Lateral sclerosis', Amyotrophic Lateral Sclerosis, pp. 1 - 9, http://dx.doi.org/10.1080/17482960903082218

Vucic S; Nicholson GA; Kiernan MC, 2009, '107. Cortical excitability in distal hereditary motor neuropathy with pyramidal tract signs linked 7q34-q36 Locus and Sporadic ALS: A Comparative Study', Journal of Clinical Neuroscience, vol. 16, pp. 463 - 463, http://dx.doi.org/10.1016/j.jocn.2008.07.006

Vucic S; Matthew C Kiernan , 2009, 'Abnormalities of Intracortical Pathways in Amyotrophic Lateral Sclerosis - Developing New Therapeutic Targets', Journal of Clinical Neuroscience, vol. 16, pp. 1516 - 1517, http://dx.doi.org/10.1016/j.jocn.2009.07.011

Cheah BC; Boland RA; Brodaty N; Jeffrey S; McKenzie DK; Kiernan MC, 2009, '201. Inspirational (inspiratory training in amyotrophic lateral sclerosis)', Journal of Clinical Neuroscience, vol. 16, pp. 469 - 470, http://dx.doi.org/10.1016/j.jocn.2008.07.028

Vucic S; Nicholson GA; Kiernan MC, 2008, 'Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis (vol 131, pg 1540, 2008)', BRAIN, vol. 131, pp. 2234 - 2234, http://dx.doi.org/10.1093/brain/awn141

Krishnan AV; Lin CSY; Park SB; Kiernan MC, 2008, 'Assessment of nerve excitability in toxic and metabolic neuropathies', Journal of the Peripheral Nervous System, vol. 13, pp. 7 - 26, http://dx.doi.org/10.1111/j.1529-8027.2008.00155.x

Bacsi AM; Kiernan MC, 2008, 'Changes in axonal excitability and burst pattern behaviour in synkinesis', Journal of Clinical Neuroscience, vol. 15, pp. 1288 - 1290

Krishnan AV; Lin CS; Park SB; Kiernan MC, 2008, 'Assessment of nerve excitability in toxic and metabolic neuropathies Assessment of nerve excitability in toxic and metabolic neuropathies. Journal of the Peripheral Nervous System 13:7-26.', Journal of the Peripheral Nervous System, vol. 13, pp. 7 - 26

Lin CS; Krishnan AV; Lee M; Zagami AS; You H; Yang C; Bostock H; Kiernan MC, 2008, 'Nerve function and dysfunction in acute intermittent porphyria', Brain, vol. 131, pp. 2510 - 2519, http://dx.doi.org/10.1093/brain/awn152

Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander ML; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, vol. 15, pp. 3081 - 3094, http://dx.doi.org/10.2174/092986708786848569

Han SH; Boland R; Krishnan AV; Vucic O; Lin CS; Kiernan MC, 2008, 'Changes in human sensory axonal excitability induced by an ischaemic insult', Clinical Neurophysiology, vol. 119, pp. 2054 - 2063, http://dx.doi.org/10.1016/j.clinph.2008.04.295

Krishnan AV; Lin CS; Kiernan MC, 2008, 'Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy', Brain, vol. 131, pp. 1209 - 1216, http://dx.doi.org/10.1093/brain/awn052

Nguyen-Lam J; Kiernan MC, 2008, 'Acute cortical blindness due to posterior reversible encephalopathy', Journal of Clinical Neuroscience, vol. 15, pp. 1182 - 1185, http://dx.doi.org/10.1016/j.jocn.2007.04.025

Kiernan MC, 2008, 'Paraspinal muscles and amyotrophic lateral sclerosis - Getting to the core?', Clinical Neurophysiology, vol. 119, pp. 1457 - 1458, http://dx.doi.org/10.1016/j.clinph.2008.03.013

Vucic O; Nicholson GA; Kiernan MC, 2008, 'Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis', Brain, vol. 131, pp. 1540 - 1550, http://dx.doi.org/10.1093/brain/awn071

Vucic O; Kiernan MC, 2008, 'Normal axonal ion channel function in large peripheral nerve fibers following chronic ciguatera sensitization', Muscle and Nerve, vol. 37, pp. 403 - 405, http://dx.doi.org/10.1002/mus.20906

Vucic O; Kiernan MC, 2008, 'Cortical excitability testing distinguishes Kennedy`s disease from amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 119, pp. 1088 - 1096, http://dx.doi.org/10.1016/j.clinph.2008.01.011

Krishnan AV; Bostock H; Ip J; Hayes M; Watson SR; Kiernan MC, 2008, 'Axonal function in a family with episodic ataxia type 2 due to a novel mutation', Journal of Neurology, vol. 255, pp. 750 - 755, http://dx.doi.org/10.1007/s00415-008-0794-x

Stone R; Archer J; Kiernan MC, 2008, 'Wernicke`s encephalopathy mimicking variant Creutzfeldt-Jakob disease', Journal of Clinical Neuroscience, vol. 15, pp. 1308 - 1310, http://dx.doi.org/10.1016/j.jocn.2007.05.022

Lin CS-Y; Krishnan A; Goldstein D; Friedlander M; Kiernan M, 2008, '457: Sensory nerve excitability in cancer patients treated with oxaliplatin', Journal of Clinical Neuroscience, vol. 15, pp. 362 - 362, http://dx.doi.org/10.1016/j.jocn.2007.07.067

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Goldstein D; Kiernan MC, 2008, 'Oxaliplatin-induced chronic changes in sensory nerve excitability', Clinical Neurophysiology, vol. 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.044

Lin CS-Y; Krishnan A; Lee M-J; Zagami AS; Kiernan MC, 2008, 'Axonal function in acute intermittent porphyria', Clinical Neurophysiology, vol. 119, pp. e21 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.043

Boland RA; Lin CS-Y; Krishnan AV; Engel S; Kiernan MC, 2008, 'Abnormalities in peripheral motor axon excitability in patients with acute spinal injury', Clinical Neurophysiology, vol. 119, pp. e19 - e19, http://dx.doi.org/10.1016/j.clinph.2007.10.033

Eric Han SH; Boland RA; Krishnan A; Vucic S; Lin CS-Y; Kiernan MC, 2008, 'Compression and ischaemia in human entrapment neuropathy', Clinical Neurophysiology, vol. 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.045

Vucic S; Nicholson GA; Kiernan M, 2008, '203: Cortical hyperexcitability precedes the development of familial amyotrophic lateral sclerosis', Journal of Clinical Neuroscience, vol. 15, pp. 337 - 338, http://dx.doi.org/10.1016/j.jocn.2007.07.007

Granot R; Kiernan M, 2008, 'Neurophysiology in the intensive care unit: Size (of surals) matters', Clinical Neurophysiology, vol. 119, pp. e23 - e23, http://dx.doi.org/10.1016/j.clinph.2007.10.047

Vucic S; Nicholson GA; Kiernan MC, 2008, 'Cortical hyperexcitability is an early feature of motor neuron disease', Clinical Neurophysiology, vol. 119, pp. e20 - e21, http://dx.doi.org/10.1016/j.clinph.2007.10.039

Cheah BC; Vucic S; Kiernan MC, 2008, 'Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 119, pp. e24 - e24, http://dx.doi.org/10.1016/j.clinph.2007.10.051

Lin CS; Macefield VG; Elam MB; Wallin BG; Engel S; Kiernan MC, 2007, 'Axonal changes in spinal cord injured patients distal to the site of injury', Brain, vol. 130, pp. 985 - 994, http://dx.doi.org/10.1093/brain/awl339

Bacsi AM; Kiernan MC, 2007, 'Changes in axonal axcitability and burst pattern behaviour in synkinesis', Journal of Clinical Neuroscience, vol. 15, pp. 1288 - 1290, http://dx.doi.org/10.1016/j.jocn.2007.09.011

Kiernan MC, 2007, 'The pain with platinum: Oxaliplatin and neuropathy', European Journal of Cancer, vol. 43, pp. 2631 - 2633, http://dx.doi.org/10.1016/j.ejca.2007.09.008

Burke D; Howells J; Trevillion L; Kiernan MC; Bostock H, 2007, 'Inflections in threshold electrotonus to depolarizing currents in sensory axons', Muscle and Nerve, vol. 36, pp. 849 - 852, http://dx.doi.org/10.1002/mus.20862

Vucic O; Kiernan MC, 2007, 'Pathophysiologic insights into motor axonal function in Kennedy disease', Neurology, vol. 69, pp. 1828 - 1935, http://dx.doi.org/10.1212/01.wnl.0000279521.81846.59

Vucic O; Krishnan AV; Kiernan MC, 2007, 'Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis', Journal of Neurology Neurosurgery and Psychiatry, vol. 78, pp. 1202 - 1208, http://dx.doi.org/10.1136/jnnp.2006.112078

Vucic O; Kiernan MC, 2007, 'Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis', Journal of Neurology Neurosurgery and Psychiatry, vol. 78, pp. 849 - 852, http://dx.doi.org/10.1136/jnnp.2006.105056

Krishnan AV; Hayes M; Kiernan MC, 2007, 'Axonal excitability properties in hemifacial spasm', Movement Disorders, vol. 22, pp. 1293 - 1298, http://dx.doi.org/10.1002/mds.21512

Boland R; Krishnan AV; Kiernan MC, 2007, 'Riche-Cannieu anastomosis as an inherited trait', Clinical Neurophysiology, vol. 118, pp. 770 - 775, http://dx.doi.org/10.1016/j.clinph.2006.12.009

Krishnan AV; Kiernan MC, 2007, 'Uremic neuropathy: Clinical features and new pathophysiological insights', Muscle and Nerve, vol. 35, pp. 273 - 290, http://dx.doi.org/10.1002/mus.20713

Hsing J; Welgampola MS; Kiernan MC, 2007, 'Reversible myeloradiculopathy due to Mycoplasma pneumoniae', Journal of Clinical Neuroscience, vol. 14, pp. 61 - 64, http://dx.doi.org/10.1016/j.jocn.2005.08.022

Kiernan MC, 2007, 'Nerve excitability in toxic and metabolic neuropathies', Journal of the Peripheral Nervous System, vol. 12, pp. 2 - 2, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249243600005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Vucic S; Kiernan MC, 2007, '644: The flail-limb variant of motor neuron disease', Journal of Clinical Neuroscience, vol. 14, pp. 1033 - 1034, http://dx.doi.org/10.1016/j.jocn.2007.02.075

Bostock H; Lin CS-Y; Kiernan MC, 2007, 'Nerve excitability changes in puffer fish poisoning', Clinical Neurophysiology, vol. 118, pp. e155 - e155, http://dx.doi.org/10.1016/j.clinph.2006.07.235

Vucic S; Howells JT; Trevillion L; Kiernan MC, 2007, '401: Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease', Journal of Clinical Neuroscience, vol. 14, pp. 1014 - 1014, http://dx.doi.org/10.1016/j.jocn.2007.02.024

Mackenzie R; Kiernan M; McKenzie D; Youl BD, 2006, 'Hyperimmune goat serum for amyotrophic lateral sclerosis', Journal of Clinical Neuroscience, vol. 13, pp. 1033 - 1036, http://dx.doi.org/10.1016/j.jocn.2006.03.009

Kiernan M, 2006, 'Annual Scientific Meeting of the AAN', JOURNAL OF CLINICAL NEUROSCIENCE, vol. 13, pp. 406 - 406, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236975700028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan M, 2006, 'The Australian Brain Foundation', JOURNAL OF CLINICAL NEUROSCIENCE, vol. 13, pp. 406 - 406, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236975700030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan M, 2006, 'Australian and New Zealand Association of Neurologists', JOURNAL OF CLINICAL NEUROSCIENCE, vol. 13, pp. 406 - 406, http://dx.doi.org/10.1016/j.jocn.2006.02.002

Kiernan M, 2006, 'Australia Day Honours List', JOURNAL OF CLINICAL NEUROSCIENCE, vol. 13, pp. 406 - 407, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236975700031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan M, 2006, 'Women in Neurology - "Jobs for the Girls" as well as the Boys', JOURNAL OF CLINICAL NEUROSCIENCE, vol. 13, pp. 406 - 406, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236975700029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan M, 2006, 'News from neurology.', Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, vol. 13, pp. 310 - 311, http://dx.doi.org/10.1016/j.jocn.2006.01.008

McKay O; Krishnan AV; Kiernan MC; Davis M, 2006, 'Activity-induced weakness in recessive myotonia congenita with a novel (696+1G > A) mutation', Clinical Neurophysiology, vol. 117, pp. 2064 - 2068, http://dx.doi.org/10.1016/j.clinph.2006.05.014

Nogajski J; Engel S; Kiernan MC, 2006, 'Focal and generalized peripheral nerve dysfunction in spinal cord-injured patients', Journal of Clinical Neurophysiology, vol. 23, pp. 273 - 279, http://dx.doi.org/10.1097/01.wnp.0000201062.99671.27

Kiernan MC; Krishnan AV, 2006, 'The pathophysiology of oxaliplatin-induced neurotoxicity', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, vol. 13, pp. 2901 - 2907, http://dx.doi.org/10.2174/092986706778521904

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, vol. 12, pp. 4481 - 4484, http://dx.doi.org/10.1158/1078-0432.CCR-06-0694

Winhammar J; Joffe D; Simmul R; Schoeffel R; Kiernan MC; Rowe DB, 2006, 'Nocturnal hypoxia in motor neuron disease is not predicted by standard respiratory function tests', Internal Medicine Journal, vol. 36, pp. 419 - 422, http://dx.doi.org/10.1111/j.1445-5994.2006.01102.x

Vucic O; Kiernan MC, 2006, 'Axonal excitability properties in amyotrophic lateral sclerosis', Clinical Neurophysiology, vol. 117, pp. 1458 - 1466, http://dx.doi.org/10.1016/j.clinph.2006.04.016

Krishnan AV; Phoon R; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2006, 'Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease', Brain, vol. 129, pp. 1585 - 1592, http://dx.doi.org/10.1093/brain/awl099

Krishnan AV; Kiernan MC, 2006, 'Axonal function and activity-dependent excitability changes in myotonic dystrophy', Muscle and Nerve, vol. 33, pp. 627 - 636, http://dx.doi.org/10.1002/mus.20516

Krishnan AV; Phoon R; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2006, 'Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease', Clinical Neurophysiology, vol. 117, pp. 992 - 999, http://dx.doi.org/10.1016/j.clinph.2006.02.002

Krishnan AV; Phoon R; Pussell BA; Charlesworth JA; Kiernan MC, 2006, 'Sensory nerve excitability and neuropathy in end stage kidney disease', Journal of Neurology Neurosurgery and Psychiatry, vol. 77, pp. 548 - 551, http://dx.doi.org/10.1136/jnnp.2005.079988

Kiernan MC, 2006, 'Back to the future: Excitability studies take on a new clinical role', Clinical Neurophysiology, vol. 117, pp. 712 - 713, http://dx.doi.org/10.1016/j.clinph.2005.12.023

Vucic O; Howells J; Trevillion L; Kiernan MC, 2006, 'Assessment of cortical excitability using threshold tracking techniques', Muscle and Nerve, vol. 33, pp. 477 - 486, http://dx.doi.org/10.1002/mus.20481

Zoing M; Burke D; Pamphlett R; Kiernan MC, 2006, 'Riluzole therapy for motor neurone disease: An early Australian experience (1996-2002)', Journal of Clinical Neuroscience, vol. 13, pp. 78 - 83, http://dx.doi.org/10.1016/j.jocn.2004.04.011

Martin AC; Friedlander ML; Kiernan MC, 2006, 'Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma', Journal of Clinical Neuroscience, vol. 13, pp. 595 - 598, http://dx.doi.org/10.1016/j.jocn.2005.06.006

Kiernan MC; Talman P; Henderson RD; Harris R, 2006, 'Establishment of an Australian motor neurone disease registry', Medical Journal of Australia, vol. 184, pp. 367 - 368

Vucic O; Kiernan MC, 2006, 'Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease', Brain, vol. 129, pp. 2436 - 2446, http://dx.doi.org/10.1093/brain/awl172

Kiernan M, 2005, 'News from neurology', JOURNAL OF CLINICAL NEUROSCIENCE, vol. 12, pp. 974 - 975, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234351700032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan M, 2005, 'Assessing fitness to drive', JOURNAL OF CLINICAL NEUROSCIENCE, vol. 12, pp. 847 - 847, http://dx.doi.org/10.1016/j.jocn.2005.08.003

Henderson RD; McCombe PA; Kiernan MC, 2005, 'Riluzole: A glimmer of hope in the treatment of motor neurone disease (multiple letters) [4]', Medical Journal of Australia, vol. 183, pp. 164 - 165, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06972.x

Kalapesi FB; Krishnan AV; Kiernan MC, 2005, 'Segmental facial anhidrosis and tonic pupils with preserved deep tendon reflexes: A novel autonomic neuropathy (vol 25, pg 7, 2005)', JOURNAL OF NEURO-OPHTHALMOLOGY, vol. 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229689000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan MC; Krishnan AV; Lin CS; Burke D; Berkovic S, 2005, 'Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability', Brain, vol. 128, pp. 1841 - 1846, http://dx.doi.org/10.1093/brain/awh520

Kiernan MC; Isbister GK; Lin CS; Burke D; Bostock H, 2005, 'Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish', Annals of Neurology, vol. 57, pp. 339 - 348, http://dx.doi.org/10.1002/ana.20395

Thomas PS; Kiernan MC; Yates D, 2005, 'Cerebral nocardiosis', Internal Medicine Journal, vol. 35, pp. 685 - 685, http://dx.doi.org/10.1111/j.1445-5994.2005.00959.x

Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2005, 'Altered motor nerve excitability in end-stage kidney disease', Brain, vol. 128, pp. 2164 - 2174, http://dx.doi.org/10.1093/brain/awh558

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, vol. 32, pp. 51 - 60, http://dx.doi.org/10.1002/mus.20340

Kiernan MC, 2005, 'Riluzole: a glimmer of hope in the treatment of motor neurone disease', Medical Journal of Australia, vol. 182, pp. 319 - 320

Winhammar J; Rowe DB; Henderson RD; Kiernan MC, 2005, 'Assessment of disease progression in motor neuron disease', Lancet Neurology, vol. 4, pp. 229 - 238, http://dx.doi.org/10.1016/S1474-4422(05)70042-9

Isbister GK; Kiernan MC, 2005, 'Neurotoxic marine poisoning', Lancet Neurology, vol. 4, pp. 219 - 228, http://dx.doi.org/10.1016/S1474-4422(05)70041-7

Kalapesi FB; Krishnan AV; Kiernan MC, 2005, 'Segmental facial anhidrosis and tonic pupils with preserved deep tendon reflexes: A novel autonomic neuropathy', Journal of Neuro - Ophthalmology, vol. 25, pp. 5 - 8, http://dx.doi.org/10.1097/00041327-200503000-00002

Krishnan AV; Colebatch JG; Kiernan MC, 2005, 'Hypokalemic weakness in hyperaldosteronism: Activity-dependent conduction block', Neurology, vol. 65, pp. 1309 - 1312, http://dx.doi.org/10.1212/01.wnl.0000181162.35142.a9

Krishnan AV; Kiernan MC, 2005, 'Altered nerve excitability properties in established diabetic neuropathy', Brain, vol. 128, pp. 1178 - 1187, http://dx.doi.org/10.1093/brain/awh476

Krishnan AV; Lin CS; Kiernan MC, 2005, 'Excitability differences in lower-limb motor axons during and after ischemia', Muscle and Nerve, vol. 31, pp. 205 - 213, http://dx.doi.org/10.1002/mus.20258

Krishnan A; Phoon RK; Pussel B; Charlesworth JA; Bostock H; Kiernan MC, 2005, 'Abnormal sensory nerve excitability underlying the development of uraemic neuropathy', Journal of the Neurological Sciences, vol. 238, pp. S189 - S190, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088001373&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Krishnan A; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC, 2005, 'Axonal dysfunction in uraemic neuropathy', Journal of the Neurological Sciences, vol. 238, pp. S93 - S94, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088001006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Vucic S; Howells JA; Trevillion L; Kiernan MC, 2005, 'The utility of threshold tracking transcranial magnetic stimulation in assessing cortical excitability', Journal of the Neurological Sciences, vol. 238, pp. S459 - S460, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088004163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Kiernan MC, 2005, 'Alterations in axonal sodium channel function in inherited epilepsy and neuropathy', Journal of the Neurological Sciences, vol. 238, pp. S34 - S35, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Burke D; Kiernan M; Maxwell I, 2005, 'Proceedings of the 11th Biennial Clinical Neurophysiology Workshop of the Australian Association of Neurologists', Clinical Neurophysiology, vol. 116, pp. e19 - e24, http://dx.doi.org/10.1016/j.clinph.2005.05.001

Kiernan MC; Lin CS; Burke D, 2004, 'Differences in activity-dependent hyperpolarization in human sensory and motor axons', The Journal of Physiology, vol. 558, pp. 341 - 349, http://dx.doi.org/10.1113/jphysiol.2004.063966

Krishnan AV; Lin CS; Kiernan MC, 2004, 'Nerve excitability properties in lower-limb motor axons: evidence for a length-dependent gradient', Muscle and Nerve, vol. 29, pp. 645 - 655, http://dx.doi.org/10.1002/mus.20013

Kiernan MC; Bullpitt P; Chan JH, 2004, 'Mitochondrial dysfunction and rod-like lesions associated with administration of beta-2 adrenoceptor agonist formoterol', Neuromuscular Disorders, vol. 14, pp. 375 - 377, http://dx.doi.org/10.1016/j.nmd.2004.02.014

Bostock H; Walters RJ; Andersen KV; Murray NM; Taube D; Kiernan MC, 2004, 'Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy?', Nephrology Dialysis Transplantation, vol. 19, pp. 1054 - 1057, http://dx.doi.org/10.1093/ndt/gfh093

Krishnan AV; Pamphlett R; Burke D; Wills EJ; Kiernan MC, 2004, 'Cytoplasmic body myopathy masquerading as motor neuron disease', Muscle and Nerve, vol. 30, pp. 667 - 672, http://dx.doi.org/10.1002/mus.20115

Kiernan MC; Baker M; Bostock H, 2003, 'Characteristics of late Na+ current in adult rat small sensory neurons', Neuroscience, vol. 119, pp. 653 - 660, http://dx.doi.org/10.1016/S0306-4522(03)00194-5

Kiernan MC, 2003, 'Motor neurone disease: a Pandora`s box', Medical Journal of Australia, vol. 178, pp. 311 - 312

Kiernan MC, 2002, 'Chapter 23 Pathophysiology of paraesthesiae', Supplements to Clinical Neurophysiology, vol. 54, pp. 156 - 162, http://dx.doi.org/10.1016/S1567-424X(09)70443-X

Kiernan MC; Walters RJL; Andersen KV; Taube D; Murray NMF; Bostock H, 2002, 'Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia', Brain, vol. 125, pp. 1366 - 1378, http://dx.doi.org/10.1093/brain/awf123

Kiernan MC; Guglielmi JM; Kaji R; Murray NMF; Bostock H, 2002, 'Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block', Brain, vol. 125, pp. 664 - 675, http://dx.doi.org/10.1093/brain/awf041

Isbister GK; Son J; Wang F; Maclean CJ; Lin CS; Ujma J; Balit CR; Smith B; Milder DG; Kiernan MC, 2002, 'Puffer fish poisoning: a potentially life-threatening condition', Medical Journal of Australia, vol. 177, pp. 650 - 653

Sharma S; Sumich PM; Francis IC; Kiernan MC; Spira PJ, 2002, 'Wernicke`s encephalopathy presenting with upbeating nystagmus', Journal of Clinical Neuroscience, vol. 9, pp. 476 - 478, http://dx.doi.org/10.1054/jocn.2002.1121

Walters RJL; Kiernan MC; Murray NMF; Bostock H, 2001, 'Distal excitability properties of median motor axons', Muscle and Nerve, vol. 24, pp. 1695 - 1698, http://dx.doi.org/10.1002/mus.1205

Kiernan MC; Vonau M; Bullpitt PR; Tohver E; Milder DG, 2001, 'Butterfly lesion of the corpus callosum due to Schilder's disease', Journal of Clinical Neuroscience, vol. 8, pp. 367 - 369, http://dx.doi.org/10.1054/jocn.2000.0797

Kiernan MC; Cikurel K; Bostock H, 2001, 'Effects of temperature on the excitability properties of human motor axons', Brain, vol. 124, pp. 816 - 825, http://dx.doi.org/10.1093/brain/124.4.816

Cumming S; Harris L; Kiernan M; Williams R, 2001, 'Semantic priming of expectancies among high-and low-restraint non-problem drinkers', Australian Journal of Psychology, vol. 53, pp. 155 - 159, http://dx.doi.org/10.1080/00049530108255139

Kiernan MC; Hart IK; Bostock H, 2001, 'Excitability properties of motor axons in patients with spontaneous motor unit activity', Journal of Neurology Neurosurgery and Psychiatry, vol. 70, pp. 56 - 64, http://dx.doi.org/10.1136/jnnp.70.1.56

Burke DJ; Kiernan MC; Bostock H, 2001, 'Excitability of human axons.', Clinical Neurophysiology, vol. 112, pp. 1575 - 1585, http://dx.doi.org/10.1016/S1388-2457(01)00595-8

Kiernan MC; Lin CS; Bostock H; Andersen KV; Murray NM, 2001, 'Clinical evaluation of excitability measures in sensory nerve.', Muscle and Nerve, vol. 24, pp. 883 - 892, http://dx.doi.org/10.1002/mus.1085

Kiernan MC; Bostock H, 2000, 'Effects of membrane polarization and ischaemia on the excitability properties of human motor axons', Brain, vol. 123, pp. 2542 - 2551, http://dx.doi.org/10.1093/brain/123.12.2542

Kiernan MC; Burke DJ; Andersen KV; Bostock H, 2000, 'Multiple measures of axonal excitability: a new approach in clinical testing', Muscle and Nerve, vol. 23, pp. 399 - 409, http://dx.doi.org/10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G

Burke D; Kiernan MC; Mogyoros I; Lin C; Rutkove SB; Raynor EM; Blum AS; Wang AK, 1999, 'Heat sensitivity of sensory fibers in carpal tunnel syndrome [2] (multiple letters)', Muscle and Nerve, vol. 22, pp. 969 - 970, http://dx.doi.org/10.1002/(SICI)1097-4598(199907)22:7<969::AID-MUS29>3.0.CO;2-V

Kiernan MC; Lethlean AK; Blum PW, 1999, 'Monomelic amyotrophy: Non progressive atrophy of the upper limb', Journal of Clinical Neuroscience, vol. 6, pp. 353 - 355, http://dx.doi.org/10.1016/S0967-5868(99)90066-8

Burke DJ; Mogyoros I; Vagg R; Kiernan MC, 1999, 'Temperature dependence of excitibility indices in human peripheral nerve', Muscle and Nerve, pp. 51 - 60

Kiernan MC; Burke DJ, 1999, 'Common entrapment neuropathies - presentation and management', Modern Medicine of Australia, pp. 62 - 71

Burke DJ; Mogyoros I; Vagg R; Kiernan MJ, 1999, 'Temperature dependence of excitability indices of human cutaneous afferents', Muscle and Nerve, vol. 22, pp. 51 - 60, http://dx.doi.org/10.1002/(SICI)1097-4598(199901)22:1<51::AID-MUS9>3.0.CO;2-Q

Kiernan MC; Mogyoros I; Burke DJ, 1999, 'Value of homonymous and heteronymous monosynaptic reflexes in the diagnosis and follow-up of cervical spinal injuries', Journal of Clinical Neuroscience, vol. 6, pp. 24 - 26, http://dx.doi.org/10.1016/S0967-5868(99)90597-0

Kiernan MC; Mogyoros I; Burke DJ, 1999, 'Conduction block in carpal tunnel syndrome', Brain, vol. 122, pp. 933 - 941, http://dx.doi.org/10.1093/brain/122.5.933

Burke DJ; Kiernan MC; Mogyoros I; Lin CS, 1999, 'Heat sensitivity of sensory fibers in carpal tunnel syndrome', Muscle and Nerve, vol. 22, pp. 969 - 970, http://dx.doi.org/10.1002/(SICI)1097-4598(199907)22:7<969::AID-MUS29>3.0.CO;2-V

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1998, 'Ischaemic resistance of cutaneous afferents and motor axons in patients with amyotrophic lateral sclerosis', Muscle and Nerve, vol. 21, pp. 1692 - 1700, http://dx.doi.org/10.1002/(SICI)1097-4598(199812)21:12<1692::AID-MUS11>3.0.CO;2-X

Burke DJ; Mogyoros I; Vagg R; Kiernan MC, 1998, 'Quantitative description of the voltage dependence of axonal excitability in human cutaneous afferents', Brain, vol. 121, pp. 1975 - 1983, http://dx.doi.org/10.1093/brain/121.10.1975

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1998, 'Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis', Brain, vol. 121, pp. 851 - 859, http://dx.doi.org/10.1093/brain/121.5.851

Vagg R; Mogyoros I; Kiernan MC; Burke DJ, 1998, 'Activity-dependent hyperpolarization of motor axons produced by natural activity', The Journal of Physiology, vol. 507, pp. 919 - 925, http://dx.doi.org/10.1111/j.1469-7793.1998.919bs.x

Mogyoros I; Kiernan MC; Burke D, 1997, 'Strength-duration properties of sensory and motor axons in carpal tunnel syndrome', MUSCLE & NERVE, vol. 20, pp. 508 - 510, http://dx.doi.org/10.1002/(SICI)1097-4598(199704)20:4<508::AID-MUS17>3.0.CO;2-U

Kiernan MC; Hales JP; Gracies J; Mogyoros I; Burke DJ, 1997, 'Paraesthesiae induced by prolonged high frequency stimulation of human cutaneous afferents', The Journal of Physiology, vol. 501, pp. 461 - 471, http://dx.doi.org/10.1111/j.1469-7793.1997.461bn.x

Mogyoros I; Kiernan MC; Burke DJ, 1997, 'Strength duration properties of cutaneous and motor axons in carpal tunnel syndrome', Muscle and Nerve, vol. 20, pp. 508 - 510, http://dx.doi.org/10.1002/(SICI)1097-4598(199704)20:4<508::AID-MUS17>3.0.CO;2-U

Kiernan MC; Mogyoros I; Hales JP; Gracies J; Burke DJ, 1997, 'Excitability changes in human cutaneous afferents induced by prolonged repetitive axonal activity', The Journal of Physiology, vol. 500, pp. 255 - 264, http://dx.doi.org/10.1113/jphysiol.1997.sp022015

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1997, 'Excitability changes in human sensory and motor axons during hyperventilation and ischaemia', Brain, vol. 120, pp. 317 - 325, http://dx.doi.org/10.1093/brain/120.2.317

Kiernan MJ; Mogyoros I; Burke DJ, 1996, 'Changes in excitability and impulse transmission following prolonged repetitive activity in normal subjects and patients with a focal nerve lesion', Brain, vol. 119, pp. 2029 - 2037, http://dx.doi.org/10.1093/brain/119.6.2029

Kiernan MJ; Mogyoros I; Burke DJ, 1996, 'Differences in the recovery of excitability in sensory and motor axons of human median nerve', Brain, vol. 119, pp. 1099 - 1105, http://dx.doi.org/10.1093/brain/119.4.1099

Miller TA; Kiernan MJ; Mogyoros I; Burke DJ, 1996, 'Activity-dependent changes in impulse conduction in focal nerve lesion', Brain, vol. 119, pp. 429 - 437, http://dx.doi.org/10.1093/brain/119.2.429

Meunier S; Mogyoros I; Kiernan MJ; Burke DJ, 1996, 'Effects of femoral nerve stimulation on the electromyogram and reflex excitability of tibialis anterior and soleus', Muscle and Nerve, vol. 19, pp. 1110 - 1115, http://dx.doi.org/10.1002/(SICI)1097-4598(199609)19:9<1110::AID-MUS5>3.0.CO;2-2

Mogyoros I; Kiernan MJ; Burke DJ, 1996, 'Strength-duration properties of human peripheral nerve', Brain, vol. 119, pp. 439 - 447, http://dx.doi.org/10.1093/brain/119.2.439

Mogyoros I; Kiernan MJ; Gracies J; Burke DJ, 1996, 'The effect of stimulus duration on the latency of submaximal nerve', Muscle and Nerve, vol. 19, pp. 1354 - 1356, http://dx.doi.org/10.1002/(SICI)1097-4598(199610)19:10<1354::AID-MUS18>3.0.CO;2-U

Burke D; Kiernan MC; Mogyoros I; Miller TA, 1996, 'W22 Activity-dependent conduction failure in a peripheral nerve lesion', Electroencephalography and Clinical Neurophysiology, vol. 99, pp. 340 - 340, http://dx.doi.org/10.1016/0013-4694(96)88429-x

Burke D; Miller TA; Kiernan MC; Mogyoros I, 1995, 'Activity-dependent modulation of excitability.', Muscle and Nerve, vol. 18, pp. 675 - 677

Vital C; Coquet M; Mazat JP; Valberg SJ; Nelson DA; Chaudhry V; Crawford TO; Clouston P; Triggs WJ; Gilmore RL; Burke D; Miller TA; Kiernan MC; Mogyoros I; Stys PK; Waxman SG, 1995, 'Letters to the editor', Muscle & Nerve, vol. 18, pp. 673 - 677, http://dx.doi.org/10.1002/mus.880180619

Miller TA; Kiernan MJ; Mogyoros I; Burke DJ, 1995, 'activity-dependent changes in impulse conduction in normal human cutaneous axons', Brain, vol. 118, pp. 1217 - 1224, http://dx.doi.org/10.1093/brain/118.5.1217

Miller TA; Mogyoros I; Kiernan MJ; Burke DJ, 1995, 'Reproducibility of a heteronymous monosynaptic reflex in biceps brachii', Electroencephalography and Clinical Neurophysiology, vol. 97, pp. 318 - 325, http://dx.doi.org/10.1016/0924-980X(95)00121-Z

Burke D; Meunier S; Mogyoros I; Kiernan M, 1995, 'PS-37-3 Heteronymous reflex connections in the human lower limb', Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control, vol. 97, pp. S178 - S178, http://dx.doi.org/10.1016/0924-980x(95)93088-b

GERAGHTY JG; COVENEY EC; KIERNAN M; OHIGGINS NJ, 1992, 'FLOW VOLUME LOOPS IN PATIENTS WITH GOITERS', ANNALS OF SURGERY, vol. 215, pp. 83 - 86, http://dx.doi.org/10.1097/00000658-199201000-00013

Conference Papers

Wang C; Barton J; Klistorner A; Ly L; Beadnall HN; Reddel S; Kiernan MC; Barnett MH, 2017, 'Conduction velocity in demyelinated cerebral white matter: a structure-function correlation study in optic radiation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 305 - 306, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Beadnall HN; Wang C; Matamala JM; Hardy TA; Howells J; Dawes C; Garber J; Barton J; Reddel S; Kiernan MC; Barnett MH, 2017, 'Multiple sclerosis: structure-function correlations in the cerebral cortex', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 304 - 305, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Abt P; Rowin EJ; Maron B; Kiernan M; Vest A; Constantino F; Maron M; DeNofrio D, 2017, 'Heart Transplantation for Hypertrophic Cardiomyopathy: The Tufts Experience', in JOURNAL OF CARDIAC FAILURE, CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, TX, Dallas, pp. S23 - S24, presented at 21st Annual Scientific Meeting of the Heart-Failure-Society-of-America (HFSA), TX, Dallas, 16 September 2017 - 19 September 2017, http://dx.doi.org/10.1016/j.cardfail.2017.07.049

Noto Y; Simon NG; Shibuya K; Matamala JM; Darmadasa T; Kiernan MC, 2017, 'Dynamic bulbar muscle ultrasound identifies upper motor neuron involvement in amyotrophic lateral sclerosis', in JOURNAL OF THE NEUROLOGICAL SCIENCES, ELSEVIER SCIENCE BV, JAPAN, Kyoto, pp. 570 - 570, presented at 23rd World Congress of Neurology (WCN), JAPAN, Kyoto, 16 September 2017 - 21 September 2017, http://dx.doi.org/10.1016/j.jns.2017.08.1605

Shahrizaila N; Noto Y; Simon NG; Huynh W; Shibuya K; Matamala JM; Dharmadasa T; Devenney E; Kennerson ML; Nicholson GA; Kiernan MC, 2017, 'QUANTITATIVE MUSCLE ULTRASOUND AS A BIOMARKER IN CHARCOT-MARIE-TOOTH NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, SPAIN, Sitges, pp. 382 - 382, presented at Peripheral-Nerve-Society Meeting, SPAIN, Sitges, 08 July 2017 - 12 July 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500388&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Noto Y; Garg N; Li T; Timmins HC; Park SB; Shibuya K; Kiernan MC, 2017, 'THE FOREARM/UPPER ARM RATIOS OF CROSS-SECTIONAL AREA ADD THE DIAGNOSTIC VALUE IN AMYOTROPHIC LATERAL SCLEROSIS', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, SPAIN, Sitges, pp. 348 - 348, presented at Peripheral-Nerve-Society Meeting, SPAIN, Sitges, 08 July 2017 - 12 July 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chang F; Menon P; VanDen Bos M; Kiernan M; Vucic S; Fung V, 2017, 'Cortical excitability during a movement compared with postural control task in healthy subjects', in MOVEMENT DISORDERS, WILEY, CANADA, Vancouver, presented at 21st International Congress of Parkinson's Disease and Movement Disorders, CANADA, Vancouver, 04 June 2017 - 08 June 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402672303167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dharmadasa T; Matamala JM; Simon NG; Noto Y; Howells J; Wang C; Barnett M; Vucic S; Kiernan MC, 2017, 'PHENOTYPIC VARIABILITY IN MND: CLUES TO SITE OF ORIGIN AND PATTERNS OF DISEASE SPREAD', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.4

Van den Bos MAJ; Geevasinga N; Menon P; Kiernan MC; Vucic S, 2017, 'IMBALANCE IN CORTICAL INHIBITION-EXCITATION NETWORKS UNDERLIES ALS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.19

Ahmed RM; Landin-Romero R; Collette T-H; Van der Klaauw A; Devenney E; Henning E; Piguet O; Farooqi S; Hodges JR; Kiernan MC, 2017, 'ENERGY EXPENDITURE IN FRONTOTEMPORAL DEMENTIA: A BEHAVIOURAL AND IMAGING STUDY', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.22

Zarog MA; Kiernan MG; Coffey SC; Bolger JC; O'Leary PD; Tibbitts P; Lowry A; Byrnes GJ; Coffey JC, 2017, 'Circulating fibrocytes are an accurate diagnostic biomarker for uncomplicated appendicitis', in IRISH JOURNAL OF MEDICAL SCIENCE, SPRINGER LONDON LTD, pp. S92 - S92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397196100071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan MG; Sahebally SM; Jarrar A; Burke JP; Hogan J; Kiely PA; Shen B; Waldron D; Moloney M; Hogan N; Skelly M; Hidayat H; Faul PN; Mulcahy E; Healy V; O'Leary DP; Lowery A; Walsh LG; O'Connell PR; Martin S; Shanahan F; Fiocchi C; Dunne C; Coffey JC, 2017, 'The mesentery - antagonist in Crohn's Disease?', in BRITISH JOURNAL OF SURGERY, WILEY, IRELAND, Royal Coll Surg Ireland, Dublin, pp. 22 - 23, presented at Annual Meeting of the Society-of-Academic-and-Research-Surgery (SARS), IRELAND, Royal Coll Surg Ireland, Dublin, 18 January 2017 - 19 January 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398842600055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Esposito ML; Annamalai S; O'Kelly R; Zisa D; Kuchibhotla S; Pham DT; Kiernan M; DeNofrio D; Vest AR; Kapur NK, 2016, 'Defining Hemodynamic Profiles and Outcomes Associated with Cardiogenic Shock and Acute Mechanical Circulatory Support', in JOURNAL OF CARDIAC FAILURE, CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, FL, Kissimmee, pp. S121 - S121, presented at 20th Annual Scientific Meeting of the Heart-Failure-Society-of-America, FL, Kissimmee, 17 September 2016 - 20 September 2016, http://dx.doi.org/10.1016/j.cardfail.2016.06.377

Garg N; Park SB; Howells J; Yiannikas C; Huynh W; Vucic S; Krishnan A; Spies J; Mathey EK; Pollard JD; Kiernan MC, 2016, 'DIFFERENCES IN RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE-MEDIATED NEUROPATHY: THE IMPORTANCE OF CONDUCTION BLOCK', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, SCOTLAND, Univ Glasgow, Glasgow, pp. 175 - 175, presented at Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and Ceilidh, SCOTLAND, Univ Glasgow, Glasgow, 21 June 2016 - 24 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383856200055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim SD; Vucic S; Mahant N; Kiernan MC; Fung VSC, 2016, 'Cortical excitability in patients with Parkinson's disease on levodopa carbidopa intestinal gel thereapy', in MOVEMENT DISORDERS, WILEY-BLACKWELL, GERMANY, Berlin, pp. S434 - S434, presented at 20th International Congress of Parkinson's Disease and Movement Disorders, GERMANY, Berlin, 19 June 2016 - 23 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382559802088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lavrov A; Meininger V; Genge A; Van den Berg LH; Robberecht W; Ludolph A; Chio A; Kim SH; Leigh N; Kiernan M; Shefner J; Desnuelle C; Morrison KE; Petri S; Boswell D; Temple J; Mohindra R; Davies M; Bullman J; Rees P, 2015, 'A Phase II Study of Ozanezumab in Amyotrophic Lateral Sclerosis', in ANNALS OF NEUROLOGY, WILEY-BLACKWELL, IL, Chicago, pp. S114 - S114, presented at 140th Annual Meeting of the American-Neurological-Association, IL, Chicago, 27 September 2015 - 29 September 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362668600349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Menezes MP; Farrar M; Burns J; Birman C; Gardener-Berry K; Kiernan M; Vucic S; Ouvrier R, 2015, 'RIBOFLAVIN TRANSPORTER MUTATIONS CAUSING BROWN-VIALETTO-VAN LAERE SYNDROME: UNIQUE CLINICAL AND AUDIOLOGICAL PROFILE, PATHOPHYSIOLOGY AND BENEFIT FROM RIBOFLAVIN', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, CANADA, Quebec, pp. 192 - 193, presented at Biennial Meeting of the Peripheral-Nerve-Society, CANADA, Quebec, 27 June 2015 - 02 July 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360214600274&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Huynh W; Vucic S; Krishnan A; Lin C; Kiernan M, 2014, 'Exploring the evolution of cortical excitability following acute stroke', in INTERNATIONAL JOURNAL OF STROKE, WILEY-BLACKWELL, pp. 176 - 177, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345767700494&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sahebally S; Kiernan M; Burke J; Dunne C; O'Connell R; Martin S; Coffey JC, 2014, 'Circulating Fibrocytes in Crohn's Disease: Novel Biomarker of Disease Severity', in IRISH JOURNAL OF MEDICAL SCIENCE, SPRINGER LONDON LTD, pp. S248 - S248, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341086600080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim SD; Vucic S; Mahant N; Kiernan MC; Fung VSC, 2014, 'Hand dominance influences side-side differences in tapping speeds but not SICI in normal subjects', in MOVEMENT DISORDERS, WILEY-BLACKWELL, SWEDEN, Stockholm, pp. S200 - S200, presented at 18th International Congress of Parkinson's Disease and Movement Disorders, SWEDEN, Stockholm, 08 June 2014 - 12 June 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337693401146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Simon NG; Lee M; Howells J; Vucic S; Lin C; Kiernan MC, 2013, 'The soleus H-reflex delineates upper motor neurone pathophysiology in amyotrophic lateral sclerosis.', in The soleus H-reflex delineates upper motor neurone pathophysiology in amyotrophic lateral sclerosis., 24th international symposium on ALS/MND, presented at 24th international symposium on ALS/MND, 06 December 2013 - 08 December 2013, http://dx.doi.org/10.3109/21678421.2013.838426

Kwai N; Arnold R; Poynten A; Lin C; Kiernan MC; Krishnan A, 2013, 'Insulin pump therapy in type 1 diabetes: Potential to be neuroprotective', in Clinical Neurophysiology, Gold Coast, Queensland, pp. e1 - e2, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.024

Arnold R; Kwai N; Pussell BA; Lin CS-Y; Kiernan MC; Krishnan AV, 2013, 'Effects of neuropathy on physical function and quality of life in moderate severity chronic kidney disease', in Clinical Neurophysiology, ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, pp. e4 - e4, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.031

Sahebally S; Kiernan M; Burke J; Walsh S; Dunne C; Kiely P; Coffey C, 2013, 'Fibroblasts and their Precursors Can be Generated from Mesocolic Mesothelium; Implications for Intraperitoneal Fibrotic Diseases', in IRISH JOURNAL OF MEDICAL SCIENCE, SPRINGER LONDON LTD, pp. S351 - S351, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324335400099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Menezes MP; Farrar MA; Burns J; Menon P; Webster R; Antony J; Kiernan MC; Vucic S, 2013, 'PERIPHERAL MOTOR CONTRIBUTIONS TO THE PATHOPHYSIOLOGY OF BVVL-RELATED MUTATIONS IN RIBOFLAVIN TRANSPORTER 3: PATHOPHYSIOLOGICAL INSIGHTS FROM NERVE EXCITABILITY TESTING', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, FRANCE, Saint Malo, pp. 71 - 72, presented at Meeting of the Peripheral-Nerve-Society, FRANCE, Saint Malo, 29 June 2013 - 03 July 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320620200182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin CSY; Farrar M; Kiernan M, 2013, 'HOW DO NERVES RESPOND TO PRESSURE? HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES (HNPP)', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, FRANCE, Saint Malo, pp. 63 - 63, presented at Meeting of the Peripheral-Nerve-Society, FRANCE, Saint Malo, 29 June 2013 - 03 July 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320620200160&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dyck PJB; Tracy JA; Kiernan M; Dyck PJ; Crum BA; Mauermann ML; Amrami KK; Spinner RJ; Taylor B, 2013, 'UNIQUE NERVE PATHOLOGY DISTINGUISHES FOCAL MOTOR CIDP FROM MULTIFOCAL MOTOR NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, FRANCE, Saint Malo, pp. 34 - 34, presented at Meeting of the Peripheral-Nerve-Society, FRANCE, Saint Malo, 29 June 2013 - 03 July 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320620200087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Simon NG; lee M; Howells J; Vucic S; Lin C; Kiernan MC, 2013, 'Pathophysiological Changes in the H-Reflex Pathway in Amyotrophic Lateral Sclerosis.', in Neurology, LIPPINCOTT WILLIAMS & WILKINS, San Diego, pp. P07.075, presented at AAN Annual Scientific Meeting, San Diego, 16 March 2013 - 23 March 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332068605057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Simon NG; Bae JS; Mioshi E; Lin CSY; Vucic S; Kiernan MC, 2013, 'The split leg in amyotrophic lateral sclerosis.', in Neurology, LIPPINCOTT WILLIAMS & WILKINS, San Diego, pp. P07.083, presented at AAN Annual Scientific Meeting, San Diego, 16 March 2013 - 23 March 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332068605065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Lillo P; Mioshi E; Burrell J; Kiernan M; Hodges J; Hornberger M, 2012, 'The FTD-ALS Continuum: Evidence from Grey and White Matter Neuroimaging', in DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, KARGER, ENGLAND, Manchester, pp. 134 - 135, presented at 8th International Conference on Frontotemporal Dementias, ENGLAND, Manchester, 05 September 2012 - 07 September 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308612400195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Burrell J; Hornberger M; Carpenter RHS; Kiernan MC; Hodges JR, 2012, 'Disinhibition of "early" saccades in frontotemporal dementia', in DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, KARGER, ENGLAND, Manchester, pp. 203 - 204, presented at 8th International Conference on Frontotemporal Dementias, ENGLAND, Manchester, 05 September 2012 - 07 September 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308612400294&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Arnold R; Pussell BA; Grinius V; Kiernan MC; Lin CS-Y; Krishnan AV, 2012, 'EVIDENCE FOR A CAUSAL RELATIONSHIP BETWEEN NERVE DYSFUNCTION AND HYPERKALAEMIA IN END-STAGE KIDNEY DISEASE', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, FRANCE, Paris, pp. 70 - 70, presented at 49th Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), FRANCE, Paris, 24 May 2012 - 27 May 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311494700155&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ramanathan S; Korgaonkar M; Grieve S; Gomes L; Burke T; Lenton K; Kiernan M; Vucic S, 2012, 'Cortical Atrophy Underlies Disability Development in Multiple Sclerosis', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, LA, New Orleans, presented at 64th Annual Meeting of the American-Academy-of-Neurology (AAN), LA, New Orleans, 21 April 2012 - 28 April 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000303204801533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Arnold R; Pussell BA; Pianta T; Lin CS-Y; Kiernan MC; Krishnan AV, 2012, 'Effects of Calcineurin Inhibitor Treatment on Peripheral Nerve Function in Renal Transplant Recipients', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, pp. 116 - 116, presented at American Transplant Congress, MA, Boston, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000303235500304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Arnold R; Kwai N; Poynten A; Lin CS-Y; Kiernan MC; Krishnan AV, 2011, 'Altered axonal excitability in asymptomatic type 1 diabetic patients', in Clinical Neurophysiology, ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, pp. e73 - e73, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 02 October 2011 - 05 October 2011, http://dx.doi.org/10.1016/j.clinph.2011.11.023

Buckley C; Pettingill P; Pettingill R; Kiernan M; Watanabe O; Irani S; Waters P; Vincent A, 2011, 'Antibodies to the VGKC-Complex Proteins LGI1 and CASPR2 in Acquired Neuromyotonia', in ANNALS OF NEUROLOGY, WILEY-BLACKWELL, CA, San Diego, pp. S69 - S69, presented at 136th Annual Meeting of the American-Neurological-Association (ANA), CA, San Diego, 25 September 2011 - 27 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000296419500269&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2011, 'A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S436 - S436, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, SWEDEN, Stockholm, 23 September 2011 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71792-0

Bennett BK; Goldstein D; Friedlander M; Park SB; Kiernan MG, 2011, 'Oxaliplatin-induced Neurotoxicity - Comparing Four Methods of Assessment', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S234 - S234, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, SWEDEN, Stockholm, 23 September 2011 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71114-5

Arnold R; Kwai N; Lin CSY; Kiernan MC; Krishnan A, 2011, 'EVIDENCE FOR DISTINCT PATTERNS OF AXONAL EXCITABILITY BETWEEN TYPE 1 AND TYPE 2 DIABETIC NERVES', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY-BLACKWELL, MD, Potomac, pp. S5 - S5, presented at Meeting of the Peripheral-Nerve-Society, MD, Potomac, 25 June 2011 - 29 June 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293510300011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Arnold R; Pianta T; Lin CS-Y; Pussell B; Grinius V; Kiernan MC; Jardine M; Krishnan AV, 2011, 'P4.17 Novel neurophysiological insights into uraemic neuropathy: implications for clinical trials', in Clinical Neurophysiology, European Congress of Clinical Neurophysiology, Rome, Italy, pp. S75 - S75, presented at European Congress of Clinical Neurophysiology, Rome, Italy, 21 June 2011 - 25 June 2011, http://dx.doi.org/10.1016/S1388-2457(11)60256-3

Burrell JR; Vucic S; Kiernan MC, 2011, 'Isolated Bulbar Palsy Phenotype of Amyotrophic Lateral Sclerosis', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, HI, Honolulu, pp. A409 - A409, presented at 63rd AAN Annual Meeting, HI, Honolulu, 09 April 2011 - 16 April 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288149302182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim SD; Fung VSC; Kiernan MC; Vucic S, 2011, 'Interhemispheric differences in cortical excitability in Parkinson's disease', in MOVEMENT DISORDERS, WILEY-BLACKWELL, CANADA, Toronto, pp. S38 - S39, presented at 15th International Congress of Parkinsons Disease and Movement Disorders, CANADA, Toronto, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291359500116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jardine M; Krishnan A; Gallagher M; Snelling P; Hawley C; Pussell B; Suranyi M; Perkovic V; Kiernan M; Eris J, 2010, 'URAEMIC NEUROPATHY REMAINS UBIQUITIOUS: RATIONALE AND FEASIBILITY OF THE FINESSE (FILTRATION IN THE NEUROPATHY OF END STAGE KIDNEY DISEASE SYMPTOM EVOLUTION) TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. 88 - 88, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim SD; Vucic S; Kiernan MC; Fung VSC, 2010, 'Dysfunction of cortical inhibitory circuits in stiff-man syndrome', in MOVEMENT DISORDERS, WILEY-LISS, ARGENTINA, Buenos Aires, pp. S219 - S219, presented at 14th International Congress of Parkinsons Disease and Movement Disorders, ARGENTINA, Buenos Aires, 13 June 2010 - 17 June 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000278341100097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Talman P; Kiernan MC; Rowe DB; Henderson RD; Edis R; Thyagarajan D; Mathers S; Mccombe P, 2010, 'Australian Motor Neuron Disease Registry 5 year Follow-Up', in Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010: Leaps and Bounds, Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010, Melbourne, presented at Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010, Melbourne, 17 May 2010 - 20 May 2010

Vucic S; Cheah B; Kiernan MC, 2010, 'Central Mechanisms Underlying Fatigue in Amyotrophic Lateral Sclerosis', in Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010: Leaps and Bounds, Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010, Melbourne, presented at Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010, Melbourne, 17 May 2010 - 20 May 2010

Toprak D; Friedlander PL; Kiernan MP, 2010, 'CRICOID CALCIFICATION MIMICKING A FOREIGN BODY IN THE AIRWAY IN A CHILD', in JOURNAL OF INVESTIGATIVE MEDICINE, LIPPINCOTT WILLIAMS & WILKINS, LA, New Orleans, pp. 414 - 414, presented at Southern Regional Meeting 2010, LA, New Orleans, 25 February 2010 - 27 February 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000274499600214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Farrar M; Lin CS-Y; Krishnan AV; Park SB; Andrews PI; Kiernan MC, 2010, 'Acute, reversible axonal energy failure during a stroke-like episode in MELAS', in Small D (ed.), 30th Annual Meeting of the Australian Neuroscience Society, Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, pp. 160 - 160, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010

Krishnan AV; Park SB; Lin CS-Y; Zagami A; Kiernan MC, 2010, 'Topiramate modulates axonal ion channel function in vivo.', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 -

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Lewis C; Kiernan MC, 2010, 'Pathophysiology of paclitaxel-induced neurotoxicity', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 160 - 160, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010

Kiernan MC, 2009, 'Marine toxin poisoning', in JOURNAL OF THE NEUROLOGICAL SCIENCES, ELSEVIER SCIENCE BV, THAILAND, Bangkok, pp. S50 - S51, presented at 19th World Congress of Neurology, THAILAND, Bangkok, 24 October 2009 - 30 October 2009, http://dx.doi.org/10.1016/S0022-510X(09)70237-0

Lin CS-Y; Krishnan AV; Zagami AS; Lee M; Kiernan MC, 2009, 'Neurotoxicity in acute intermittent porphyria - understand the madness of King George', in Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2010: Leaps and Bounds, Australian Neuroscience Society 29th Annual Meeting, Canberra, presented at Australian Neuroscience Society 29th Annual Meeting, Canberra, 27 January 2009 - 30 January 2009

Lin C; Krishnan AV; Lee M; Zagami AS; Kiernan MC; Bostock H, 2009, 'INSANE IN THE MEMBRANE: ION CHANNEL DYSFUNCTION IN PORPHYRIC NEUROPATHY', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, pp. 89 - 89, presented at Annual Meeting of the Peripheral-Nerve-Society, Wurzburg, GERMANY, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269527000202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Lin C; Krishnan AV; Kiernan MC; Park SB, 2009, 'EFFECTS OF IMMUNOTHERAPY ON NERVE EXCITABILITY IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, pp. 89 - 90, presented at Annual Meeting of the Peripheral-Nerve-Society, Wurzburg, GERMANY, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269527000203&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Vucic O; Burke T; Yiannikas C; Kiernan MC, 2009, 'Cortical dysfunction in multiple sclerosis - developing a biomarker of disease severity', in Multiple Sclerosis, Arnold, London, England, pp. S117 - S118, presented at 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Dusseldorf, GERMANY, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269652500349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2008, 'Early detection of oxaliplatin-induced neurotoxicity: Getting it before it hurts', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.15015

Vucic S; Kiernan MC, 2007, 'Cortical excitability testing in Kennedy's disease', in MUSCLE & NERVE, JOHN WILEY & SONS INC, AZ, Phoenix, pp. 574 - 574, presented at 54th Annual Meeting of the American-Association-of-Neuromuscular-and-electrodiagnostic-Medicine, AZ, Phoenix, 17 October 2007 - 20 October 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249842300079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vucic O; Kiernan MC, 2006, 'The flail-limb variant of motor neurone disease', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 1033 - 1033, presented at Australian Association of Neurologists Annual Scientific Meeting 2006, Canberra, 01 May 2006 - 05 May 2006

Talman P; Rowe D; Kiernan M, 2005, 'Australian Motor Neurone Disease Registry (AMNDR)', in JOURNAL OF THE NEUROLOGICAL SCIENCES, ELSEVIER, AUSTRALIA, Sydney, pp. S214 - S214, presented at 18th World Congress of Neurology, AUSTRALIA, Sydney, 05 November 2005 - 11 November 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088002073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Kiernan MC, 2004, 'Nerve excitability properties in uremic neuropathy', in MUSCLE & NERVE, JOHN WILEY & SONS INC, GA, Savannah, pp. 521 - 522, presented at 51st Annual Meeting of the American-Association-of-Electrodiagnostic-Medicine (AAEM), GA, Savannah, 03 November 2004 - 06 November 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224116900041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krishnan AV; Lin CS; Kiernan MC, 2004, 'Excitability differences of lower limb motor axons exposed to ischemia', in MUSCLE & NERVE, JOHN WILEY & SONS INC, GA, Savannah, pp. 527 - 528, presented at 51st Annual Meeting of the American-Association-of-Electrodiagnostic-Medicine (AAEM), GA, Savannah, 03 November 2004 - 06 November 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224116900057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Walters RJL; Kiernan MC; Taube D; Andersen KV; Murray NMF; Bostock H, 2002, 'Axonal depolarisation in chronic renal failure', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, B M J PUBLISHING GROUP, pp. 235 - 235, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177059900142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Burke DJ; Kiernan MC; Mogyoros I, 1998, 'Mechanisms of conduction slowing in carpal tunnel syndrome', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S95 - S95, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998

Burke DJ; Mogyoros I; Kiernan MC, 1998, 'Activity-dependentconduction block in human axons', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S78 - S78, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998

Mogyoros I; Kiernan MC; Burke DJ, 1998, 'Pathophysiology of entrapment and compression neuropathies', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S81 - S81, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998

Kiernan MC; Mogyoros I; Hales JP; Gracies J; Burke DJ, 1997, 'Excitability changes and paraesthesiae following high-frequency stimulation of human cutaneous afferents', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 39 - 39, presented at 14th International Cong EEG and Clin Neurophysiol, Florence, Italy, 24 August 1997 - 30 August 1997

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1997, 'Axonal ion channel abnormality in amyotrophic lateral sclerosis', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 167 - 168, presented at 14th International Cong EEG and Clin Neurophysiol, Florence, Italy, 24 August 1997 - 30 August 1997

Kiernan MC; Hales JP; Gracies J; Mogyoros I; Burke DJ, 1997, 'Vagrant behaviour of hyperstimulated cutaneous afferent axons: a mechanism for paraesthesiae', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 397 - 397, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1997, 'Ion channel abnormality in motor axons in amyotrophic lateral sclerosis', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 402 - 403, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1996, 'Strength-duration properties of cutaneous afferents in motor neuron disease', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 62P - 62P, presented at 7th Biennial Clin Neurophysiol Workshop, Southport, Qld, 30 September 1996 - 02 October 1996

GERAGHTY JG; COVENEY EC; KIERNAN M; OHIGGINS NJ, 1992, 'A COMPARISON OF PLAIN RADIOLOGY AND FLOW VOLUME LOOP CURVES IN PATIENTS WITH GOITERS', in JOURNAL OF PHYSIOLOGY-LONDON, CAMBRIDGE UNIV PRESS, pp. P432 - P432, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992HD60500423&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Han SH; Lin CS-Y; Boland R; Kiernan MC, 2010, 'The effects of focal nerve compression in carpal tunnel syndrome', in The effects of focal nerve compression in carpal tunnel syndrome, 11th Triennial Congress of the International Federation of Societies for Surgery of the Hand, Seoul, Korea, presented at 11th Triennial Congress of the International Federation of Societies for Surgery of the Hand, Seoul, Korea, 31 October 2010 - 04 November 2010

Kiernan MC, 2010, 'Hyperexcitability, persistent Na+ conductances and ndurodegeneration in motor neurone disease', in Hyperexcitability, persistent Na+ conductances and ndurodegeneration in motor neurone disease, Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010

Cheah BC; Boland R; Jeffrey S; Mckenzie DK; Kiernan MC, 2008, 'Inspirational (Inspiratory Training in Amyotrophic Lateral Sclerosis)', in Amyotrophic Lateral Sclerosis, Brisbane, Vol. 10, pp. 384 - 392, presented at Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2008, Brisbane, 19 May 2008 - 23 May 2008, http://dx.doi.org/10.3109/17482960903082218

Conference Abstracts

Farrar MA; Tomlinson SE; Howells J; Lin CS-Y; Carey K; Park SB; Hollingsworth G; Lawson JA; Kiernan MC; Berkovic SF; Burke D; Scheffer IE, 2019, '009 Axonal excitability properties in dravet’s syndrome reflect effect of loss of sodium channels', in Journal of Neurology, Neurosurgery & Psychiatry, BMJ, Vol. 90, pp. A4.1 - A4, http://dx.doi.org/10.1136/jnnp-2019-anzan.9

Timmins HC; Li T; Kiernan MC; Horvath LG; Harrison M; Grimison P; Cox KM; Boyle FM; Goldstein D; Park SB, 2017, 'NEUROPHYSIOLOGICAL MEASURES CORRELATE WITH PATIENT REPORTED SYMPTOMS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, SPAIN, Sitges, Vol. 22, pp. 395 - 396, presented at Peripheral-Nerve-Society Meeting, SPAIN, Sitges, 08 July 2017 - 12 July 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Geevasinga N; Korgaonkar M; Menon P; Van den Bos M; Gomes L; Forster S; Kiernan M; Vucic S, 2017, 'FUNCTIONAL AND STRUCTURAL CONNECTIVITY IN ALS: INSIGHTS FROM MRI CONNECTOME ANALYSES AND TMS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.21

Menon P; Geevasinga N; Van den Bos M; Yiannikas C; Kiernan MC; Vucic S, 2017, 'CORTICAL HYPEREXCITABILITY MAY CONTRIBUTE TO DISEASE SPREAD IN ALS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.20

Tan R; Kiernan M; Kril J; Hasegawa M; Masada-Suzukake M; Dobson-Stone C; Kwok J; Hornberger M; Hodges J; Halliday G, 2016, 'TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, GERMANY, Munich, Vol. 138, pp. 367 - 367, presented at 10th International Conference on Frontotemporal Dementias, GERMANY, Munich, 31 August 2016 - 02 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382568400375&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Theses / Dissertations

Kiernan MC, 1997, Activity-dependent changes in axonal excitability

Preprints

Willemse SW; Roes KCB; Damme PV; Hardiman O; Ingre C; Povedano M; Wray NR; Gijzen M; de Pagter MS; Demaegd KC; Janse AFC; Vink RC; Sleutjes BTHM; Chiò A; Corcia P; Reviers E; Al-Chalabi A; Kiernan MC; Berg LHVD; Es MAV; Eijk RPAV, 2022, Lithium carbonate in Amyotrophic Lateral Sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A; protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial., http://dx.doi.org/10.21203/rs.3.rs-2125381/v1

Haidar M; Viden A; Cuic B; Wang T; Rosier M; Tomas D; Mills SA; Govier-Cole A; Djouma E; Luikinga S; Rytova V; Barton SK; Gonsalvez DG; Palmer LM; McLean C; Kiernan MC; Vucic S; Turner BJ, 2021, Cortical hyperexcitability drives dying forward ALS symptoms and pathology in mice, http://dx.doi.org/10.1101/2021.08.13.456320

Hop PJ; Zwamborn RAJ; Hannon E; Shireby GL; Nabais MF; Walker EM; van Rheenen W; van Vugt JJFA; Dekker AM; Westeneng H-J; Tazelaar GHP; van Eijk KR; Moisse M; Baird D; Khleifat AA; Iacoangeli A; Ticozzi N; Ratti A; Cooper-Knock J; Morrison KE; Shaw PJ; Basak AN; Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Grassano M; Gotkine M; Lerner Y; Zabari M; Vourc’h P; Corcia P; Couratier P; Mora Pardina JS; Salas T; Dion P; Ross JP; Henderson RD; Mathers S; McCombe PA; Needham M; Nicholson G; Rowe DB; Pamphlett R; Mather KA; Sachdev PS; Furlong S; Garton FC; Henders AK; Lin T; Ngo ST; Steyn FJ; Wallace L; Williams KL; Neto MM; Cauchi RJ; Blair IP; Kiernan MC; Drory V; Povedano M; de Carvalho M; Pinto S; Weber M; Rouleau G; Silani V; Landers JE; Shaw CE; Andersen PM; McRae AF; van Es MA; Pasterkamp RJ; Wray NR; McLaughlin RL; Hardiman O; Kenna KP; Tsai E; Runz H; Al-Chalabi A; van den Berg LH; Damme PV; Mill J; Veldink JH, 2021, Genome-wide study of DNA methylation in Amyotrophic Lateral Sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways, http://dx.doi.org/10.1101/2021.03.12.21253115

Henden L; Twine NA; Szul P; McCann EP; Nicholson GA; Rowe DB; Kiernan MC; Bauer DC; Blair IP; Williams KL, 2019, IBD analysis of Australian amyotrophic lateral sclerosis SOD1-mutation carriers identifies five founder events and links sporadic cases to existing ALS families, http://dx.doi.org/10.1101/685925

Gold J; Rowe DB; Kiernan MC; Vucic S; Mathers S; van Eijk RP; Nath A; Garcia Montojo M; Norato G; Santamaria UA; Rogers M-L; Malaspina A; Lombardi V; Mehta PR; Westeneng H-J; van den Berg LH; Al-Chalabi A, Safety and Tolerability of Triumeq in Amyotrophic Lateral Sclerosis: The Lighthouse Trial, http://dx.doi.org/10.2139/ssrn.3347916

Other

Geevasinga N; Menon P; Scherman DB; Simon N; Yiannikas C; Henderson RD; Kiernan MC; Vucic S, 2017, Author response: Diagnostic criteria in amyotrophic lateral sclerosis: A multicenter prospective study, http://dx.doi.org/10.1212/WNL.0000000000003628

Find a Person

Quick Links

	Scholarships
	Contact Us